-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 SXthNR63dhuPsF87237SvePLakpRu5Y5xw8WuX8EBexiKj5Ml6M2YHsVQ9fbTOAq
 3njq+zA70PwmiVQ68NaNoQ==

<SEC-DOCUMENT>0001167379-10-000197.txt : 20101216
<SEC-HEADER>0001167379-10-000197.hdr.sgml : 20101216
<ACCEPTANCE-DATETIME>20101216153629
ACCESSION NUMBER:		0001167379-10-000197
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20101216
FILED AS OF DATE:		20101216
DATE AS OF CHANGE:		20101216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALCON INC
		CENTRAL INDEX KEY:			0001167379
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		IRS NUMBER:				980205094
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31269
		FILM NUMBER:		101256362

	BUSINESS ADDRESS:	
		STREET 1:		6201 SOUTH FREEWAY
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76134
		BUSINESS PHONE:		8175686248

	MAIL ADDRESS:	
		STREET 1:		BOSCH 69 6331 HUNENBERG
		CITY:			SWITZERLAND
		STATE:			V8
		ZIP:			0000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>acl6k1216finalmerger.htm
<TEXT>
<html>
<head>
    <title>acl6k1216finalmerger.htm</title>
    <!-- Licensed to: Alcon -->
    <!-- Document Created using EDGARizer 5.3.0.0 -->
    <!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>


<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<br>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UNITED STATES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Washington, D.C. 20549</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form 6-K</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For the month of <font style="DISPLAY: inline; FONT-WEIGHT: bold">December 2010</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Commission File Number 001-31269</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ALCON, INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Translation of registrant's name into English)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B&#246;sch 69</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">P.O. Box 62</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6331 H&#252;nenberg, Switzerland</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;41-41-785-8888</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Address of principal executive offices)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Form 20-F</font></div>
</td>
<td valign="top" width="2%" style="BORDER-TOP: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">x</font></div>
</td>
<td align="left" valign="top" width="9%" style="BORDER-LEFT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Form 40-F</font></div>
</td>
<td valign="top" width="2%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-TOP: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1): ____</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (7): ____</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Yes</font></div>
</td>
<td valign="top" width="2%" style="BORDER-TOP: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="9%" style="BORDER-LEFT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">No</font></div>
</td>
<td valign="top" width="2%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-TOP: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">x</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ______</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Attached as Exhibit 99.1 is the Merger Agreement.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SIGNATURES</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Alcon, Inc.</font></div>
</td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Registrant)</font></div>
</td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date:&#160; </font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 16, 2010</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:&#160; </font></div>
</td>
<td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Stefan Basler&#160; </font></td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name: Stefan Basler</font></div>
</td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title: Attorney-in-fact</font></div>
</td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date:&#160; </font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 16, 2010</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:&#160; </font></div>
</td>
<td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Patrick Bachmann&#160; </font></td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name: Patrick Bachmann</font></div>
</td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title: Attorney-in-fact</font></div>
</td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>acl6k1216finalmergerex991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
<head>
    <title>acl6k1216finalmergerex991.htm</title>
    <!-- Licensed to: Alcon -->
    <!-- Document Created using EDGARizer 5.3.0.0 -->
    <!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>


<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="56%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Merger Agreement</font></div>
</td>
</tr><tr>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="56%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 11.3pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Of</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="56%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 14, 2010</font></div>
</td>
</tr><tr>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="56%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 11.3pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Between</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="56%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Novartis AG</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Company Number CH-270.3.002.061-2</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Lichtstrasse 35</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">CH-4056 Basel</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Switzerland</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">a company limited by shares (<font style="DISPLAY: inline; FONT-STYLE: italic">Aktiengesellschaft</font>) pursuant to art. 620 ff. CO having its seat in Basel (hereinafter &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Novartis</font>&#8221;)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
</tr><tr>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="56%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 11.3pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">And</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="56%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Alcon, Inc.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Company Number CH-170.3.017.372-9</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">B&#246;sch 69</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">CH-6331 H&#252;nenberg</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Switzerland</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">a company limited by shares (<font style="DISPLAY: inline; FONT-STYLE: italic">Aktiengesellschaft</font>) pursuant to art. 620 ff. CO having its seat in H&#252;nenberg (hereinafter &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Alcon</font>&#8221;)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(each a &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Party</font>&#8221; and together the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Parties</font>&#8221;)</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Table of contents</font><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 38px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 24px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">1</font></font></div>
</td>
<td style="WIDTH: 492px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Merger</font></font></div>
</td>
<td width="632">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">1.1</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Agreement to Merge</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">1.2</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Merger Report and Merger Balance Sheet</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 39px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 24px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">2</font></font></div>
</td>
<td width="1123">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Exchange of Alcon Shares for Merger Consideration</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">2.1</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Merger Consideration</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">2.2</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Implementation of the Exchange</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">2.3</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Treatment of Certain Share Capital and Equity</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">2.4</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Share Register</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">2.5</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Cessation of Trading in Shares of Alcon</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 39px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 24px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">3</font></font></div>
</td>
<td width="1123">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Listing and Registration of Novartis Shares and Novartis ADSs</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">3.1</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Listing of Novartis Shares</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">3.2</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Listing of Novartis ADSs</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">3.3</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Registration of Novartis Shares</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 39px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 24px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">4</font></font></div>
</td>
<td width="1123">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Shareholders&#8217; Meetings</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">4.1</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Shareholders&#8217; Meeting of Novartis</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">4.2</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Shareholders&#8217; Meeting of Alcon</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 39px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 24px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">5</font></font></div>
</td>
<td width="1123">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Interim Covenants</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">5.1</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Merger Audit</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">5.2</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Listing</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">5.3</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Conduct of Business</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-ALIGN: right; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right;">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px; TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">5.4</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Announcements</font></font></div>
</td>
<td width="52">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">5.5</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Consultation of Employees</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">5.6</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Third Party Claims in Connection with the Merger</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">5.7</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Amendments to Alcon Incentive Plans</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">5.8</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Alcon Dividend</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">5.9</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Alcon Litigation Trust</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">5.10</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Directors&#8217; and Officers&#8217; Insurance</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">5.11</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Further Assurances</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">5.12</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Swiss Withholding Tax</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13</font></div>
</td>
</tr></table>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div>&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 39px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 24px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">6</font></font></div>
</td>
<td width="1123">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Validity and Completion</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">6.1</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Effectiveness of the Merger Agreement</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">6.2</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Subsequent Material Changes</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">6.3</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Conditions Precedent to the Merger</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">6.4</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Applications to the Commercial Register</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">6.5</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Completion</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">6.6</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Termination of the Merger Agreement</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 39px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 24px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">7</font></font></div>
</td>
<td width="1123">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Miscellaneous</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-ALIGN: right; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right;">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px; TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">7.1</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Confidentiality</font></font></div>
</td>
<td width="52">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-ALIGN: right; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right;">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px; TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">7.2</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Notices</font></font></div>
</td>
<td width="52">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">15</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">7.3</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Costs</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">15</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">7.4</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Modifications and Amendments, Right to Amend, Joint Negotiation</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">15</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">7.5</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Severability</font></font></div>
</td>
<td width="52" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">16</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-ALIGN: right; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right;">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px; TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">7.6</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Non-Assignment</font></font></div>
</td>
<td width="52">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">16</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-ALIGN: right; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right;">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px; TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">7.7</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Applicable Law and Jurisdiction</font></font></div>
</td>
<td width="52">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">16</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: right">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-ALIGN: right; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: right;">
<td style="WIDTH: 60px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 48px; TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">7.8</font></font></div>
</td>
<td width="1078">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Jurisdiction on Shareholders&#8217; Claims</font></font></div>
</td>
<td width="52">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">16</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">&#160;</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">&#160;</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div><br>
&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 47px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 113px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Exhibits</font></font></font></div>
</td>
<td width="1078">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 47px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 113px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 1.2(b)(i)</font></font></div>
</td>
<td width="1078">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Merger balance sheet of Novartis AG as of 30 September 2010</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 47px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 113px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 1.2(b)(ii)</font></font></div>
</td>
<td width="1078">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Merger balance sheet of&#160;Alcon, Inc.&#160;as of 30 September 2010</font></div>
</td>
</tr></table>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 47px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 113px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 2.2(a)</font></font></font></font></div>
</div>
</td>
<td width="1078">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Settlement Procedures</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 47px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 113px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 2.3(d)</font></font></div>
</td>
<td width="1078">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Equity Awards granted under the Alcon Incentive Plan</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 47px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 113px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 5.3</font></font></div>
</td>
<td width="1078">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Conduct of Business</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 47px">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 113px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 5.9</font></font></div>
</td>
<td width="1078">
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon Litigation Trust</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">&#160;</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>&#160;</div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;1</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">WHEREAS, Novartis proposed that Alcon merge into Novartis;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">WHEREAS the Parties then negotiated the terms of this merger agreement (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Merger Agreement</font>&#8221;);</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">WHEREAS, the Independent Director Committee of the Alcon Board has recommended that the Alcon Board approve the Merger Agreement; and</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">WHEREAS the boards of directors of both Parties have approved the execution of this Merger Agreement on the date hereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOW, THEREFORE, the Parties agree to enter into this Merger Agreement:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Merger</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.1&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Agreement to Merge</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Parties hereby agree that Novartis and Alcon shall merge pursuant to art. 3 para. 1 lit. a and art. 4 para.&#160;1 lit. a of the Swiss Federal Act on Mergers, Demergers, Conversion and Transfer of Assets and Liabilities (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Merger Act</font>&#8221;) (merger by absorption between two companies limited by shares) and in accordance with this Merger Agreement (hereinafter the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Merger</font>&#8221;). Novartis shall be the acquiring company which shall continue to operate, and Alcon shall be the transferring company which shall be dissolved upon Completion (as defined below). By operation of law, Alcon&#8217;s assets, liabilities and contracts shall be transferred to Novartis in their entirety (<font style="DISPLAY: inline; FON
T-STYLE: italic">Universalsukzession</font>).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.2&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Merger Report and Merger Balance Sheet</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Merger Report</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Novartis board of directors (the full board of directors of Novartis being referred to herein as the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Novartis Board</font>&#8221;) and the Alcon board of directors (the full board of directors of Alcon being referred to herein as the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Alcon Board</font>&#8221;) shall approve a joint merger report as set forth in art. 14 Merger Act (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Merger Report</font>&#8221;) as soon as practicable but no later than on 19 January 2011.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Merger Balance Sheet</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Merger shall be implemented on the basis of the non-consolidated, non-audited interim balance sheets <font style="DISPLAY: inline; FONT-STYLE: italic">(Zwischenabschl&#252;sse</font>), prepared under Swiss statutory accounting principles as of 30 September 2010 of Novartis and of Alcon, respectively (attached hereto as<font style="DISPLAY: inline; FONT-WEIGHT: bold"> Exhibit 1.2(b)(i)</font> and<font style="DISPLAY: inline; FONT-WEIGHT: bold"> Exhibit 1.2(b)(ii)</font>, respectively, each a &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Merger Balance Sheet</font>&#8221;). Each Merger Balance Sheet shall be superseded for purposes of this Merger Agreement by an audited balance sheet of Novartis or of Alcon, as the case may </font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;2</font></td>
</tr></table>
</div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">be, dated 31 December 2010 when such audited balance sheet becomes available, whereupon such audited balance sheet shall become the applicable Merger Balance Sheet.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Merger Consideration (as defined in section 2.1(a) (Stock Consideration and Put Option)) is not based on the Merger Balance Sheets but based on the factors enumerated in section 2.1(d) (Basis for Determining Merger Consideration). In the event that Completion (as described in section 6.5 (Completion)) occurs more than six months after the closing date of the Merger Balance Sheets, the Merger Balance Sheets shall be replaced by updated balance sheets (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Updated Merger Balance Sheets</font>&#8221;) in accordance with art. 11 Merger Act.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Effective Date Agreed between the Parties</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Upon the completion and effectiveness of the Merger (&#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Completion</font>&#8221;) and for the purpose of the non-consolidated financial statements of Novartis, the assets and liabilities of Alcon shall be booked in the Novartis non-consolidated balance sheet pursuant to Alcon&#8217;s Merger Balance Sheet or Alcon&#8217;s Updated Merger Balance Sheet, as the case may be, with retroactive effect as from and including January 1, 2011, or the relevant later date as agreed by the Parties hereto, and all acts and operations of Alcon as from such date shall be deemed to be conducted for Novartis&#8217; account and shall be recorded in the non-consolidated financial statements of Novartis.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exchange of Alcon Shares for Merger Consideration</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.1&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Merger Consideration</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Stock Consideration and Put Option</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the Merger, the shareholders of Alcon (with the exception of Novartis) shall receive for each registered Alcon Share with a nominal value of CHF 0.20 (each, an &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Alcon Share</font>&#8221;) issued and outstanding immediately prior to Completion the merger consideration described below (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Merger Consideration</font>&#8221;). The Merger Consideration shall have a value, determined in accordance with the definitions below, of USD 168 and shall be composed of:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i) the right to receive from Novartis a number of Novartis Shares (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Stock Consideration</font>&#8221;) equal to the Exchange Ratio (as defined below); and</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii) the right to receive from Novartis a cash-settled, non-transferable put option (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Put Option</font>&#8221;) exercisable for an amount equal to the Contingent Value Amount<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>(as defined in section 2.1(b) (Determination of the Merger Consideration)), without interest.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Parties have concluded, after seeking financial and legal advice, that the parameters of art. 7 para. 2 Merger Act are met with respect to the Merger Consideration.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;3</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>
</div>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Determination of the Merger Consideration</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The exchange ratio shall be the quotient, rounded to the nearest ten thousandth, or if there shall not be a nearest ten thousandth, the higher ten thousandth, obtained by dividing USD 168 by the Novartis Share Value (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Exchange Ratio</font>&#8221;); provided that the Exchange Ratio shall not be greater than 2.8; <font style="DISPLAY: inline; TEXT-DECORATION: underline">provided</font>, <font style="DISPLAY: inline; TEXT-DECORATION: underline">further</font>, that if the Novartis Share Value is less than USD 60, then the Exchange Ratio shall be the sum of (x) 2.8 plus (y) the Dividend Adjustment Factor.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Dividend</font> <font style="DISPLAY: inline; FONT-WEIGHT: bold">Adjustment Factor</font>&#8221; shall mean the quotient of (x) the product of (i) the Dividend Value Adjustment multiplied by (ii) 2.8 divided by (y) the Novartis Share Value.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">USD Dividend Value</font>&#8221; shall mean the amount of any Novartis cash dividend declared or paid after the date of this Merger Agreement (including the 2010 Novartis Annual Dividend) and on or prior to the Completion Date (as defined in section 6.5 (Completion)) per Novartis Share in Swiss Francs converted into US dollars on the basis of the USD/CHF spot rate prevailing at 4:30 pm (London time) on the last day of the Measurement Period (as defined in the definition of &#8220;Novartis Share Value&#8221;) reported on the Bloomberg Professional Service under function &#8220;BFIX.&#8221;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Dividend Value Adjustment</font>&#8221; shall mean the lesser of (i) the USD Dividend Value and (ii) USD 60 minus the Novartis Share Value.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">2010 Novartis Annual Dividend</font>&#8221; means the dividend with respect to Novartis Shares to be approved at the Novartis annual general meeting in 2011.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Novartis Share Value</font>&#8221; means the average of the Daily Novartis Share Values for each of the ten (10) Trading Days ending on (and including) the Trading Day prior to the date of the Alcon Shareholders&#8217; Meeting (such ten (10) Trading Days, the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Measurement Period</font>&#8221;) weighted by the total volume of trading in Novartis Shares as reported on the NOVN.VX VWAP page on the Bloomberg Professional Service each such Trading Day.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Daily Novartis Share Value</font>&#8221; means, for any Trading Day, the Daily Novartis VWAP for such Trading Day converted into US dollars on the basis of the USD/CHF London spot rate prevailing at 4:30 pm (London time) for such Trading Day reported on the Bloomberg Professional Service under function &#8220;BFIX&#8221; minus, for any Trading Day prior to the Ex-Dividend Date for any Novartis cash dividend declared or paid after the date of this Merger Agreement and on or prior to the Completion Date, the USD Dividend Value.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Daily Novartis VWAP</font>&#8221; means, for any Trading Day, the per share volume-weighted average price of Novartis Shares as reported on the NOVN.VX VWAP page (which prices are displayed in Swiss Francs) on the Bloomberg Professional Service in respect of the period from the open of trading on the relevant Trading Day to the close of such Trading Day.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Ex-Dividend Date</font>&#8221; means the date on which Novartis Shares first trade on the SIX Swiss Exchange without the right to the applicable dividend.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;4</font></td>
</tr></table>
</div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Stock Consideration Value</font>&#8221; means the product of (x) the Exchange Ratio and (y) the Novartis Share Value.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Contingent</font> <font style="DISPLAY: inline; FONT-WEIGHT: bold">Value Amount</font>&#8221; means an amount in US dollars equal to USD 168 minus the Stock Consideration Value. If the Stock Consideration Value is equal to or above USD 168, the Contingent Value Amount shall be zero.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Trading Day</font>&#8221; means a date on which trading occurs on the SIX Swiss Exchange.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Novartis Shares</font>&#8221; mean ordinary shares of Novartis with a nominal value of CHF 0.50 each.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Adjustment of Merger Consideration</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Merger Consideration shall be adjusted to reflect the economic effect of any share split, share combination, subdivision, reclassification, stock dividend, exchange of shares or similar transaction with respect to Alcon Shares or Novartis Shares that (i) is approved after the date hereof but prior to Completion and (ii) is entered into the commercial register, or has a record or effective date that occurs during such period.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Basis for Determining Merger Consideration</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Merger Consideration was agreed by the Parties after negotiations based on a variety of different factors including market capitalization and fundamental values of both companies and the proposed terms of the Merger Agreement including the structure of the merger consideration. Prior to the execution of this Merger Agreement, the Alcon Board and the Novartis Board received and considered fairness opinions with respect to the Merger Consideration.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Implementation of the Exchange</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Appointment and Duties of Exchange Agent</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Novartis shall appoint an Exchange Agent (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Exchange Agent</font>&#8221;) to implement the exchange of Alcon Shares for Merger Consideration in accordance with the terms set out in the agreement between Novartis and the Exchange Agent and this Merger Agreement, including <font style="DISPLAY: inline; FONT-WEIGHT: bold">Exhibit 2.2(a)</font>. Novartis will, to this effect, use reasonable best efforts to ensure that the Merger Consideration is credited to the Exchange Agent as promptly as practicable following Completion.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon shall provide to the Exchange Agent all information reasonably necessary for it to perform as specified in this Merger Agreement and as specified in any agreement with the Exchange Agent.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">&#160;</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;5</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>
</div>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Entitlement of Alcon Shareholders and Settlement</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The right to receive the Merger Consideration shall vest by operation of law in those record holders of Alcon Shares (each, an &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Alcon Shareholder</font>&#8221; and collectively, the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Alcon Shareholders</font>&#8221;) who hold Alcon Shares at Completion.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon Shareholders can, by returning a properly completed form of election (&#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Form of Election</font>&#8221;) to the Exchange Agent not later than five (5) Trading Days prior to the Alcon Shareholders' Meeting, elect to receive either Novartis Shares (listed on the SIX Swiss Exchange) or an equivalent number of receipts representing Novartis American Depository Shares (listed on the New York Stock Exchange), each Novartis American Depository Share representing one registered Novartis Share (hereinafter each a &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Novartis ADS</font>&#8221;). The number of Novartis ADSs to be received by any Alcon Shareholder who does not receive Novartis Shares is therefore equal to the number of Novartis Shares otherwise issuable to such Alcon Sha
reholder in accordance with Section 2.1.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In case no Form of Election is received, Alcon Shareholders with a registered address in Switzerland shall receive the Stock Consideration in the form of Novartis Shares; Alcon Shareholders with a registered address outside of Switzerland shall receive the Stock Consideration after Completion in the form of Novartis ADSs.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Settlement of Fractions</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each shareholder of record of Alcon (but not, for the avoidance of doubt, any beneficial owner of Alcon Shares) who, based on its shareholding at Completion and on the Merger Consideration, does not receive an integral number of Novartis Shares or Novartis ADSs shall receive rights corresponding to the resulting fraction (each a &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Fraction Right</font>&#8221;). The Exchange Agent shall (i) receive all Novartis Shares or Novartis ADSs not used for the share exchange in the Merger because of the existence of Fraction Rights and (ii) sell such shares or ADSs on behalf of the holders of Fraction Rights (on the SIX Swiss Exchange or the New York Stock Exchange, as applicable) and pass on the proceeds to such shareholders of record of Alcon in cash. This sale shall occur during a period o
f three Trading Days after Completion, as determined by Novartis in a manner reasonably designed to achieve the highest possible sale price.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exercise of Put Option</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the event that the Stock Consideration Value is less than USD 168, the Exchange Agent shall exercise all Put Options included in the Merger Consideration pursuant to section 2.1(a)(ii) (Stock Consideration and Put Option), and (if the Put Options are so exercised) the Exchange Agent shall in accordance with section 2.2(a) (Appointment and Duties of Exchange Agent) pay an amount in cash payable in USD equal to the applicable Contingent Value Amount per Alcon Share (net of applicable Swiss withholding tax) as part of the Merger Consideration in satisfaction of section 2.1(a)(ii) (Stock Consideration and Put Option). Each outstanding Put Option shall terminate and be of no further force and effect (i) following the payment of the Merger Consideration or (ii) in the event the Stock Consideration Value is greater than or equal to USD 168
.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;6</font></td>
</tr></table>
</div>

<div>&#160;</div>
</div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.3&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Treatment of Certain Share Capital and Equity</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon Shares Held by Novartis</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Alcon Shares that Novartis holds shall not be exchanged in the Merger, and such Alcon Shares shall be cancelled upon Completion.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon Shares Held by Alcon</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Alcon Shares that Alcon or any of its subsidiaries hold shall be exchanged in the Merger and the Novartis Shares so issued in connection therewith may be used by Novartis upon effectiveness of the Merger in the exchange as described in section 2.2 (Implementation of the Exchange) to the extent these Novartis Shares are held by Alcon.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Novartis Shares Held by Alcon</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any Novartis Shares that Alcon or any of its subsidiaries may hold at Completion shall be transferred to Novartis by operation of the Merger.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Equity Awards Granted under Alcon Incentive Plan</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">After Completion, all Awards (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Awards</font>&#8221;) as defined in and outstanding under the Amended 2002 Alcon Incentive Plan (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Incentive Plan</font>&#8221;) shall be (upon exercise or vesting as applicable) settled in the form of Novartis Shares instead of Alcon Shares and shall be structured so that the beneficiaries shall receive for each Alcon Share otherwise issuable the Merger Consideration as determined in accordance with the procedures set forth in <font style="DISPLAY: inline; FONT-WEIGHT: bold">Exhibit 2.3(d) </font>whereby any cash component of the Merger Consideration (including cash payable upon exercise of the Put Option) shall be substituted by a number of Novartis Shares based on the Novartis Share Valu
e, pursuant to <font style="DISPLAY: inline; FONT-WEIGHT: bold">Exhibit 2.3(d)</font>. The Alcon Board shall make all necessary adjustments to the Awards to accomplish the foregoing.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e)&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No Special Benefits to Directors and Members of Senior Management</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Save as otherwise provided herein, Alcon represents that other than (i) in the ordinary course of business consistent with past practice, or (ii) as approved by the Alcon Board prior to the date hereof, neither any member of the Alcon Board nor any member of senior management of Alcon has been awarded any compensation or benefits since December 31, 2009.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon represents that no member of the Alcon Board, nor any member of senior management, has received any actual or contingent compensation or benefits, the vesting or payment of which is contingent upon the Merger, or any severance payments in the event of a termination of employment at any time following Completion other than the vesting terms in the 2009 and 2010 Award agreements under the Incentive Plan and the 2011 Award agreements under the Incentive Plan to be entered into with respect to Awards for the performance year 2010 and the severance terms set out in individual employment agreements as set forth in a schedule delivered to Novartis on the date hereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;7</font></td>
</tr></table>
</div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon covenants that Alcon shall not enter into any new compensation or benefit arrangement with any director or member of senior management from and after the date hereof without the prior written consent of Novartis, other than in the ordinary course of business consistent with past practice, including the issuance of Awards for the performance year 2010, consistent with past practice, to be approved or ratified by the Alcon Board in February, 2011.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon represents that, other than as set forth in section 2.3(d) (Equity Awards Granted under Alcon Incentive Plan), no compensation or benefits shall become payable to any current or former director or employee of Alcon as a result of Completion other than the vesting terms in the 2009 and 2010 Award agreements under the Incentive Plan and the 2011 Award agreements under the Incentive Plan to be entered into with respect to Awards for the performance year 2010 and the severance terms set out in individual employment agreements as set forth in a schedule delivered to Novartis on the date hereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.4&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Share Register</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Novartis shall register in its share register any Alcon Shareholder who is duly registered with voting rights in the Alcon share register at Completion, subject to the Articles of Incorporation of Novartis.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Applications for registration of Alcon Shareholders that are pending at Completion shall be treated in accordance with the Articles of Incorporation of Novartis.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">An Alcon Shareholder who fails to declare its beneficial ownership to Novartis may avail itself of nominee registration in accordance with art. 5 of the Articles of Incorporation of Novartis.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Novartis Shares issued to Alcon Shareholders in the Merger shall receive any future dividends paid by Novartis on the same basis as the Novartis Shares currently outstanding (other than with respect to dividends with an Ex-Dividend Date that is prior to Completion).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.5&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cessation of Trading in Shares of Alcon</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At the opening of the first Trading Day following the approval by the Swiss Federal Commercial Registry Office (<font style="DISPLAY: inline; FONT-STYLE: italic">EHRA</font>) of the entry in the journal (<font style="DISPLAY: inline; FONT-STYLE: italic">Tagesregistereintrag</font>) of the Merger, trading in the shares of Alcon on the New York Stock Exchange shall be discontinued.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Listing and Registration of Novartis Shares and Novartis ADSs</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.1&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Listing of Novartis Shares</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Novartis shall use its reasonable best efforts to cause any Novartis Shares to be issued in the Merger&#160;&#160;(including Novartis Shares underlying Novartis ADSs) to be listed on the SIX Swiss Exchange in order to make such shares tradable as of the first Trading Day following the approval by the Swiss Federal Commercial Registry Office (<font style="DISPLAY: inline; FONT-STYLE: italic">EHRA</font>) of the entry in the journal (<font style="DISPLAY: inline; FONT-STYLE: italic">Tagesregistereintrag</font>) of the Merger.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;8</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>
</div>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.2&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Listing of Novartis ADSs</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Novartis shall use its reasonable best efforts to cause any newly issued Novartis ADSs to be issued in the Merger to be approved for listing on the New York Stock Exchange (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">NYSE</font>&#8221;), as of the first date on which trading occurs on the NYSE following the approval by the Swiss Federal Commercial Registry Office (<font style="DISPLAY: inline; FONT-STYLE: italic">EHRA</font>) of the entry in the journal (<font style="DISPLAY: inline; FONT-STYLE: italic">Tagesregistereintrag</font>) of the Merger, subject to official notice of issuance.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.3&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Registration of Novartis Shares</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As soon as practicable following the date of this Merger Agreement, Novartis shall prepare and file with the U.S. Securities and Exchange Commission (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">SEC</font>&#8221;) a registration statement on Form F-4 (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Form F-4</font>&#8221;) with respect to the Novartis Shares to be issued in the Merger. Novartis shall use its reasonable best efforts as promptly as practicable to respond to any comments made by the SEC with respect to the Form F-4 and to have the Form F-4 declared effective under the Securities Act of 1933, as amended, as promptly as practicable after filing with the SEC. Novartis shall also take any action as it deems necessary (other than qualifying to do business in any jurisdiction in which it is not now so 
qualified) under any applicable foreign or state securities or &#8220;Blue Sky&#8221; laws and the rules and regulations thereunder in connection with the registration of the Novartis Shares. Alcon shall furnish as promptly as practicable such information concerning Alcon reasonably requested in connection with such actions or in connection with any other filing required under applicable law.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If, prior to the Completion Date, any event occurs with respect to Alcon or its subsidiaries, or any change occurs with respect to other information supplied by Alcon to Novartis for inclusion in the Form F-4, that is required to be described in an amendment of, or a supplement to, the Form F-4, Alcon shall promptly notify Novartis of such event, and Alcon and Novartis shall cooperate in the prompt filing with the SEC of any necessary amendment or supplement to the Form F-4.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Novartis shall notify Alcon promptly of the receipt of any comments from the SEC or its staff, and of any request by the SEC or its staff for amendments or supplements to the Form F-4, to the extent such comments or requests address information pertaining to or provided by Alcon, including the proxy information of Alcon, and shall cooperate with Alcon to address any such comments or requests.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shareholders&#8217; Meetings</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shareholders&#8217; Meeting of Novartis</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Novartis Board shall submit this Merger Agreement and related resolutions to a shareholders&#8217; meeting of Novartis on a date to be determined by Novartis in its sole discretion but in any event at the latest on the date following the date the Alcon Shareholders' Meeting (as defined in section 4.2) takes place. The Novartis Board shall recommend that Novartis shareholders approve all resolutions necessary in connection with this Merger Agreement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;9</font></td>
</tr></table>
</div>

<div>&#160;</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.2&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shareholders&#8217; Meeting of Alcon</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Alcon Board shall submit (i) this Merger Agreement and related resolutions and (ii) a proposal to grant discharge to the current and former members of the Alcon Board for the financial year 2010 to a shareholders&#8217; meeting of Alcon on a date in accordance with the subsequent paragraph (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Alcon Shareholders&#8217; Meeting</font>&#8221;). Novartis shall vote or cause to be voted any Alcon Shares beneficially owned by it or any of its subsidiaries in favor of the approval of such resolutions at the Alcon Shareholders' Meeting; <font style="DISPLAY: inline; TEXT-DECORATION: underline">provided</font> that the obligation to vote in favor of (i) the Merger-related resolutions shall not apply in the event that the Alcon Board recommends to the Alcon Shareholders not to approve
 the Merger or a Material Change (as defined in section 6.2. (Subsequent Material Changes)) has occurred irrespective of whether such a Material Change affects Novartis or Alcon and (ii) the discharge resolution is subject to no new material facts with respect thereto becoming known by the Alcon Board and the Novartis Board after the date hereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon shall (a) send an invitation to the Alcon Shareholders&#8217; Meeting as promptly as practicable but in no event later than two (2) days after the date on which the Form F-4 is declared effective or on such other date thereafter as may be agreed by the Parties, (b) convene the Alcon Shareholders&#8217; Meeting on the date that is twenty (20) Business Days (as such term is defined in the U.S. Securities Exchange Act of 1934, as amended) following delivery of the invitation or on such other date as the Parties may agree; (c) make this Merger Agreement, the Merger Report and all other documents required by law available for inspection by its shareholders at least thirty (30) days prior to the Alcon Shareholders&#8217; Meeting and (d) shall take all actions to ensure that (a), (b) and (c) of this paragraph will be performed in accord
ance with the terms herein, including but not limited to, reserving a venue for the Alcon Shareholders&#8217; Meeting.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Interim Covenants</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Merger Audit</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Novartis Board and Alcon Board shall jointly appoint Ernst &amp; Young as their joint auditor to conduct the audit of the Merger, as set forth in art. 15 Merger Act.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.2&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Listing</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In connection with section 3 (Listing and Registration of Novartis Shares and Novartis ADSs) herein, Alcon shall furnish any information and support requested by Novartis with respect to any listings of Novartis Shares on the SIX Swiss Exchange and Novartis ADSs on the NYSE and any filings with and clearance by the SEC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.3&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Conduct of Business</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">From the date hereof until the Completion Date (as defined in section 6.5 (Completion)), Alcon shall conduct its business in the ordinary course consistent with past practice and use its reasonable best efforts to (x) preserve intact its present business organization, (y) keep available the services of its officers, employees and consultants and (z) maintain relationships with its customers, suppliers and others having </font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;10</font></td>
</tr></table>
</div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">significant business relationships with it. Without limiting the generality of the foregoing, except as expressly contemplated by this Merger Agreement, without the prior written consent of Novartis (which consent shall not be unreasonably withheld), Alcon shall not, nor shall it permit any of its subsidiaries to do or permit to be done any of the following, save for the implementation of decisions taken or ratified by the Alcon Board prior to the date of this Agreement that are set forth on <font style="DISPLAY: inline; FONT-WEIGHT: bold">Exhibit 5.3</font> hereto:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">amend its Articles of Association (other than amendments of its Articles of Association reflecting the issuance of Alcon Shares in 2010 under the Incentive Plan), Organizational Regulations or any other organizational document (whether by merger, consolidation or otherwise);</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i) issue, sell or otherwise deliver, or authorize the issuance, sale or other delivery of, any Alcon securities or securities of any of its subsidiaries, other than (aa) the issuance of Alcon Shares pursuant to Awards outstanding on the date hereof under the Incentive Plan, or (bb) the issuance of Awards for the performance year 2010, consistent with past practice, to be approved or ratified by the Alcon Board in February, 2011, or (ii) amend any term of any Alcon security or securities of any of its subsidiaries (whether by merger, consolidation or otherwise);</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i) acquire any material assets or property other than (aa) in the ordinary course of business consistent with past practice or (bb) as required by contracts or agreements in effect on the date hereof; or (ii)(aa) sell, lease, license, dispose of or otherwise transfer any material assets or property, other than in the ordinary course of business consistent with past practice or as required by existing contracts or agreements in effect on the date hereof or (bb) sell, assign, license or otherwise transfer any material intellectual property owned by or licensed to Alcon except pursuant to contracts or agreements in effect on the date hereof;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">incur, guarantee or otherwise become liable for any indebtedness for borrowed money other than in the ordinary course of business and in amounts and on terms consistent with past practice;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">create or incur any lien on any material assets or property other than in the ordinary course of business consistent with past practice;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">f)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">enter into any agreement or arrangement that limits or otherwise restricts in any material respect Alcon or any of its subsidiaries (or that could, after Completion, limit or otherwise restrict in any material respect Novartis, Alcon or any of their respective subsidiaries or any successor thereto) from engaging or competing in any line of business, in any location or with any person;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i) settle, or propose to settle, any action, suit, investigation, proceeding or claim that is material to Alcon and its subsidiaries taken as a whole or that relates to the transactions contemplated hereby or (ii) intentionally waive, release or assign any material right or claim;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">h)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">institute (i) any amendment or termination of any employee benefit plan, except as required by law, or adoption of any new employee benefit plan (it being understood that Alcon shall be at liberty to convert the former Nestl&#233; pension plans, as part of the separation from Nestl&#233; and within the committed timelines previously agreed to or to be agreed to by Nestl&#233; and Alcon, into either (a) a</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;11</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">free-standing Alcon pension plan, or (b) if agreed with Novartis, a Novartis pension plan) or any material individual employment, severance, change in control or consulting agreement (other than in the ordinary course of business consistent with past practice); or (ii) enter into any new labor or collective bargaining agreement or terminate any such existing agreement, except as required by law or by the terms thereof; or</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">i)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">resolve, commit or agree to do any of the foregoing.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.4&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Announcements</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except as required by applicable legal requirements or by the requirements of any stock exchange on which the securities of a Party hereto are listed, each Party shall provide reasonable prior notice to the other Party of any press release or public announcement in respect of this Merger Agreement or the transactions contemplated hereby or any other communication with the news media, and the Parties shall to the extent reasonably practicable consult with each other in good faith in order to reach agreement as to the form, timing and contents of any such press release, public announcement or disclosure.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.5&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Consultation of Employees</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The employees of Novartis and Alcon shall be informed and consulted by Novartis and Alcon, respectively, in accordance with art. 28 Merger Act.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.6&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Third Party Claims in Connection with the Merger</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If any person other than the Parties (such persons including but not limited to shareholders of a Party) raises claims against a Party, including but not limited to a member of the board of directors or the management of a Party in connection with the Merger, the Parties undertake to fully support and closely co-operate with each other in order to defend their position. Alcon shall not settle any such claim without the consent of Novartis.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.7&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Amendments to Alcon Incentive Plans</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except as expressly permitted by this Merger Agreement or as required by applicable law, Alcon will not after the date of execution of this Merger Agreement (i) amend the Incentive Plan or the terms of any Awards outstanding under the Incentive Plan, (ii) issue any new Awards under the Incentive Plan or under any other benefit plan or scheme (other than the Awards for the performance year 2010, consistent with past practice, to be approved or ratified by the Alcon Board in February 2011)&#160;&#160;or (iii) otherwise exercise any permissible authority under section 5.6 of the Incentive Plan.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.8&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon Dividend</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">From the date hereof until the Completion Date, Alcon shall not, nor shall Alcon permit any of its subsidiaries to, split, combine or reclassify any Alcon Shares or declare, set aside or pay any dividend or other distribution (whether in cash, shares or property or any combination thereof) in respect of its share </font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;12</font></td>
</tr></table>
</div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">capital except for dividends or other distributions payable by any wholly owned subsidiary of Alcon, or redeem, repurchase or otherwise acquire or offer to redeem, repurchase or otherwise acquire any Alcon securities or securities of any of its subsidiaries. Alcon represents and warrants that neither Alcon nor any of its subsidiaries has taken any action or resolved to take any action since the date of Alcon&#8217;s Merger Balance Sheet that would have violated this section 5.8 (Alcon Dividend) if such action or resolution had been taken after the date hereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.9&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon Litigation Trust</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon represents and warrants that upon execution of this Merger Agreement the trust (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Alcon Litigation Trust</font>&#8221;) formed under the Alcon Litigation Trust Agreement dated as of July 7, 2010 by and between Alcon, as Grantor and Thomas G. Plaskett, Joan W. Miller and Lodewijk J. R. De Vink, as Trustees (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Alcon Litigation Trust Agreement</font>&#8221;) shall have been terminated. Alcon further represents, warrants and undertakes that the Trust Property (as defined in the Alcon Litigation Trust Agreement) remaining at the termination of the Alcon Litigation Trust shall be paid over to Alcon within five (5) Trading Days following such termination and (i)&#160;that no amount of Trust Property shall be withheld, (ii)
 except as set forth on <font style="DISPLAY: inline; FONT-WEIGHT: bold">Exhibit 5.9</font>, that no amount of Trust Property has been expended to date and (iii)&#160;that the Trustees of the Alcon Litigation Trust have irrevocably waived any claim to any future reimbursement, disbursement or refund of any amounts from the Alcon Litigation Trust.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.10&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Directors&#8217; and Officers&#8217; Insurance</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Novartis shall obtain or shall cause Alcon to obtain prior to Completion, effective as of Completion, &#8220;tail&#8221; insurance policies with a claims period of six years following Completion with at least the same coverage and amounts as&#160;&#160;the current policies of directors&#8217; and officers&#8217; liability insurance maintained by Alcon, in each case with respect to claims arising out of or relating to events that occurred before or at the Completion (including in connection with the transactions contemplated by this Merger Agreement); <font style="DISPLAY: inline; TEXT-DECORATION: underline">provided</font> that in no event shall Novartis be required to expend or shall Alcon expend an annual premium for such coverage in excess of 300% of the last annual premium paid by Alcon for such insurance for the covered persons pr
ior to the date hereof (which amount is set forth in a letter delivered to Novartis on the date hereof).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.11&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Further Assurances</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject to, and without limiting the generality of, each other term and condition set forth in this Merger Agreement, Novartis and Alcon shall cooperate with each other and use (and shall cause their respective subsidiaries to use) their respective reasonable best efforts to take or cause to be taken all actions, and do or cause to be done all things, reasonably necessary, proper or advisable on its part under this Merger Agreement and applicable laws to cause Completion, and completion of the other transactions contemplated by this Merger Agreement, to occur as soon as practicable, including executing and delivering all such other agreements, certificates, instruments and documents as any Party reasonably may request in order to carry out the intent and accomplish the purposes of this Merger Agreement. Alcon shall further grant access
 to Novartis, subject to the requirements of Section 7.1 in case of a transfer of non-</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13</font></td>
</tr></table>
</div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">public information, to all information reasonably required by Novartis to prepare the integration of Alcon's business.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.12&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Swiss Withholding Tax</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Novartis shall use its best efforts to obtain within 30 days from the date hereof a tax ruling from the Swiss Federal Tax Administration confirming that the payment of the Contingent Value Amount to the Alcon Shareholders qualifies as a dividend for the purpose of the Swiss-American Double Taxation Treaty.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To the extent that the Merger will result in a gain in nominal value (such gain, i.e. the amount of the aggregate nominal value of the Stock Consideration less the nominal value of one Alcon Share, the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Nominal Value Amount Increase</font>&#8221;), the Swiss withholding tax due on the Nominal Value Amount Increase shall be borne and paid by Novartis, and the amount subject to withholding tax shall be grossed up accordingly (i.e. equal to approximately 153.8% of the Nominal Value Amount Increase).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Validity and Completion</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.1&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Effectiveness of the Merger Agreement</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This Merger Agreement shall be effective upon its execution.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.2&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subsequent Material Changes</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If any material change (as defined under art. 17 Merger Act, <font style="DISPLAY: inline; FONT-WEIGHT: bold">"Material Change"</font>) occurs in the period between the execution of this Merger Agreement and the later to occur of the Novartis shareholders&#8217; meeting or the Alcon Shareholders&#8217; Meeting referred to in section 4 (Shareholders&#8217; Meetings), the Parties agree that they shall comply with the process set forth in art. 17 Merger Act (including apprising each other of any events that are reasonably likely to lead to a Material Change), and that (without prejudice to section 7.4 (Modifications and Amendments, Right to Amend, Joint Negotiation)) any action taken in connection therewith can only be taken by the Novartis Board or the Alcon Board, as the case may be.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Parties agree that they shall interpret any Material Change under art. 17 Merger Act as a change in the consolidated net assets of either Party of more than 10% of the market value of all outstanding shares of such Party, which market value shall be measured as of the date of execution of this Merger Agreement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.3&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Conditions Precedent to the Merger</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Completion shall be subject to the following conditions precedent:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Approval of this Merger Agreement and all related resolutions at the shareholders meetings of Alcon and Novartis;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The SEC has declared the Form F-4 effective, and the SEC has not taken any action to suspend effectiveness;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;14</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Approval of the SIX Exchange and the NYSE of the listing of any newly issued Novartis Shares and Novartis ADSs, respectively, in each case in accordance with section 3 (Listing and Registration of Novartis Shares and Novartis ADSs) above; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No order or injunction have been issued by any governmental authority or a competent court that (i) prohibits the completion of the Merger and (ii) is enforceable in Switzerland.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.4&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Applications to the Commercial Register</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The applications for the entry in the Commercial Register of Zug, in the case of Alcon, and the Commercial Register of Basel, in the case of Novartis, shall be filed by the respective Party on the later to occur date of the Alcon Shareholders&#8217; Meeting or the date of the Novartis shareholder meeting referred to in section 4.1 but in no event prior to the record date for payment of the 2010 Novartis Annual Dividend (or, if there is any other Novartis cash dividend declared or paid after the 2010 Novartis Annual Dividend that would be included in the definition of "USD Dividend Value", in no event prior to the record date for payment for such dividend).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.5&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Completion</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject to section 6.3 (Conditions Precedent to the Merger), Completion shall occur on the date (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Completion Date</font>&#8221;) in which entries into the Commercial Register in respect to both Parties have been made.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.6&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Termination of the Merger Agreement</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Either Novartis (by decision of the Novartis Board) or Alcon (by decision of the Alcon Board) may terminate this Merger Agreement if the conditions precedent to the Merger specified in section 6.3 (Conditions Precedent to the Merger) above have not been satisfied by October 1, 2011 (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Long Stop Date</font>&#8221;) other than as a result of the fault of the Party seeking termination.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The termination of this Merger Agreement shall also terminate all rights and obligations arising out of this Merger Agreement, with the exception of (i) those under sections 7.3 (Costs), 7.7 (Applicable Law and Jurisdiction) and this section 6.6 (Termination of the Merger Agreement), which shall continue to be in full force and effect, as well as (ii) any claims for damages if a Party has caused the termination of this Merger Agreement by a breach of this Merger Agreement or applicable law.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 34px">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7&#160;&#160;</font></div>
</td>
<td width="1204" style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Miscellaneous</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.1&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Confidentiality</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The content of the negotiations of the Merger Agreement and matters related thereto, including any documents and information exchanged in this regard shall be treated as confidential by the Parties, subject to any legal or regulatory obligations to provide information to governmental authorities (including courts, securities regulators and stock exchanges).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;15</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.2&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notices</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any notice, request, or other communication under this Merger Agreement shall be deemed validly given upon receipt by the Party to whom it is addressed, provided, however, that it has been given in writing and sent by registered mail or by facsimile transmission to the following address:</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="29%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">If to Alcon:</font></div>
</td>
<td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="29%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Alcon, Inc.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6201 South Freeway</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ft. Worth, TX 76134-2099</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States of America</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Facsimile no. +1 817 568 7579</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Attn: General Counsel</font></div>
</td>
</tr><tr>
<td valign="top" width="29%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">If to Novartis:</font></div>
</td>
<td valign="top" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="29%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Novartis AG</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Lichtstrasse 35</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4056 Basel</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Switzerland</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Facsimile no. +41 61 324 7826</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Attn: Group General Counsel</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">or to such other address which a Party may have communicated to the other Party in accordance with this section 7.2 (Notices).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.3&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Costs</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each Party shall bear its own costs (such as attorneys&#8217; and bankers&#8217; fees). Costs that are jointly incurred (such as the fees of the joint auditor) shall be evenly divided.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.4&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Modifications and Amendments, Right to Amend, Joint Negotiation</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except as set forth in the paragraph immediately below, any modifications to, or waivers of any provisions of, this Merger Agreement must be made in writing and shall be subject to approval by the Novartis Board and the Alcon Board.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Novartis and Alcon Boards acknowledge and agree that any amendment to an essential term of this Merger Agreement shall be subject to approval by the Novartis Board and the Alcon Board (and, in the case of the Alcon Board, upon recommendation of the Independent Director Committee, which recommendation shall not be unreasonably withheld).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;CONFIDENTIAL</font></td>
</tr></table>
</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;16</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Parties agree that they jointly negotiated and prepared this Merger Agreement and that this Merger Agreement shall not be construed against any Party on the grounds that such Party prepared or drafted the same.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.5&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Severability</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each provision of this Merger Agreement shall be interpreted in such manner that it is effective and valid under applicable law. If any provision of this Merger Agreement shall be unenforceable or invalid even though, such provision shall be ineffective only to the extent of such unenforceability or invalidity and be replaced by such valid and enforceable provision which a reasonable party acting in good faith would consider to match as closely as possible the invalid or unenforceable provision and to attain the same or a similar economic effect. The remaining provisions of this Merger Agreement shall continue to be binding and in full force and effect.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.6&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Non-Assignment</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Neither Party may assign any of its rights under this Merger Agreement without the prior written consent of the other Party.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.7&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Applicable Law and Jurisdiction</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Merger and this Merger Agreement (and any claims or disputes arising out of or related thereto or hereto or to the inducement of any Party to enter therein or herein) shall in all respects be governed by, and construed in accordance with, the laws of Switzerland, including all matters of construction, validity and performance, in each case without reference to any conflict of laws rules that might lead to the application of&#160;the laws of any other jurisdiction. Any dispute between the Parties shall be resolved, at the exclusion of any other competent courts of law, by the courts of the City of Zurich, Switzerland, venue being Zurich 1, and if permitted under applicable rules of civil procedure shall be submitted to the Commercial Court of the Canton of Zurich (<font style="DISPLAY: inline; FONT-STYLE: italic">Handelsgericht des 
Kantons Z&#252;rich</font>).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.8&#160;&#160;</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Jurisdiction on Shareholders&#8217; Claims</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any shareholders&#8217; claims based on the Merger Act which arise out of or are made in connection with the Merger or this Merger Agreement shall exclusively be decided by the Swiss courts either at the seat of Novartis or at the seat of Alcon.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">[Signatures on next page]</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Basel, December 14, 2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Novartis AG</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="15%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Dr. Daniel Vasella&#160;&#160;</font></td>
<td width="10%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="17%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Hans-J&#246;rg Rudloff&#160;&#160;</font></td>
<td width="58%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td width="15%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dr. Daniel Vasella&#160;&#160;</font></td>
<td width="10%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="17%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Hans-J&#246;rg Rudloff&#160;&#160;</font></td>
<td width="58%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Basel, December 14, 2010</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon, Inc.</font><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div>&#160;</div>

<div>
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="15%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/&#160;Cary Rayment&#160;&#160;</font></td>
<td width="10%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="17%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Thomas G. Plaskett</font></td>
<td width="58%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td width="15%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cary Rayment&#160;&#160;</font></td>
<td width="10%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="17%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Thomas G. Plaskett&#160;&#160;</font></td>
<td width="58%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>
</div>
</div>

<div>&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>3
<FILENAME>acl6k1216finalmerger.pdf
<DESCRIPTION>6K PDF
<TEXT>
<PDF>
begin 644 acl6k1216finalmerger.pdf
M)5!$1BTQ+C0-)>+CS],-"CD@,"!O8FH@/#PO3&EN96%R:7IE9"`Q+TP@,3,Y
M,#,O3R`Q,2]%(#@S.#(O3B`R+U0@,3,V-S<O2"!;(#4Y-B`Q.#E=/CX-96YD
M;V)J#2`@("`@("`@("`@("`@("`@("`@#0IX<F5F#0HY(#$U#0HP,#`P,#`P
M,#$V(#`P,#`P(&X-"C`P,#`P,#`W.#4@,#`P,#`@;@T*,#`P,#`P,#@V,B`P
M,#`P,"!N#0HP,#`P,#`P.3DP(#`P,#`P(&X-"C`P,#`P,#$Q,C(@,#`P,#`@
M;@T*,#`P,#`P,34T.2`P,#`P,"!N#0HP,#`P,#`R,C<V(#`P,#`P(&X-"C`P
M,#`P,#(S,3`@,#`P,#`@;@T*,#`P,#`P,C4U."`P,#`P,"!N#0HP,#`P,#`R
M.#`P(#`P,#`P(&X-"C`P,#`P,#(X-S8@,#`P,#`@;@T*,#`P,#`P-3,T-"`P
M,#`P,"!N#0HP,#`P,#`U-#DR(#`P,#`P(&X-"C`P,#`P,#@Q-C$@,#`P,#`@
M;@T*,#`P,#`P,#4Y-B`P,#`P,"!N#0IT<F%I;&5R#0H\/"]3:7IE(#(T+U!R
M978@,3,V-C<O4F]O="`Q,"`P(%(O26YF;R`X(#`@4B])1%L\-D,U1$,W,T(V
M-S0V1$0Y.3DU,C$W,4(T,#@Y13DU03`^/#=#.$5#0D(Y-T)$0D(P-$)!,#E$
M03-"0T%%13$S.#4T/ET^/@T*<W1A<G1X<F5F#0HP#0HE)45/1@T*("`@("`@
M("`@("`@("`@#0HR,R`P(&]B:CP\+TQE;F=T:"`Q,#,O1FEL=&5R+T9L871E
M1&5C;V1E+TD@,3(R+TP@,3`V+U,@-C(^/G-T<F5A;0T*>-IB8&!@9F!@6LC`
MPL#`*LW`RX``O$`Q$.28<$B#@:$=).2J9KX`2%D`<0-($`GP0#$#@Q(##^N#
M)(E)6QD8KO$R:,U0*%JR83=8!FB'J@R09H*:P<'`8+P+2#,"\1N```,`A2</
M<0T*96YD<W1R96%M#65N9&]B:@TQ,"`P(&]B:CP\+TUE=&%D871A(#<@,"!2
M+U!A9V5S(#8@,"!2+U1Y<&4O0V%T86QO9R]086=E3&%B96QS(#0@,"!2/CX-
M96YD;V)J#3$Q(#`@;V)J/#PO0W)O<$)O>%LP(#`@-C$R(#<Y,ETO4&%R96YT
M(#8@,"!2+T-O;G1E;G1S(#$Y(#`@4B]2;W1A=&4@,"]-961I84)O>%LP(#`@
M-C$R(#<Y,ETO4F5S;W5R8V5S(#$R(#`@4B]4>7!E+U!A9V4^/@UE;F1O8FH-
M,3(@,"!O8FH\/"]#;VQO<E-P86-E/#PO0W,V(#$U(#`@4CX^+T9O;G0\/"]4
M5#(@,3,@,"!2+U14-"`Q-"`P(%(O5%0V(#(P(#`@4CX^+U!R;V-3971;+U!$
M1B]497AT72]%>'1'4W1A=&4\/"]'4S$@,3@@,"!2/CX^/@UE;F1O8FH-,3,@
M,"!O8FH\/"]3=6)T>7!E+U1R=654>7!E+T9O;G1$97-C<FEP=&]R(#$V(#`@
M4B],87-T0VAA<B`Q,38O5VED=&AS6S(U,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,C4P(#,S,R`R-3`@,"`U,#`@-3`P(#4P,"`U,#`@-3`P(#4P,"`U,#`@
M,"`P(#4P,"`P(#`@,"`P(#`@,"`P(#<R,B`P(#<R,B`W,C(@-C8W(#8Q,2`W
M-S@@-S<X(#,X.2`P(#<W."`V-C<@.30T(#<R,B`W-S@@-C$Q(#`@-S(R(#4U
M-B`V-C<@-S(R(#<R,B`Q,#`P(#<R,B`P(#`@,"`P(#`@,"`P(#`@-3`P(#4U
M-B`T-#0@-34V(#0T-"`P(#4P,"`U-38@,C<X(#`@,"`R-S@@.#,S(#4U-B`U
M,#`@,"`P(#0T-"`S.#D@,S,S72]"87-E1F]N="]4:6UE<TYE=U)O;6%N4%,M
M0F]L9$U4+T9I<G-T0VAA<B`S,B]%;F-O9&EN9R]7:6Y!;G-I16YC;V1I;F<O
M5'EP92]&;VYT/CX-96YD;V)J#3$T(#`@;V)J/#PO4W5B='EP92]4<G5E5'EP
M92]&;VYT1&5S8W)I<'1O<B`Q-R`P(%(O3&%S=$-H87(@,C4R+U=I9'1H<ULR
M-3`@,"`T,#@@,"`P(#`@,"`Q.#`@,S,S(#,S,R`P(#`@,C4P(#,S,R`R-3`@
M,C<X(#4P,"`U,#`@-3`P(#4P,"`U,#`@-3`P(#4P,"`U,#`@-3`P(#4P,"`R
M-S@@,"`P(#`@,"`P(#`@-S(R(#8V-R`V-C<@-S(R(#8Q,2`U-38@,"`W,C(@
M,S,S(#`@-S(R(#`@.#@Y(#<R,B`W,C(@-34V(#`@-C8W(#4U-B`V,3$@,"`P
M(#`@,"`W,C(@,"`P(#`@,"`P(#4P,"`P(#0T-"`U,#`@-#0T(#4P,"`T-#0@
M,S,S(#4P,"`U,#`@,C<X(#`@-3`P(#(W."`W-S@@-3`P(#4P,"`U,#`@-3`P
M(#,S,R`S.#D@,C<X(#4P,"`U,#`@-S(R(#4P,"`U,#`@-#0T(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(#4P,"`P(#`@,"`P(#`@-3`P72]"87-E1F]N="]4:6UE
M<TYE=U)O;6%N4%--5"]&:7)S=$-H87(@,S(O16YC;V1I;F<O5VEN06YS:45N
M8V]D:6YG+U1Y<&4O1F]N=#X^#65N9&]B:@TQ-2`P(&]B:ELO24-#0F%S960@
M,C$@,"!270UE;F1O8FH-,38@,"!O8FH\/"]3=&5M5B`Q,S8O1F]N=$YA;64O
M5&EM97-.97=2;VUA;E!3+4)O;&1-5"]&;VYT4W1R971C:"].;W)M86PO1F]N
M=%=E:6=H="`W,#`O1FQA9W,@,S0O1&5S8V5N="`M,C$V+T9O;G1"0F]X6RTU
M-3@@+3,P-R`R,#`P(#$P,C9=+T%S8V5N="`X.3$O1F]N=$9A;6EL>2A4:6UE
M<R!.97<@4F]M86XI+T-A<$AE:6=H="`V-38O6$AE:6=H="`M-30V+U1Y<&4O
M1F]N=$1E<V-R:7!T;W(O271A;&EC06YG;&4@,#X^#65N9&]B:@TQ-R`P(&]B
M:CP\+U-T96U6(#@R+T9O;G1.86UE+U1I;65S3F5W4F]M86Y04TU4+T9O;G13
M=')E=&-H+TYO<FUA;"]&;VYT5V5I9VAT(#0P,"]&;&%G<R`S-"]$97-C96YT
M("TR,38O1F]N=$)";WA;+34V."`M,S`W(#(P,#`@,3`P-UTO07-C96YT(#@Y
M,2]&;VYT1F%M:6QY*%1I;65S($YE=R!2;VUA;BDO0V%P2&5I9VAT(#8U-B]8
M2&5I9VAT("TU-#8O5'EP92]&;VYT1&5S8W)I<'1O<B])=&%L:6-!;F=L92`P
M/CX-96YD;V)J#3$X(#`@;V)J/#PO3U!-(#$O3U`@9F%L<V4O;W`@9F%L<V4O
M5'EP92]%>'1'4W1A=&4O4T$@9F%L<V4O4TT@,"XP,CX^#65N9&]B:@TQ.2`P
M(&]B:CP\+TQE;F=T:"`R,SDX+T9I;'1E<B]&;&%T941E8V]D93X^<W1R96%M
M#0I(B>Q72V_CR!&^ZU<T]I)F,.2P'VR2N7ED><?[L`<VG601!P-9HF1F9,H@
MI?5,?GA..:0>34JRJ'&N`0(;8C^JJJNKOGKT^Q]OE5BVHP_%Z'U1:*%$L1BI
M.(JUB.&/1R9V(H5A*HJGT?MQZ\2LI>U8M+-Z%(MBAC\O(RF"XA^CT$1YID6H
M(F5SX#D?@908Y"`9C)1!VK_)NZO+8A)D42+/Q6U!@[/`1)DL)K<B^'OQTRAT
M4>KBA$49$A6B!-/+LBG+NIV,@S")G+P+XLC*&YY<!J"+D<4E"#R[XK5S,?EK
M$"H%P_'',UZ[(J8?)V)\_>NON)3(R]O;R^LK5@/F+LOW+T1:J`RUH*'V:OQE
M&H06;M`^5O5R@V,EU_4[<8Y#+:-`1ZD<=Q-23NB8>1*;\W$*[<?FIQ&:W[DX
MRM'\1\;6D=)91LHE:&-O[7RG&Q%?K)LGX<*?B0E<;7M7=V?%_5D&C)/%:NBX
MTR#)L\A8X50>98XX48ND]SG;YV;RZ3I(HES>%.+Z(G!@:!$X>7%],[F$&?@@
M`)T5.`0M)SX1!3A3`<OEGVGQK)@(IKU%6@V?!*QWQT23&Y3WZ8Y(;[HMXKLJ
M!((LD]=\!A+>\-XO$S`U0"^14_H-45@F%4U<`#9F/;WN?!0NJ(1(YF&`'E6.
M9H*%\AW.=WJ1;^/(Y(D^QI+I+*4S-E7Q<2(`U7<WEP3?29!*P&V.^/EX=@58
MA>//Q@4L@R6%R@VBR$C+QWC/:&'C/++@EYC<,^S1[V`AR5T4$Q]3'WD]%DEF
M.]$^$CSPE.:;`/3(7V(#YE/R$<UO9!GDN/84*`X2OXG76B^8GJZR0YP#I5"_
MSF:@7G>4R?FH\W)6/@&SD@]E`Y&EXDY&=\?>,%HG49KM:__*,$-7374$F:VW
M1GR4F72?F8Q/">,U)A0MGYZJMJW\I.:/N*A`62U7I;A"]SFY]<1@'"T?>%(V
MN,<(C&->4R&O&:5YP>4]P`Z<B%I;0'WV1C2[_K(TTHE#V"20"BRQLL73/IX=
M23G[97Q]]4Y<7HVC8S`=6$]#+LM`H,H@I?=@4;T'8\?FNI=%,Z4PK=M58"DD
MP>AR0^.*?M>(H!R,F/@P!L!@H(NF),XED[7,TTQK'OP!-IUL`[![S4<\!2FL
MEW2`8*::96_V#Q)8I<!IR]6>$FV0R<?[X%6X&4B#:O^6QZ`ZCK'8>0CZE`ZY
M)\U]2C=]1N]S:4Q@EQ_^U<X>!?H=>>+(Q4J]XE&["(E],'Z*KB/Q8?U5.!U@
MOO"%%O*6`L2^8N^34I>_G3$J@,C\^.^ZK!]@5#;+=^+VI=K\LVQ6TWH>=&&K
M(Z=\FDN33J"VN^3``H55(?R3'](LX4%&CLVRS#O8X_H03QI*@Q/6VBAV.X#:
M'J!YAZ>S^;PIVS;`JB[6"\3+<U.!]VHLP%;.JN?I2I00B$9^Y:5R1K/MIOJ]
M!)9%-2O;SM6O'9@ED<GV]#@JT&FD=<X]C'$.37$ROUBLGKMP4_UMM+_-)5@8
MXMX"!I6<33>E>.#YMP`;&C%[Y&DY^\(#S*\QA!#(2V73+8()7CK*#5201TB6
MFVX!HFBY.Z3=8/R(1;4J6P&)G'RK(F,`)GNI..\UM=ZQ>$:U6A&GF)*M(62W
M_`6#PWY3/J^;32NV?G?.GY*"N1&S-<]_/US&?L'O-'@[="OV4+@07H".'M*=
MEGLI^D3.P=XH4%2Z+4$NYK@/+P".%AJU(<<K`X"R4%^SR.K_LGX8J*:>^$U-
M](`F`IJ)3#-0.33"),=$]L8-ADN#UM"-8LI*(CL(W4DQ4E`[-(19#&VRB+$6
MP$^:`W=3CA:'V[YO/=AW"A/A*7:MDL-MS`NG*08.@-`ZU.](@E?1Y#JRK`*(
MT0-[:+Y>Q+[VPZQ'>P>L7N_=-N[LN`^VCP_VMSK)/;1](("?<^YT7V<R'>TU
M,J?K-J(VA>+2HU;M7A:Q[;(2E!((WXHJ"J0E^D)N^D;K8D:%]Q$[825+FLR@
MYCKY11!J#=5XR`=?!(M8('JI8<1^N>?DG+%DFI9/H6;!R9IGGK\-L'T7+8`_
M@Y8*E7CP)U5,R+],72\%3_?/P<#1V`#@2N.9X0$5X'OQ9W\.WUL\LP[/-"OY
M*F+:4J7AZS9#IS/EO#?3#3TBF&&Y71'-=%_1-='5*/<V+#BHXZ.G1%^T;>(?
M79!T'?:8*E8XNL?&$CZ!N)<*RAKTCT;^"4T.%>3SY\^X^?E57Z/2%#%NDCP:
M?!<.P<9"+<].-,O_1]+_`))TWW+:'9*PC>JPA.-[?J8DC*<4\63!5H0GY?&$
MVY_YE.*/1]@Y!D9ZU+82,%(&AO+`4!TP4@:&9;,;NK@E8-@.&(J`81$8U/R4
M!`A\C")[R7N"I1Y(X3>%Y3>%8JPHQHJ5K!0O]:K@6\3B0PZ%-#2I>>)%`!X`
MPSQA"4O>1]4.51#[5(LU?9KN0DS*%`"O%&'D#;&N>7/J^?D.<Q!'MZY/G-<I
M2+TDX)91:_HCQ0'!=,6S]2G\J+XK-!Y`W&0"M)OR@4??Q&++HZ;F;]4^5GZX
MY`_X!9I]V?&*J@93,,]3D.,3<5/YA;KC6(O^+#%>/SU5\`(`$X'X5Y086CS<
M!A2AK==GBG?7'=TFH$:3-?$B(,X<NQIG&!3::VQ"S8-[20G$7Q:"@]+)EMMX
MM,/KN]V6LVU3;2KHMKMX"5\]G;1_.TV^8F0!T!_Y.ZV7/"A1<T#B&8?BC*<;
ML>;M1<#.AS2O<L-K-AKN$55F(P>M8IKY7/Y6XE<ZQ7>9=JYCZ-^A(!"74/7?
MRI9>>@*T,'&.C?T5HAM0!4A#&WWU,U1JUX?J%$CUZ4;4[Y_N1$\*\!W9WOZI
M7O3T&;XO^YZ,3D]G4!3WE!I?C@.[75]X?(D3W,>[@_KO]JFMW`DX)#@^OKO?
M:0&#!`<RWNQ,=0+GNGBPR_ANFZJM`AG,V->.65]0J(HLQ`\0;IG\+0BQ8I;M
M#Z)J(45#L$"*PW"?4IPW00B`EU_P50F%=/X.<LZ\@K)#%?VA7*U?('#!61BX
M1(+K]-2MMU[2@]_!`MY6!&1XDF89Z=V76-6G2/\$7-88D5#;YOSM4EFRU[?P
MK`IBZEZ:J6?9T(*H_%3,UG[4B:28FE&RI&7Q4FT>!5=UA0D,Q"O-LZ4)2>>P
M4WJPS^0\[QM-S=TE:)%V+:9O+D5&>R$EG:[%'&XT$^BTA#8`FA,@&'*]RJ+<
MGF@U^[?L?P08`$RYUX\*#0IE;F1S=')E86T-96YD;V)J#3(P(#`@;V)J/#PO
M4W5B='EP92]4<G5E5'EP92]&;VYT1&5S8W)I<'1O<B`R,B`P(%(O3&%S=$-H
M87(@,S(O5VED=&AS6S(W.%TO0F%S949O;G0O07)I86Q-5"]&:7)S=$-H87(@
M,S(O16YC;V1I;F<O5VEN06YS:45N8V]D:6YG+U1Y<&4O1F]N=#X^#65N9&]B
M:@TR,2`P(&]B:CP\+TQE;F=T:"`R-3<U+T9I;'1E<B]&;&%T941E8V]D92].
M(#,O06QT97)N871E+T1E=FEC95)'0CX^<W1R96%M#0I(B9R6>513=Q;'?V_)
MGI"5L,-C#5N`L`:0-6QAD1T$40A)"`$20DC8!4%$!11%1(2JE3+6;71&3T6=
M+JYCK0[6?>K2`_4PZN@XM!;7CIT7.$>=3F>FT^\?[_<Y]W?O[]W?O?>=\P"@
M)Z6JM=4P"P"-UJ#/2HS%%A448J0)``,*(`(1`#)YK2XM.R$'X)+&2[!:W`G\
MBYY>!Y!IO2),RL`P\/^)+=?I#0!`&3@'*)2U<IP[<:ZJ-^A,]AF<>:65)H91
M$^OQ!'&V-+%JGKWG?.8YVL0*C5:!LREGG4*C,/%IG%?7&94X(ZDX=]6IE?4X
M7\79I<JH4>/\W!2K4<IJ`4#I)KM!*2_'V0]GNCXG2X+S`@#(=-4[7/H.&Y0-
M!M.E)-6Z1KU:56[`W.4>F"@T5(PE*>NKE`:#,$,FKY3I%9BD6J.3:1L!F+_S
MG#BFVF)XD8-%H<'!0G\?T3N%^J^;OU"FWL[3D\RYGD'\"V]M/^=7/0J`>!:O
MS?JWMM(M`(RO!,#RYEN;R_L`,/&^';[XSGWXIGDI-QAT8;Z^]?7U/FJEW,=4
MT#?ZGPZ_0.^\S\=TW)OR8''*,IFQRH"9ZB:OKJHVZK%:G4RNQ(0_'>)?'?CS
M>7AG*<N4>J46C\C#ITRM5>'MUBK4!G6U%E-K_U,3?V783S0_U[BX8Z\!K]@'
ML"[R`/*W"P#ET@!2M`W?@=[T+962!S+P-=_AWOS<SPGZ]U/A/M.C5JV:BY-D
MY6!RH[YN?L_T60("H`(FX`$K8`^<@3L0`G\0`L)!-(@'R2`=Y(`"L!3(03G0
M`#VH!RV@'72!'K`>;`+#8#L8`[O!?G`0C(./P0GP1W`>?`FN@5M@$DR#AV`&
M/`6O(`@B00R("UE!#I`KY`7Y0V(H$HJ'4J$LJ``J@520%C)"+=`*J`?JAX:A
M'=!NZ/?04>@$=`ZZ!'T%34$/H.^@ES`"TV$>;`>[P;ZP&(Z!4^`<>`FL@FO@
M)K@37@</P:/P/O@P?`(^#U^#)^&'\"P"$!K"1QP1(2)&)$@Z4HB4(7JD%>E&
M!I%19#]R##F+7$$FD4?("Y2(<E$,%:+A:!*:B\K1&K05[46'T5WH8?0T>@6=
M0F?0UP0&P9;@10@C2`F+""I"/:&+,$C82?B(<(9PC3!->$HD$OE$`3&$F$0L
M(%80FXF]Q*W$`\3CQ$O$N\19$HED1?(B19#223*2@=1%VD+:1_J,=)DT37I.
MII$=R/[D!'(A64ON(`^2]Y`_)5\FWR._HK`HKI0P2CI%06FD]%'&*,<H%RG3
ME%=4-E5`C:#F4"NH[=0AZG[J&>IMZA,:C>9$"Z5ETM2TY;0AVN]HG].F:"_H
M'+HG74(OHAOIZ^@?TH_3OZ(_83`8;HQH1B'#P%C'V,TXQ?B:\=R,:^9C)C53
MF+69C9@=-KML]IA)8;HR8YA+F4W,0>8AYD7F(Q:%Y<:2L&2L5M8(ZRCK!FN6
MS66+V.EL#;N7O8=]CGV?0^*X<>(Y"DXGYP/.*<Y=+L)UYDJX<NX*[ACW#'>:
M1^0)>%)>!:^']UO>!&_&G&,>:)YGWF`^8OZ)^20?X;OQI?PJ?A__(/\Z_Z6%
MG46,A=)BC<5^B\L6SRQM+*,ME9;=E@<LKUF^M,*LXJTJK398C5O=L4:M/:TS
MK>NMMUF?L7YDP[,)MY';=-L<M+EI"]MZVF;9-MM^8'O!=M;.WB[13F>WQ>Z4
MW2-[OGVT?87]@/VG]@\<N`Z1#FJ'`8?/'/Z*F6,Q6!4VA)W&9AQM'9,<C8X[
M'"<<7SD)G'*=.IP..-UQICJ+G<N<!YQ/.L^X.+BDN;2X['6YZ4IQ%;N6NVYV
M/>OZS$W@EN^VRFW<[;[`4B`5-`GV"FZ[,]RCW&O<1]VO>A`]Q!Z5'EL]OO2$
M/8,\RSU'/"]ZP5[!7FJOK5Z7O`G>H=Y:[U'O&T*Z,$98)]PKG/+A^Z3Z=/B,
M^SSV=?$M]-W@>];WM5^07Y7?F-\M$4>4+.H0'1-]Y^_I+_<?\;\:P`A("&@+
M.!+P;:!7H#)P6^"?@[A!:4&K@DX&_2,X)%@?O#_X08A+2$G(>R$WQ#QQAKA7
M_'DH(30VM"WTX]`78<%AAK"#87\/%X97AN\)O[]`L$"Y8&S!W0BG"%G$CHC)
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M`XH'R@AEO_)>6419?]E]581JH^I!>53Y8/DCM40]K/ZV(JEB>\6SRO3*#RM_
MK,JO.J`A:THT1[4<;:7V=+5]=4/U)9V7KDLW61-6LZEF1I^BWUD+U2ZI/6+@
MX3]3%XSNQI7&J;K(NI&ZY_5Y]8<:V`W:A@N-GHUK&N\U)33]IAEMEC>?;'%L
M:6^96A:S;$<KU%K:>K+-N:VS;7IYXO)=[=3VRO8_=?AU]'=\OR)_Q;%.N\[E
MG7=7)J[<VV76I>^ZL2I\U?;5Z&KUZHDU`6NVK'G=K>C^HL>O9[#GAUYY[Q=K
M16N'UOZXKFS=1%]PW[;UQ/7:]=<W1&W8U<_N;^J_NS%MX^$!;*![X/M-Q9O.
M#08.;M],W6S</#F4^D\`I`%;_IBXF229D)G\FFB:U9M"FZ^<')R)G/>=9)W2
MGD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16I,>E.*6IIAJFBZ;]IVZG
MX*A2J,2I-ZFIJARJCZL"JW6KZ:Q<K-"M1*VXKBVNH:\6KXNP`+!UL.JQ8+'6
MLDNRPK,XLZZT);2<M1.UBK8!MGFV\+=HM^"X6;C1N4JYPKH[NK6[+KNGO"&\
MF[T5O8^^"KZ$OO^_>K_UP'#`[,%GP>/"7\+;PUC#U,11Q,[%2\7(QD;&P\=!
MQ[_(/<B\R3K)N<HXRK?+-LNVS#7,M<TUS;7.-LZVSS?/N-`YT+K1/-&^TC_2
MP=-$T\;42=3+U4[5T=95UMC77-?@V&38Z-ELV?':=MK[VX#<!=R*W1#=EMX<
MWJ+?*=^OX#;@O>%$X<SB4^+;XV/CZ^1SY/SEA.8-YI;G'^>IZ#+HO.E&Z=#J
M6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_RC/,9\Z?T-/3"]5#UWO9M
M]OOWBO@9^*CY./G'^E?ZY_MW_`?\F/TI_;K^2_[<_VW__P(,`/>$\_L*#0IE
M;F1S=')E86T-96YD;V)J#3(R(#`@;V)J/#PO4W1E;58@.#@O1F]N=$YA;64O
M07)I86Q-5"]&;VYT4W1R971C:"].;W)M86PO1F]N=%=E:6=H="`T,#`O1FQA
M9W,@,S(O1&5S8V5N="`M,C$Q+T9O;G1"0F]X6RTV-C4@+3,R-2`R,#`P(#$P
M,#9=+T%S8V5N="`Y,#4O1F]N=$9A;6EL>2A!<FEA;"DO0V%P2&5I9VAT(#<Q
M."]82&5I9VAT(#4Q-2]4>7!E+T9O;G1$97-C<FEP=&]R+TET86QI8T%N9VQE
M(#`^/@UE;F1O8FH-,2`P(&]B:CP\+T-R;W!";WA;,"`P(#8Q,B`W.3)=+U!A
M<F5N="`V(#`@4B]#;VYT96YT<R`S(#`@4B]2;W1A=&4@,"]-961I84)O>%LP
M(#`@-C$R(#<Y,ETO4F5S;W5R8V5S(#(@,"!2+U1Y<&4O4&%G93X^#65N9&]B
M:@TR(#`@;V)J/#PO0V]L;W)3<&%C93P\+T-S-B`Q-2`P(%(^/B]&;VYT/#PO
M5%0R(#$S(#`@4B]45#0@,30@,"!2/CXO4')O8U-E=%LO4$1&+U1E>'1=+T5X
M=$=3=&%T93P\+T=3,2`Q."`P(%(^/CX^#65N9&]B:@TS(#`@;V)J/#PO3&5N
M9W1H(#DY-"]&:6QT97(O1FQA=&5$96-O9&4^/G-T<F5A;0T*2(FT5EMOVS84
M?O>OX"-91#(ODBCE+6F"H@-6%+7VU.Y!D>E8K2-O$HTU^_4]AX=R["3N/&"#
M`>N(E^\[EX^'FK];*'8_SJ[KV;RN,Z98O9HIF4K-)/S(JB2S8)6:U0^S^=NQ
M8.T8IB4;VWXF6=WBWU\SSD3]%<Q$I2JK+*MO9@D@2,#`)6`IB^L^\ROOFW;M
MEJP9V:W(TXI_%SHM^;J[ZSRKJE0Q\7O]"[JB=&Z!:<)2Q81E%&%U(_-KQWYU
MP[U(LK3@;F"BX%?Q;7!.)`4P/(@*&%Q/PSZ-#"K-C%+DLPD^_S0@&JK?1`.R
MIBEKB4EUEN=A;9X3$/J;(=IGOGC_[H/(^54-7EC^VZ?;\%R0$T^Y/P`Q]LF;
MDX[(0\=/KDJT2O.\J%Y41AG*IE*RH&Q^W&%^#!_&:#10GHSW].(%`'#FMR'E
M@_LS+NH&]R"P6#&_L')D6[)64-D,]JSIU6%Q%J[=#9WO')3_.XVW<;[I0TJT
M3E69%P>5E]7>5TV^0H4-%!;J*U/-0]%;S[8KM!3-528CXX)Y8=.<K^,><#YN
M[R"FG(]^$EQ1EH>T6D^T*B?:`5Q,<F#T(O"N0<3+'0UM'EG;1'L$?6/4:(-(
M`WYB0.8V,T=ZV\N:XHRZ'MP?`I4*:02-\L$+S")D>1K!,.\<&SL<NP]K>YIQ
MR_`&%3@89!T`(,@8`J;=HH24KYOPV,#<"G-I.;M[)(3`MXZHN&77AXFE&T`7
M)F(A\GU/8,L+402-P-BT<:"I770GG#^8WC+R<T?+D#_2-KM#8@IC(-="M'^[
M94HT(:M'DC]Q?$\>$0L]+H^GE#&1:%U2?N+)C.=;FS2#3L&P1DJ_4"4()0N<
M5YMVVU^P]WV;3ATBGNUD#_%TNND4!@STPQJJ_9$?18'A?^&?7&AIH-C1!PVB
M[;\()G1EY7$JS+/0Y$E<&%&V*O81'^7FK!U9*DW^LK?(<I^9&-5-X]TE["YU
M`6JX<2TU#=3AP%1Q@?K24DE8DD.[@NBN'R\Q3-1ZW#4?YVSAW:KIV74S;N!,
M4\,//2-5!=PP!PD@1[+]]5/%-$QH8%1&YD100!0P]J$!KZ"1P>$V_))-;.`;
M$DY<K]QREFA*7>9/V2XS6P6=0DC&\+KS&\P!T<,UN,4F9/G0T],]AI.2=/$]
M$=!`FQ9[EXWIALM,5;9X7<+_NL[F_#K_=\K8W^%:_509Y3\J0Q\KXV/CAZ[]
M!M)HUQ&A$7@M]?TIB9RC!L1Q`0?T$#FP/A`Q,I%YS$=C/=U]KS2I_UTF\(F"
M)+9\)HMG3%A$:;-R7[,C>9DS/D'VWT+G?8N\LNJVGOT08`#Z^4ZI"@T*96YD
M<W1R96%M#65N9&]B:@TT(#`@;V)J/#PO3G5M<ULP(#4@,"!273X^#65N9&]B
M:@TU(#`@;V)J/#PO4R]$/CX-96YD;V)J#38@,"!O8FH\/"]#;W5N="`R+U1Y
M<&4O4&%G97,O2VED<ULQ,2`P(%(@,2`P(%)=/CX-96YD;V)J#3<@,"!O8FH\
M/"]3=6)T>7!E+UA-3"],96YG=&@@,S4U,R]4>7!E+TUE=&%D871A/CYS=')E
M86T-"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53
M>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T
M82\B('@Z>&UP=&L](C,N,2TW,#$B/@H@("`\<F1F.E)$1B!X;6QN<SIR9&8]
M(FAT='`Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B
M/@H@("`@("`\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@("`@("`@
M("`@("!X;6QN<SIP9&8](FAT='`Z+R]N<RYA9&]B92YC;VTO<&1F+S$N,R\B
M/@H@("`@("`@("`\<&1F.E!R;V1U8V5R/D%C<F]B870@1&ES=&EL;&5R(#<N
M,"`H5VEN9&]W<RD\+W!D9CI0<F]D=6-E<CX*("`@("`@/"]R9&8Z1&5S8W)I
M<'1I;VX^"B`@("`@(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B`@
M("`@("`@("`@('AM;&YS.GAA<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O
M,2XP+R(^"B`@("`@("`@(#QX87`Z0W)E871O<E1O;VP^4%-C<FEP=#4N9&QL
M(%9E<G-I;VX@-2XR+C(\+WAA<#I#<F5A=&]R5&]O;#X*("`@("`@("`@/'AA
M<#I-;V1I9GE$871E/C(P,3`M,3(M,394,3`Z,S,Z-#`M,#8Z,#`\+WAA<#I-
M;V1I9GE$871E/@H@("`@("`@("`\>&%P.D-R96%T941A=&4^,C`Q,"TQ,BTQ
M-E0Q,#HS,SHT,"TP-CHP,#PO>&%P.D-R96%T941A=&4^"B`@("`@(#PO<F1F
M.D1E<V-R:7!T:6]N/@H@("`@("`\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U
M=#TB(@H@("`@("`@("`@("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C
M+V5L96UE;G1S+S$N,2\B/@H@("`@("`@("`\9&,Z9F]R;6%T/F%P<&QI8V%T
M:6]N+W!D9CPO9&,Z9F]R;6%T/@H@("`@("`@("`\9&,Z=&ET;&4^"B`@("`@
M("`@("`@(#QR9&8Z06QT/@H@("`@("`@("`@("`@("`\<F1F.FQI('AM;#IL
M86YG/2)X+61E9F%U;'0B/DUI8W)O<V]F="!7;W)D("T@86-L-FLQ,C$V9FEN
M86QM97)G97(N9&]C/"]R9&8Z;&D^"B`@("`@("`@("`@(#PO<F1F.D%L=#X*
M("`@("`@("`@/"]D8SIT:71L93X*("`@("`@("`@/&1C.F-R96%T;W(^"B`@
M("`@("`@("`@(#QR9&8Z4V5Q/@H@("`@("`@("`@("`@("`\<F1F.FQI/G5S
M,#,Y.#$P/"]R9&8Z;&D^"B`@("`@("`@("`@(#PO<F1F.E-E<3X*("`@("`@
M("`@/"]D8SIC<F5A=&]R/@H@("`@("`\+W)D9CI$97-C<FEP=&EO;CX*("`@
M("`@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*("`@("`@("`@("`@
M>&UL;G,Z>&%P34T](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B
M/@H@("`@("`@("`\>&%P34TZ1&]C=6UE;G1)1#YU=6ED.F9A-S0R-F,S+60Q
M-C,M-#%C-BUB93@S+6%D8V(W-C5A8C1A8SPO>&%P34TZ1&]C=6UE;G1)1#X*
M("`@("`@("`@/'AA<$U-.DEN<W1A;F-E240^=75I9#IE.#)C8S`T,"TT,C)D
M+30V-V(M.3=F,2TW,&4P9#`X,&5C,C`\+WAA<$U-.DEN<W1A;F-E240^"B`@
M("`@(#PO<F1F.D1E<V-R:7!T:6]N/@H@("`\+W)D9CI21$8^"CPO>#IX;7!M
M971A/@H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"CP_>'!A8VME="!E;F0](G<B
M/SX-"F5N9'-T<F5A;0UE;F1O8FH-."`P(&]B:CP\+T-R96%T:6]N1&%T92A$
M.C(P,3`Q,C$V,3`S,S0P+3`V)S`P)RDO075T:&]R*'5S,#,Y.#$P*2]#<F5A
M=&]R*%!38W)I<'0U+F1L;"!697)S:6]N(#4N,BXR*2]0<F]D=6-E<BA!8W)O
M8F%T($1I<W1I;&QE<B`W+C`@7"A7:6YD;W=S7"DI+TUO9$1A=&4H1#HR,#$P
M,3(Q-C$P,S,T,"TP-B<P,"<I+U1I=&QE*$UI8W)O<V]F="!7;W)D("T@86-L
M-FLQ,C$V9FEN86QM97)G97(N9&]C*3X^#65N9&]B:@UX<F5F#0HP(#D-"C`P
M,#`P,#`P,#`@-C4U,S4@9@T*,#`P,#`P.#,X,B`P,#`P,"!N#0HP,#`P,#`X
M-3`W(#`P,#`P(&X-"C`P,#`P,#@V,C<@,#`P,#`@;@T*,#`P,#`P.38X.2`P
M,#`P,"!N#0HP,#`P,#`Y-S(R(#`P,#`P(&X-"C`P,#`P,#DW-#4@,#`P,#`@
M;@T*,#`P,#`P.3@P,B`P,#`P,"!N#0HP,#`P,#$S-#,Q(#`P,#`P(&X-"G1R
K86EL97(-"CP\+U-I>F4@.3X^#0IS=&%R='AR968-"C$Q-@T*)25%3T8-"C\_
`
end
</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>acl6k1216finalmergerex991.pdf
<DESCRIPTION>EXHIBIT 99.1 PDF
<TEXT>
<PDF>
begin 644 acl6k1216finalmergerex991.pdf
M)5!$1BTQ+C0-)>+CS],-"C<Q(#`@;V)J(#P\+TQI;F5A<FEZ960@,2],(#DR
M,30Y+T\@-S,O12`X-34V+TX@,C$O5"`Y,#8X,B]((%L@-C,V(#,S-UT^/@UE
M;F1O8FH-("`@("`@("`@("`@("`@("`@#0IX<F5F#0HW,2`Q-PT*,#`P,#`P
M,#`Q-B`P,#`P,"!N#0HP,#`P,#`P.3<S(#`P,#`P(&X-"C`P,#`P,#$P-3,@
M,#`P,#`@;@T*,#`P,#`P,3$X,B`P,#`P,"!N#0HP,#`P,#`Q,S(U(#`P,#`P
M(&X-"C`P,#`P,#$V,3<@,#`P,#`@;@T*,#`P,#`P,C,W."`P,#`P,"!N#0HP
M,#`P,#`R.#DY(#`P,#`P(&X-"C`P,#`P,#(Y,S,@,#`P,#`@;@T*,#`P,#`P
M,S$U-B`P,#`P,"!N#0HP,#`P,#`S,SDX(#`P,#`P(&X-"C`P,#`P,#,V-#8@
M,#`P,#`@;@T*,#`P,#`P,S<R,B`P,#`P,"!N#0HP,#`P,#`T.38V(#`P,#`P
M(&X-"C`P,#`P,#4V,S(@,#`P,#`@;@T*,#`P,#`P-3@X-R`P,#`P,"!N#0HP
M,#`P,#`P-C,V(#`P,#`P(&X-"G1R86EL97(-"CP\+U-I>F4@.#@O4')E=B`Y
M,#8W,2]2;V]T(#<R(#`@4B]);F9O(#<P(#`@4B])1%L\0T(T-#E&0T5",S8V
M.48Y,#0W0S(Y1D)",3`X-S!!140^/#!#.3A&,3DW,$5$-$-&-#,X-SA$,T(P
M03%"-CA!0D8W/ET^/@T*<W1A<G1X<F5F#0HP#0HE)45/1@T*("`@("`@("`@
M("`@(`T*.#<@,"!O8FH\/"],96YG=&@@,C4P+T9I;'1E<B]&;&%T941E8V]D
M92])(#0R-B],(#0Q,"]3(#,V,#X^<W1R96%M#0IXVF)@8&!F8&`ZP\#"P,`2
MS,#+@`"\0#$0Y-B`$#O^<$%K$>?6C1O_/N]:6.UM)77E47JD(V<;_]\$;=8^
MOP4'&!AVSKR]>_?=W;MW[YT`UL*:5-PR-TS=LN4JA&'A^?XTB#G_+9#M_Q*-
M^0^LXA]8Q;\Y>U&5>/[#IAJJX`U(L><%D)5*#4""`XC38`P&06,0DTD#["0T
M)D2%4BB8S2@!%X<P!1M012&J(0I$(\!,(D(%"&P9&/UJ@#0?$`N`1908>%@_
MY`HH79<K8."^<($W0<M[407O+6_V@H-@>7L&1O\?(+<"L340NS$PQK\!V0O$
MGP`"#``"E'I<#0IE;F1S=')E86T-96YD;V)J#3<R(#`@;V)J/#PO365T861A
M=&$@-CD@,"!2+U!A9V5S(#8U(#`@4B]4>7!E+T-A=&%L;V<O4&%G94QA8F5L
M<R`V,R`P(%(^/@UE;F1O8FH--S,@,"!O8FH\/"]#<F]P0F]X6S`@,"`V,3(@
M-SDR72]087)E;G0@-C8@,"!2+T-O;G1E;G1S(#@S(#`@4B]2;W1A=&4@,"]-
M961I84)O>%LP(#`@-C$R(#<Y,ETO4F5S;W5R8V5S(#<T(#`@4B]4>7!E+U!A
M9V4^/@UE;F1O8FH--S0@,"!O8FH\/"]#;VQO<E-P86-E/#PO0W,V(#<X(#`@
M4CX^+T9O;G0\/"]45#(@-S4@,"!2+U14-"`W-B`P(%(O5%0V(#<W(#`@4B]4
M5#@@.#0@,"!2/CXO4')O8U-E=%LO4$1&+U1E>'1=+T5X=$=3=&%T93P\+T=3
M,2`X,B`P(%(^/CX^#65N9&]B:@TW-2`P(&]B:CP\+U-U8G1Y<&4O5')U951Y
M<&4O1F]N=$1E<V-R:7!T;W(@-SD@,"!2+TQA<W1#:&%R(#@T+U=I9'1H<ULS
M-3(@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@-C,V(#8S-B`V,S8@
M-C,V(#8S-B`V,S8@-C,V(#8S-B`V,S8@-C,V(#`@,"`P(#`@,"`P(#`@-C@T
M(#`@-CDX(#<W,2`V,S(@-3<U(#`@,"`T,C$@,"`P(#4U-R`P(#<T."`W.#<@
M,"`P(#`@,"`V,39=+T)A<V5&;VYT+U9E<F1A;F$O1FER<W1#:&%R(#,R+T5N
M8V]D:6YG+U=I;D%N<VE%;F-O9&EN9R]4>7!E+T9O;G0^/@UE;F1O8FH--S8@
M,"!O8FH\/"]3=6)T>7!E+U1R=654>7!E+T9O;G1$97-C<FEP=&]R(#@P(#`@
M4B],87-T0VAA<B`R-3(O5VED=&AS6S(U,"`P(#0P."`P(#`@.#,S(#<W."`Q
M.#`@,S,S(#,S,R`P(#4V-"`R-3`@,S,S(#(U,"`R-S@@-3`P(#4P,"`U,#`@
M-3`P(#4P,"`U,#`@-3`P(#4P,"`U,#`@-3`P(#(W."`R-S@@,"`P(#`@,"`P
M(#<R,B`V-C<@-C8W(#<R,B`V,3$@-34V(#<R,B`W,C(@,S,S(#,X.2`P(#8Q
M,2`X.#D@-S(R(#<R,B`U-38@,"`V-C<@-34V(#8Q,2`W,C(@-S(R(#DT-"`W
M,C(@-S(R(#8Q,2`S,S,@,"`S,S,@,"`P(#`@-#0T(#4P,"`T-#0@-3`P(#0T
M-"`S,S,@-3`P(#4P,"`R-S@@,C<X(#4P,"`R-S@@-S<X(#4P,"`U,#`@-3`P
M(#4P,"`S,S,@,S@Y(#(W."`U,#`@-3`P(#<R,B`U,#`@-3`P(#0T-"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,S,S
M(#0T-"`T-#0@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@-#0T
M(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#4P,"`P(#`@,"`P(#`@-3`P72]"
M87-E1F]N="]4:6UE<TYE=U)O;6%N4%--5"]&:7)S=$-H87(@,S(O16YC;V1I
M;F<O5VEN06YS:45N8V]D:6YG+U1Y<&4O1F]N=#X^#65N9&]B:@TW-R`P(&]B
M:CP\+U-U8G1Y<&4O5')U951Y<&4O1F]N=$1E<V-R:7!T;W(@.#$@,"!2+TQA
M<W1#:&%R(#$T-B]7:61T:'-;,C4P(#`@-34U(#`@,"`P(#`@,"`S,S,@,S,S
M(#`@,"`R-3`@,S,S(#(U,"`P(#4P,"`U,#`@-3`P(#4P,"`U,#`@-3`P(#4P
M,"`U,#`@-3`P(#4P,"`P(#`@,"`P(#`@,"`P(#<R,B`V-C<@-S(R(#<R,B`V
M-C<@-C$Q(#<W."`W-S@@,S@Y(#4P,"`P(#8V-R`Y-#0@-S(R(#<W."`V,3$@
M,"`W,C(@-34V(#8V-R`W,C(@-S(R(#$P,#`@,"`W,C(@,"`P(#`@,"`P(#`@
M,"`U,#`@-34V(#0T-"`U-38@-#0T(#,S,R`U,#`@-34V(#(W."`S,S,@-34V
M(#(W."`X,S,@-34V(#4P,"`U-38@-34V(#0T-"`S.#D@,S,S(#4U-B`U,#`@
M-S(R(#4P,"`U,#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(#`@,S,S72]"87-E1F]N="]4:6UE<TYE=U)O;6%N4%,M
M0F]L9$U4+T9I<G-T0VAA<B`S,B]%;F-O9&EN9R]7:6Y!;G-I16YC;V1I;F<O
M5'EP92]&;VYT/CX-96YD;V)J#3<X(#`@;V)J6R])0T-"87-E9"`X-B`P(%)=
M#65N9&]B:@TW.2`P(&]B:CP\+U-T96U6(#DR+T9O;G1.86UE+U9E<F1A;F$O
M1F]N=%-T<F5T8V@O3F]R;6%L+T9O;G1796EG:'0@-#`P+T9L86=S(#,R+T1E
M<V-E;G0@+3(P.2]&;VYT0D)O>%LM-3`@+3(P-R`Q-#0W(#$P,#!=+T%S8V5N
M="`Q,#`U+T9O;G1&86UI;'DH5F5R9&%N82DO0V%P2&5I9VAT(#<S-"]82&5I
M9VAT(#4T-B]4>7!E+T9O;G1$97-C<FEP=&]R+TET86QI8T%N9VQE(#`^/@UE
M;F1O8FH-.#`@,"!O8FH\/"]3=&5M5B`X,B]&;VYT3F%M92]4:6UE<TYE=U)O
M;6%N4%--5"]&;VYT4W1R971C:"].;W)M86PO1F]N=%=E:6=H="`T,#`O1FQA
M9W,@,S0O1&5S8V5N="`M,C$V+T9O;G1"0F]X6RTU-C@@+3,P-R`R,#`P(#$P
M,#==+T%S8V5N="`X.3$O1F]N=$9A;6EL>2A4:6UE<R!.97<@4F]M86XI+T-A
M<$AE:6=H="`V-38O6$AE:6=H="`M-30V+U1Y<&4O1F]N=$1E<V-R:7!T;W(O
M271A;&EC06YG;&4@,#X^#65N9&]B:@TX,2`P(&]B:CP\+U-T96U6(#$S-B]&
M;VYT3F%M92]4:6UE<TYE=U)O;6%N4%,M0F]L9$U4+T9O;G13=')E=&-H+TYO
M<FUA;"]&;VYT5V5I9VAT(#<P,"]&;&%G<R`S-"]$97-C96YT("TR,38O1F]N
M=$)";WA;+34U."`M,S`W(#(P,#`@,3`R-ETO07-C96YT(#@Y,2]&;VYT1F%M
M:6QY*%1I;65S($YE=R!2;VUA;BDO0V%P2&5I9VAT(#8U-B]82&5I9VAT("TU
M-#8O5'EP92]&;VYT1&5S8W)I<'1O<B])=&%L:6-!;F=L92`P/CX-96YD;V)J
M#3@R(#`@;V)J/#PO3U!-(#$O3U`@9F%L<V4O;W`@9F%L<V4O5'EP92]%>'1'
M4W1A=&4O4T$@9F%L<V4O4TT@,"XP,CX^#65N9&]B:@TX,R`P(&]B:CP\+TQE
M;F=T:"`Q,3<T+T9I;'1E<B]&;&%T941E8V]D93X^<W1R96%M#0I(B>Q6R7+<
M-A"]SU?@"*1,"#O`HR2GK*02.U7FS<J!&F.69,1QD;14RF_$W^J3#VDTN(PX
MUC&52TJE(8BE^_7K[D=<O'DOR;9;756KBZI21))JLRJ)@+^26%-RYXBW@0=%
MJOO5Q77GR+K#94&Z=;,2I%JGG\<5):SZ8R4%%PI7\R@8+L""%CPD`WF3YJ:4
MI/"PP\N25*^'>4!@,@)!G.>JU"8M2@<HG$J>*,&-@A2*>Z]L6A9Y(<U7/\R6
M7+:D>%D:4EC)G73AN[X@.&&("=Q:@6@4UR*-)G^S.:EY&7)\.)(!CBEB(<Z`
M$180E!`::8&1MHF;#_37V&Y9X;BGL267VS;&^]CT:48#GM^KGT\`+3F46G&C
MQFR`#_"L2G?"_`*DY;8$-`F*5`N*9C>%X=)K3PK--5"=]F7P:%ER8]/A!/[=
M!CRH`%/T=5S'>P:X`KV#2)@T@$I2:5ZEL;4P5D**')+DPNH2'1B/#I)5,2/_
M0"?#^4212@,@25X:(6=(/AW!H0[YX%7L'V-LX'PAE0!F9AH'%ES.^,P"GE=J
M,J5T-O66`16.'A]J5EBN:-NG"4OW';G,2V^8AOEEG@3B=&;&J>68=^.R[>MC
MRK&D]RQ`IC_EE[K)SR?R]O.P?)>?0.GU39%@&*J\R)-<#\_A7:CQW>6!9.!=
MTD)EA!F7=Q,LJ6?ZAI3^LE_O4FR:]EW?UET7"93J?%Q#=\V<36'I,:R;PB24
M`,:Z/"!7=1</V03T878LYR)]_[CO_XKMH6X^CCW\'*6PV8LR?FB:FJR/6&QE
M8DY#2NKFB1SV]_L^?B1W3Z3;U<REC&%^8D=NZ9BC,/6KTA"9F,D()^5W^6>_
MC\TV,1'@?#P<NLQ+H'5^;)B``N@7J0=QLGZPBD9'Z-GL+2.?/C-#VP[@E30-
M:R:A^9L>ZA7,'?%1,P]S+4M\TYX3!_L4_$.>H=HV&\Z@DRENO7['S%3CA1)9
M01=Y$FK,D_09R*Y^V$/E*=ILR;[O2!=K0.#HOAG2=4MWL8W#GGK30P'^O>@C
M"30(B&P*5I\0^!8"A-8!DP]URTH(IV=)Y?8LE7"WH$US9Y6?+0G,!?T"?*62
M*&0`?;`RJWLP"^F""I`2-!?U1"[TY%Q*@&\9W)F6Z%'=QEJ^S.T&9;E4$`A<
M![U4D/QEP+[`=-/+P_K8O"(_-6M^]AG[5Q5"OJ00TH_SPT`-"E&^H!!JJAP]
M5,[5URR&T`_$E=]1!CP6)F'Q@YA>LR0&-]`UAA90"I:ZY%M1#0MA^)5YBMQ\
MP]<F0N58VMSE9XO'MKCTOY[\-WHR$CB)2)E:9`O&R![(,1"!Q@9/9**LX#MJ
M"XX:]'F#7K[!L28V\'N79N,I3#0)-!N8VN%JDB/T!G*$IF*+J^?"Y'EB?R;M
M628.*=&*0FLNN%9XQ9@3:-5"A*`&I3VKINE*)_$&0F]IK*$W:H#U[/*E\S5R
MMN_D":S?H`S2A:G-'0PW#8!#G\X@8A[$XDXV?HN3H2\D%7Y_W,9^ERYB4`2[
M>$:1SW?;V9!1"S`>RQV;`:^C<.V)^74IWODF_2)O/U:K?P08`*/OOI@*#0IE
M;F1S=')E86T-96YD;V)J#3@T(#`@;V)J/#PO4W5B='EP92]4<G5E5'EP92]&
M;VYT1&5S8W)I<'1O<B`X-2`P(%(O3&%S=$-H87(@,C4R+U=I9'1H<ULR-3`@
M,"`P(#`@,"`P(#`@,"`S,S,@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(#`@,"`P(#`@-C$Q(#`@,"`P(#8Q,2`P(#`@-S(R(#`@
M,"`V-C<@,"`P(#`@,"`P(#`@-C$Q(#`@-34V(#<R,B`P(#`@,"`P(#4U-B`P
M(#`@,"`P(#`@,"`U,#`@-3`P(#0T-"`U,#`@-#0T(#(W."`U,#`@-3`P(#(W
M."`P(#0T-"`R-S@@,"`U,#`@-3`P(#`@,"`S.#D@,S@Y(#(W."`U,#`@-#0T
M(#8V-R`P(#`@,S@Y(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#4P,%TO0F%S949O;G0O5&EM97-.97=2;VUA;E!3+4ET86QI8TU4+T9I<G-T
M0VAA<B`S,B]%;F-O9&EN9R]7:6Y!;G-I16YC;V1I;F<O5'EP92]&;VYT/CX-
M96YD;V)J#3@U(#`@;V)J/#PO4W1E;58@-S$N-S0R+T9O;G1.86UE+U1I;65S
M3F5W4F]M86Y04RU)=&%L:6--5"]&;VYT4W1R971C:"].;W)M86PO1F]N=%=E
M:6=H="`T,#`O1FQA9W,@.3@O1&5S8V5N="`M,C$V+T9O;G1"0F]X6RTT.3@@
M+3,P-R`Q,3(P(#$P,C-=+T%S8V5N="`X.3$O1F]N=$9A;6EL>2A4:6UE<R!.
M97<@4F]M86XI+T-A<$AE:6=H="`V-38O6$AE:6=H="`M-30V+U1Y<&4O1F]N
M=$1E<V-R:7!T;W(O271A;&EC06YG;&4@+3$U/CX-96YD;V)J#3@V(#`@;V)J
M/#PO3&5N9W1H(#(U-S4O1FEL=&5R+T9L871E1&5C;V1E+TX@,R]!;'1E<FYA
M=&4O1&5V:6-E4D="/CYS=')E86T-"DB)G)9Y5%-W%L=_;\F>D)6PPV,-6X"P
M!I`U;&&1'011"$D(`1)"2-@%040%%$5$A*J5,M9M=$9/19TNKF.M#M9]ZM(#
M]3#JZ#BT%M>.G1<X1YU.9Z;3[Q_O]SGW=^_OW=^]]YWS`*`GI:JUU3`+`(W6
MH,]*C,46%11BI`D``PH@`A$`,GFM+BT[(0?@DL9+L%K<"?R+GEX'D&F](DS*
MP##P_XDMU^D-`$`9.`<HE+5RG#MQKJHWZ$SV&9QYI94FAE$3Z_$$<;8TL6J>
MO>=\YCG:Q`J-5H&S*6>=0J,P\6F<5]<9E3@CJ3AWU:F5]3A?Q=FERJA1X_S<
M%*M1RFH!0.DFNT$I+\?9#V>Z/B=+@O,"`,ATU3M<^@X;E`T&TZ4DU;I&O5I5
M;L#<Y1Z8*#14C"4IZZN4!H,P0R:OE.D5F*1:HY-I&P&8O_.<.*;:8GB1@T6A
MP<%"?Q_1.X7ZKYN_4*;>SM.3S+F>0?P+;VT_YU<]"H!X%J_-^K>VTBT`C*\$
MP/+F6YO+^P`P\;X=OOC.??BF>2DW&'1AOK[U]?4^:J7<QU30-_J?#K]`[[S/
MQW3<F_)@<<HRF;'*@)GJ)J^NJC;JL5J=3*[$A#\=XE\=^/-Y>&<IRY1ZI1:/
MR,.G3*U5X>W6*M0&=;464VO_4Q-_9=A/-#_7N+ACKP&OV`>P+O(`\K<+`.72
M`%*T#=^!WO0ME9(',O`UW^'>_-S/"?KW4^$^TZ-6K9J+DV3E8'*COFY^S_19
M`@*@`B;@`2M@#YR!.Q`"?Q`"PD$TB`?)(!WD@`*P%,A!.=``/:@'+:`==($>
ML!YL`L-@.Q@#N\%^<!",@X_!"?!'<!Y\":Z!6V`23(.'8`8\!:\@"")!#(@+
M64$.D"OD!?E#8B@2BH=2H2RH`"J!5)`6,D(MT`JH!^J'AJ$=T&[H]]!1Z`1T
M#KH$?05-00^@[Z"7,`+381YL![O!OK`8CH%3X!QX":R":^`FN!->!P_!H_`^
M^#!\`CX/7X,GX8?P+`(0&L)''!$A(D8D2#I2B)0A>J05Z48&D5%D/W(,.8M<
M02:11\@+E(AR40P5HN%H$IJ+RM$:M!7M18?17>AA]#1Z!9U"9]#7!`;!EN!%
M""-("8L(*D(]H8LP2-A)^(APAG"-,$UX2B02^40!,8281"P@5A";B;W$K<0#
MQ./$2\2[Q%D2B61%\B)%D-)),I*!U$7:0MI'^HQTF31->DZFD1W(_N0$<B%9
M2^X@#Y+WD#\E7R;?([^BL"BNE#!*.D5!::3T4<8HQR@7*=.45U0V54"-H.90
M*ZCMU"'J?NH9ZFWJ$QJ-YD0+I672U+3EM"':[VB?TZ9H+^@<NB==0B^B&^GK
MZ!_2C]._HC]A,!ANC&A&(</`6,?8S3C%^)KQW(QKYF,F-5.8M9F-F!TVNVSV
MF$EANC)CF$N93<Q!YB'F1>8C%H7EQI*P9*Q6U@CK*.L&:Y;-98O8Z6P-NY>]
MAWV.?9]#XKAQXCD*3B?G`\XISETNPG7F2KAR[@KN&/<,=YI'Y`EX4EX%KX?W
M6]X$;\:<8QYHGF?>8#YB_HGY)!_AN_&E_"I^'_\@_SK_I86=18R%TF*-Q7Z+
MRQ;/+&TLHRV5EMV6!RRO6;ZTPJSBK2JM-EB-6]VQ1JT]K3.MZZVW69^Q?F3#
MLPFWD=MTVQRTN6D+VWK:9MDVVWY@>\%VUL[>+M%.9[?%[I3=(WN^?;1]A?V`
M_:?V#QRX#I$.:H<!A\\<_HJ98S%8%3:$G<9F'&T=DQR-CCL<)QQ?.0F<<ITZ
MG`XXW7&F.HN=RYP'G$\ZS[@XN*2YM+CL=;GI2G$5NY:[;G8]Z_K,3>"6[[;*
M;=SMOL!2(!4T"?8*;KLSW*/<:]Q'W:]Z$#W$'I4>6SV^](0]@SS+/4<\+WK!
M7L%>:J^M7I>\"=ZAWEKO4>\;0KHP1E@GW"N<\N'[I/IT^(S[//9U\2WTW>![
MUO>U7Y!?E=^8WRT11Y0LZA`=$WWG[^DO]Q_QOQK`"$@(:`LX$O!MH%>@,G!;
MX)^#N$%I0:N"3@;](S@D6!^\/_A!B$M(2<A[(3?$/'&&N%?\>2@A-#:T+?3C
MT!=AP6&&L(-A?P\7AE>&[PF_OT"P0+E@;,'="*<(6<2.B,E(++(D\OW(R2C'
M*%G4:-0WT<[1BNB=T?=B/&(J8O;%/([UB]7'?A3[3!(F628Y'H?$)<9UQTW$
M<^)SXX?COTYP2E`E[$V820Q*;$X\GD1(2DG:D'1#:B>52W=+9Y)#DI<EGTZA
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M.93Z3P"D`5O^F+B9))F0F?R::)K5FT*;KYP<G(F<]YUDG=*>0)ZNGQV?BY_Z
MH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4XI:FF&J:+IOVG;J?@J%*HQ*DWJ:FJ
M'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[``L'6PZK%@L=:R2[+"LSBSKK0E
MM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\(;R;O16]C[X*OH2^
M_[]ZO_7`<,#LP6?!X\)?PMO#6,/4Q%'$SL5+Q<C&1L;#QT''O\@]R+S).LFY
MRCC*M\LVR[;,-<RUS37-M<XVSK;/-\^XT#G0NM$\T;[2/]+!TT33QM1)U,O5
M3M71UE76V-=<U^#89-CHV6S9\=IVVOO;@-P%W(K=$-V6WAS>HM\IWZ_@-N"]
MX43AS.)3XMOC8^/KY'/D_.6$Y@WFEN<?YZGH,NB\Z4;IT.I;ZN7K<.O[[(;M
M$>V<[BCNM.]`[\SP6/#E\7+Q__*,\QGSI_0T],+U4/7>]FWV^_>*^!GXJ/DX
M^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?__`@P`]X3S^PH-"F5N9'-T<F5A;0UE
M;F1O8FH-,2`P(&]B:CP\+T-R;W!";WA;,"`P(#8Q,B`W.3)=+U!A<F5N="`V
M-B`P(%(O0V]N=&5N=',@,R`P(%(O4F]T871E(#`O365D:6%";WA;,"`P(#8Q
M,B`W.3)=+U)E<V]U<F-E<R`R(#`@4B]4>7!E+U!A9V4^/@UE;F1O8FH-,B`P
M(&]B:CP\+T-O;&]R4W!A8V4\/"]#<S8@-S@@,"!2/CXO1F]N=#P\+U14,B`W
M-2`P(%(O5%0T(#<V(#`@4B]45#8@-S<@,"!2/CXO4')O8U-E=%LO4$1&+U1E
M>'1=+T5X=$=3=&%T93P\+T=3,2`X,B`P(%(^/CX^#65N9&]B:@TS(#`@;V)J
M/#PO3&5N9W1H(#(T-#<O1FEL=&5R+T9L871E1&5C;V1E/CYS=')E86T-"DB)
MQ)?+<MLX%H;W>@HLP848@L2%6"JV>\I=B;NKK:I>N'K!EFB94PJ5$6DG>8T\
M<9\#\$Z14">R1ZER)!(`P>\_EQ_O_G//R*Y8O%\OWJW7(6%D_;C0)(!_FH1:
M^W%,%.>^BLGZT^+=52')IC"W`U)L\L4R\(,@T&2]601D_67Q0*]^N_OE]OKF
M;GWK+:6OZ,I;<OJ!>'^M?UTP&!V:N?:;X-J7DB@&`R4^(,"%*/'6_UTL>>AK
MN+J4L2]5H,CZNKH#&Y5VHS!"<R(%[%*&.,!L1T1F.[BQV.YIG7C+V(_HW[`E
MNO>6,(^FL"]?4G*PMQZ]I<*?.&)37<M+>S'-\6KUH_`",P[?9VDW`/\I%7+<
M0-"0L'L-[,U8]+;/F^USR7`$[%F;$0Q'L(H1R"$B7\`;LA`Y`2"[Q)`CD]SO
MCL)W9P*W@D"TJ#!\3(^[U(O]D!X]`7\)\2(!*/S_S\<@C"*?14K!JUCY6"B4
MP=<=20981`3HF-;=5QZ`/XU(:'A<@\C$R0-EOJ=\`>A-B+;LE<3H[TQI@W.T
MNA9^)`?+LS8.0RO`:G=,TT\>;%I!4)6D/!!/UK+`RHQ'<.?UR<.30@%/&KYR
MPW7PTFZN*NJ$7I]K.,&UG>+FVHRU]4;48,-N8$L3V)!-@/*/]//A6)(DWQ*X
MZ45P:]>4(+,73-:3(J$4L`RCY+T'Y8DF7DCW2;Y)R3T\0M(GN(?ZI27<5K#O
M,-+PFF\@2I_8G"@\]@5@$[Q2$40X55<Z`^;$;4898&%=5P*;J0_TYNL&E-:6
M3$R3?)>2PZ/'X9*IIROX&D/=A>U#;<W)_5-BQB-EG]&T(';PP;XYT`T"V50$
M4(;7&C%MGXB*1I34ND=6=Q#CRBP,]3OR.<T+LR"TAQ"6:"6OWP!X<P,QVZ;'
MI,P.^4_I%TX4J0Z_\Y(IXN-D"N>+5#O%G4R]Y0/6L.7]9(HM5&@35X>\R*!O
M"+HUCY>G4@AY,EC>YI#%27XZ*5S,/8@6/2HQ+?H^%S=Z)L;](9RO8^T4-_K>
M\K9#/]!;TQ$T_;Q/JV_0&RP_Z`Z02*97ET\IN?'0@7S%M!%T8SKYD_V1F!]Y
MU=X!2Z!`P,O3-A6*3^(^BX4AS8'(5)!'ITEWICA)]Y=O&P:K#.$Q3<I/-GA2
MCR&Z$DH6E(\8L-DKQS+)H%8!_1@IATCY6/<0+@1S-1%8K>X?G[,RV9MNA!)R
M^K_GS#2/\MM/-_U:%#DER@";,P<XT)[*@:'RM3+M%+<RO>71U_>]NFT.W#8'
M\-[0RG>9>2QLCD7=NL/KNJ.5L).+,D5K"[W[@F%_A@1+A9&D)B7H\W%+(.1D
M<H@)"=HI;@EZRP=-\+(J>*_2HNC6'T[)NNFR--EB+U`TMRUW1R!+S)X@V+E4
MK3[5L1"_R:ZVTFK+(4GJ`Q4D"V2?/1#X&EZG;?[(K4:VVJ-]P#>#;(R#N!,+
MHNWIX_/#C^JJ)CKZ`+;;B?%(U48K.NG$.@/FXJ(9->&+/F1%F>4[DABY<FN#
MMI!"YO<.[E:-&6E+>F>,\>'%#C^6F35,;)1IC4D(*I-@O#"WW4=#74P+#ZTP
M5#NH<7?@YA28,+`]]"7!9?'.RER]QAD1O;?C_[5UKJO==*HUB,Y,-:;&J1;-
MFJW.%'>J]98/:J<$'..^8C;-T"VC*!I%.59F2XJPDU6L$;UN9L@7,RL&W)!9
M`?8TP(L&V3-UZ0*I\*-J]%$YU8AT/.X]T:S_ZDQQJM&.M1J(D0:1.=%5*DB3
M&E:$B"D^)X*)\I4G3(";\#;\N7I-_HT`\90``SIN`50\F0X3MJPSQ2U`,W8Y
M:#U5.F"S[Q0I#^L7N3.GO5J+V(\4&*X9\V6TP`(E;8%2:-P$GC/!\467]\7G
MZ-"'Y.X8D=!U0^`G.T9GP)R>S:B>8P)'K-N6W"T<3X?]-K57BN_62GU,4TR/
M*J0OSF[B8\V`\'7`NYUHW.=)/-&E.^]^7NQ#,QK%/I]M!9TI[MAOQO:*#PH@
M(7306P'?2@!S!00P]<@(4,4^!'#7]HP%-74,4D:8!LRK!ER5(Z:PJEU2)DPI
M/1OY?41N%<)@W`+X?`MHI[A5Z"T?M/RX[GI49CUJDQ"J2@A>)839"&Q)AGI6
MC:JO$'"N)JD.]E0#)I;%XL)2=.70DW+T69U1B(*@T@^.'B<+43M@3M9FU.G^
M>9O#T2W[!'44#P-7AQ=;A/(D+YO@E5C*+TUL]F.+$/=C'<\7(<->3Q6B]MW/
M2H$P9J`1DNDE@9@M1;U)SC08/L(Z?!NZU6'M8WK<8>#'-A5"2E;/YM&PQ4"%
MI\)>Z*J-;[/RS1J%9>])`3N=#/L1';<($&VC;B!FZU!GBEN`9FSGE%LY47O`
MC4(=G8#,-#.=@^[>EG#[P>U%@<]C,=^7I])A@,FM!`_''4',>M+.%+<2O>7'
M;O+JD&^?-R56\?<>]#+Z#%T@HD66IP66)D@,+]:OX2I'G]IF3H=Y_[W=:,-P
M,LCY!-IVBAMM,W;9=ML'NLKSPW.^2:':,YKFYCF0O6'`3P14H%155,KBK2*^
M.K>Q8:EM.?<AN#D'T60(BPG.[10WY][R-H1M+8^;&+:A^KPOZ[.5.>;>F(ZK
MZ.?]X5MJ#DA*OX(MJ;%:<S+#M?_23JXLCB;C5Y[FVIGBY-J.7=85H3JN*LMU
M_90=P:,+NB6_HXT7</;\1J[V"3H9[)D%'JO`O&0Y>)K<ACK<"+3HNOBQ8.!^
MZ,8+J='J2U8^&;5*#_%59]J4V`Z-_5G`:X3!#RGG%F5`S"T*_)T*=C4A2CO%
M+4IO^1/L5E5,I_FV^0:UPP`\H!,'I+=0?H!<;HEF+ZFY_?L^R>N2#GWV0HEP
M!N'^Z[L)<SX9]L.#6$VXG>(FW%L^B%O"D=F917B=O62X"&Q(*G;"J80<3@?6
M#E9F?OMFE@7D1.CQ'/0^$3=T:+U383ULR#7T=HH;>C/6UAI5UYHP[$#_D)79
M#BLXKB2MVQJ0[YZJ<K(V^SMB&=+TN2B))S1\>V7XUJ:PH4]NV??!N-D'8C+@
M63"$#UY?A]TY;OB]]<<>\#H[IIOR<"R^8ZE-()`]27][A!^/V28]VIKQ'6*.
MDENXF-L*7;5<^P.+=`(5W18>0'1)PW@&\3X-)_%83@;[**4JX.T4)^_>ZM;J
M/=!?GH]8CC5]2@&6.7`B04Z+YV,"!<2PLU?,<>^5H_A,L&>]M4$JY70,CTZ4
M%FD[Q8FTM_J)KGC_)2L*\B=8B:?#WG2];9;O3-M;`UWZ]94QVA8X/*\U&/MO
MV@G/F_7B'P$&`%4@)V$*#0IE;F1S=')E86T-96YD;V)J#30@,"!O8FH\/"]#
M<F]P0F]X6S`@,"`V,3(@-SDR72]087)E;G0@-C8@,"!2+T-O;G1E;G1S(#8@
M,"!2+U)O=&%T92`P+TUE9&EA0F]X6S`@,"`V,3(@-SDR72]297-O=7)C97,@
M-2`P(%(O5'EP92]086=E/CX-96YD;V)J#34@,"!O8FH\/"]#;VQO<E-P86-E
M/#PO0W,V(#<X(#`@4CX^+T9O;G0\/"]45#(@-S4@,"!2+U14-"`W-B`P(%(O
M5%0V(#<W(#`@4CX^+U!R;V-3971;+U!$1B]497AT72]%>'1'4W1A=&4\/"]'
M4S$@.#(@,"!2/CX^/@UE;F1O8FH--B`P(&]B:CP\+TQE;F=T:"`Q-#<X+T9I
M;'1E<B]&;&%T941E8V]D93X^<W1R96%M#0I(B<276V_;-A3'W_TI^$@!%4.*
M%Y&/6=H-+9IL:(2]%'MP;=K1X,J=I738U]@GWB&I>TRK0X/4`1(K(@_)W__<
M>/7+/4/[>O53L;HJB@PQ5.Q6!E'X,2@SAFB-<B%(KE'Q>75U4RNTJ?UKBNI-
MM4HIH90:5&Q6%!5_KS[BFU_O?G[[^LU=\39)%<GQ=9(*_!XE?Q3O5@Q&9WYN
M^":%(4JAG,%`Y1:@SA!&2?'G*A49,?#?5&FB<IJCXG7[!C8JPD9AA%`,J9QP
M*H4?H=P(UBX"YY&<P)N<<D+]$8*)^4:8$F0\*AR+^V/!-Z;=V?#OZT.Y+9M_
MT+K:>C.29$PJL`(K^W'"S8#)+.>JQ9$8@'!,4D84_IRPC&C\)3P=;%,>*T1>
MY!,$X)1(E9EAQ[Q7#C,^12<YX&7&C+",Y#E/4&G`'89VQC]B19*<2,R""PS2
MY,IYUVC*!>M&$B`Z-4]9KX\(L-_L=G;3E%]M`J9QE:1P`FSK.E$8'7>H>0@O
M`@L-*IFQ>+P5CU*I@[U;>THDWCNY<FQ/Z#H18+!]/EGK]80W58.2/`?+SZ$3
M8\YC0(TIKEZ.&;`@WB5-X#?5#M8Y5;*(*N-)R[K,EJ"B5X8%DO>/GVK[UZ.%
M-1D&7+<0%ARO$P:/C3V5?A>P'VKFT=0I[:RL#^CF85WM;0+BX1HE6>;.\/W4
MSZB0R<LJS`$MZP!I-!8;\V4Z%88IRQI,S,/_.P5XFXB.%>0N2#@0#0`/_99(
M6/CD8H1A%Q<&;^S6NW*(#IV!C!?$:$!"W64V%)X>PI-%$'$0/*U0$$1NQ81+
M6.0%)9K26Q8([-&(0"(BT#!E6:!^;#K+7FVIN/[RY5!NUD$CZ?)4<W0Y"]T`
MQ0Q(NRT80OTN0):S1>HC%!E'._RV"24"GS8E1,X'NP]A!J:-SLY5+=YMI6YL
M*]KWRY0JS.;X!HVF`)<UHC(:1#*BT3!E6:.)^1X,55U%N#G^P!H^,)4NV"Y0
MG1YYD:K4*NKYZCS5T91%JL/8=):;\D"UL"?`RL#)R\K[/U3K!*H<]NY_:SO/
M5W)<'F1?KUNO=2Z;A?(LL?5!`_F-NDBZWG?EVH1RS7@.R>-YU&@K=E2.&:M+
M<@@-#1J22K7ZX?QL/SL:<$G6?E3:T0:E;LMZ8P^'M9O'B>!0HL\P%<P$J)4]
M/M;@">+[<\'__G0]JU%BO$G3Y:M,^5H49`1XD09VX/"-X2#RI^&07^QB1U.6
MPZ$?&\(A#PM`@=Z56ZC$KG'EX%!-N?:+P>T+3GHV7^>MYQ_<K>3%9(&<SK)+
M_CZ%L<S;=7$1WI'^=#1EF??$_$!/==7N[MB4&^N<G/\`)V^)<M7Z%N>$&=;I
M/0"4,>_NCW>1,=51GXYTGZ,IRXPGYH?"J8U/\>#<=5/_&+8>K\MU&5%:C^*(
M#VQ9%.XW,?"$A=91+XZTCZ,IBX2GYD?=HVCOJL=MN>O:1]=_KZLMNO9E%8IA
MM>V_-?4K]*'</X0M@6W&1GU^R$;^6]OR-*X-=3=?#DVENSJ`L5=N@7?'$II^
MYM)5!B\;=&=]G=A#.(4JGK"<QZILW[_/V[:>_8S.8AH1RD1=/-(;CJ8L"S`Q
M/Z21G+=IY-Y^;>\[ZT_ERV;DEF@JH"N<-VP#S^EAEWD*$W7H2%<XFK+,<V*^
M[SP@+>==6JY2W]%=U[7S-(/WU:B%>S&H+C/'H4Y/O`R5TZB3YA&HPY1EJ!/S
M3[-$>\?\=+#H_1JB6>._4?A;^<5A&P:6'.Z7K,\'/`LFMNC=XZFL(2%D>`LN
M!S%<;D+E(EK"D9XV*E3R+ID\^VT))3DC%]U^BF]9(7B(N;V.*#1,65:H'YMV
M63;PS7A`%.A*R"-;UP=JH!NN1!6Z?UC#"^-N-=PE8K\;340FS_;PW;WHX7CP
MX;.UI]#)_XMN#NNRC:7:::BPOU2:9[D1C>Y$<56FR$:J7!6%0N"XNZ<$P285
MB&ONH/<-SYMB]9\``P#EEQ79"@T*96YD<W1R96%M#65N9&]B:@TW(#`@;V)J
M/#PO0W)O<$)O>%LP(#`@-C$R(#<Y,ETO4&%R96YT(#8V(#`@4B]#;VYT96YT
M<R`Y(#`@4B]2;W1A=&4@,"]-961I84)O>%LP(#`@-C$R(#<Y,ETO4F5S;W5R
M8V5S(#@@,"!2+U1Y<&4O4&%G93X^#65N9&]B:@TX(#`@;V)J/#PO0V]L;W)3
M<&%C93P\+T-S-B`W."`P(%(^/B]&;VYT/#PO5%0R(#<U(#`@4B]45#0@-S8@
M,"!2+U14-B`W-R`P(%(^/B]0<F]C4V5T6R]01$8O5&5X=%TO17AT1U-T871E
M/#PO1U,Q(#@R(#`@4CX^/CX-96YD;V)J#3D@,"!O8FH\/"],96YG=&@@.3,W
M+T9I;'1E<B]&;&%T941E8V]D93X^<W1R96%M#0I(B:Q52V_<-A"^ZU?P2`(5
MS9?X.#J.&[A('`/6+<Y!EK5K%<YN*\EY_/O,#*75QDZ0%@D66%'BD)SO,9R3
M5]>:;<?B15V<U+5AFM6;(C$%O\1,2C)&%IR3(;+Z0W%R-GK6CC2MV-CNBE))
MI51B=5LH5G\JWO&SMY=_7KP\OZPO1.EEX*>B=/PU$^_KOPH-T8;6YE'EDO2>
M!0V!'@]0N!%GHOZ[*)V1";Z6/DH?5&#URWD&$O4Y48A(COD*LO0&`R@;@YN\
MX^>?[_O;?AJ%EYKG\V&ERRL5*PV<J2I<12",)1`PLC$C@0U$64G+>Z%@B]OY
M96):FAL.L*3GMS<B#VYX#T,\Y+PN-.!2F!C`H_RJR)1T(:7(AJ[8(-U/N3`:
MMC',>]A=*8ULY+P.:54Y+29*HZ*5D;_I!CS<\BVDQI<7)CSERAM1:GA_:';X
MU@I0D7=LO*?@;L*X/8XW0L,,N]Q_;.8MIGYDIZ]P[#AK1K;?K%M;7*($4'K=
M_8/C"=AQO/L@$CSHX"X?O.1C:(5660,P1>5<(OY#=+^1_^\(8+6,#`QDW7_@
M/T@XV5LK;?8BI*+=DA0J,K.OHXH`]8U`=)TPD-NP[43$IP`L*4O0/`@4J:&`
M74OS2#]03Q/$_T94Z,[3')N#]@)YW_V!`1<TOT-"/6\EB"$"<IIC-NMQECXH
M^D=E\AF@BC;PO.T&##)Y7L]ABQ[1`%>DAUGK08>#'N9(#S01ZA%0#WJ9F)GU
MX,US!92C0H<2\#^7`((]+*%Z6?RO<QK:H$%(`2R`*B&LZVZ:'CJ\9RP'I.1#
MI,0B8PZ<J0FFUG"/\:MAWW9W^/UQZ,89?'5DQB/P9JVZ\(T9#8$WV8PF@[?9
MC!6_>P:_"EX:>,`5A.BC@F\_1@]2XY(@5_3/JP+0PX62Z!H((*[GY_\^+J7Q
MA9U^:H:[D6T'JGJL9<1<S<4[!^Y(P/E[E\U%!IGFBNO`D>U^#F87\U9MM^S9
M?USBKN!Z6;E,T"Z."IOTBX@@]PF[<`G^B_R^AP=0F1\3_;.*IJ1`$>U3-AW4
M'8-NY'[N)9VLK*C!)+]Z*1W8=&LY&Q-`O)7/LSW*F?CN[C$/VFF^`2&_%]!.
MP$'@+,W'?I<#B$+#1W!5Z10.#_UF[E30X:S!6XAH.;3+0T.;VQ+<[+DK'1GR
M%TE,3TF$(Z#/_"\6#5QA\:@GY72(1_MC'M%"1!#<=:_[J=_F<3/UA\_U\#A.
MLWT@(1OT-\B?\`0@O@HP`)R[XZ\*#0IE;F1S=')E86T-96YD;V)J#3$P(#`@
M;V)J/#PO0W)O<$)O>%LP(#`@-C$R(#<Y,ETO4&%R96YT(#8V(#`@4B]#;VYT
M96YT<R`Q,B`P(%(O4F]T871E(#`O365D:6%";WA;,"`P(#8Q,B`W.3)=+U)E
M<V]U<F-E<R`Q,2`P(%(O5'EP92]086=E/CX-96YD;V)J#3$Q(#`@;V)J/#PO
M0V]L;W)3<&%C93P\+T-S-B`W."`P(%(^/B]&;VYT/#PO5%0R(#<U(#`@4B]4
M5#0@-S8@,"!2+U14-B`W-R`P(%(O5%0X(#@T(#`@4B]45#$P(#8Q(#`@4CX^
M+U!R;V-3971;+U!$1B]497AT72]%>'1'4W1A=&4\/"]'4S$@.#(@,"!2/CX^
M/@UE;F1O8FH-,3(@,"!O8FH\/"],96YG=&@@,S8V."]&:6QT97(O1FQA=&5$
M96-O9&4^/G-T<F5A;0T*2(FD5]MRV\@1?>=7S".0$F',X)Y]HFPYV=2NG-A,
M^2'.`T0.16PH@`M`TCJ?D<T'YW3W#`A2<BJ7<EG$W+I[^G+ZS)O??=+J?EA<
MKQ=OUFNCM%KO%I6*\:]2IHJCK%1%5D6ZC+'TL'CS=LC59N`-L1HV[6(91W$<
M5VJ]6<1J_;SX2_#VP^W[[]_=W*Z_#Y=Y5`2K<)D&/ZCPK^L_D))<E)119E@(
M?^C$1(DJ3!XE.>F)25Z@PO5/BR**92-_)&4:%6:VT^@H+3/9SOM/]S!I9*I*
MX^CZW5RBCKU(^=*ZC$J5%SG^0J)LBM4RARI=YG1:YE(8:2K8"9UIHGE!T\+-
M>O'S0JM&+;*THHM@9UPJ2,^JJBJ5-I$VJK>+SZHE7U]:0*=@:H6#Z>1KT0G1
M?W+A2>5:WS`?(C#`.8Z(+C@B^$J,A.7S[V\^WJP^7:DP#VX[Q`2A>9*?.LR"
M?FP&=>S=PC'441*XP1`N=50&=BM#->[=L9%DK0Z;KG4K#V&%'XO]07\O<U8U
M;G7LU&UWH?$[20LXVT1%4:;D4K$_F^P_,Q_*K?ICC;-V<(9D@6U5:^_ENY.?
ML:E'NSWM4*-E3?!57.C*Y02E;NH5:2V:^H=0TWT'U>T@`&YQ$Q9.H8O97M7W
MO;5^NAW5EX#L^O4BQS42,,VRF3)#ROB":2':?K1]F$=5`/,-">O5BF3SW`-$
M>Y&I+QM=5+E(9#E%/BN]?WX)PV6%D\ZORS2.TJH0[YK,FT$WI3MKDVOOW9#"
M<O,Q3*(TN%GQ"+DR8IP%>TJ`"D[\'O-ET&YM6.#W*#]^V&)1!W)"O6OXM[<;
MF>AZ]1;)D2(^M.L!]\O<WX9NGKF#\M=:]OVY\M6!QQN1T*IKMK63Y;IGT[8J
MS##:UP.J;<-FN0U>HS:<,.&RP.264@1F35IJ9_ZE:O:'UR\7G3(7E5+H9`H(
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M8$1&T>)AM^-!%.;!:^DPP<'4QT[%_XT$O?WP^4JM"6`AN0C>$WY_^'ASQ;D)
M-1Q)1D_H-WH./U/FQ<8!&@%SS6#,SE%C)]\DR+;R/<)E=!V(`$:X#N&G_7[!
M;A,`@*D^9`!\G)5&3#/^\&_IMW0^67I39^5YZ9H34%/-&5.2J[+<5*?&CBTZ
MECV"I/&)#9R.4W?/BLN>PMB.9H%+>;2@VB=C+O`XD>TZPM8,BAWD>\UZWD5.
M-.9U_<N+IE9)5'Q32;BI("CD1@\[2:`NVHQD31Z?LL83"FU<0U[O?8-W&4*!
M#[F.>)HZO+V3P5>F$RXM"DF+$XEXP0H8Z>:\8O";V4QC9@XY8PN:@LC6'0YD
MRX/+FTRL/,KW8TA5U@^/,JPI#0$1HTM5E"1N$ZE$'?T&JK>^CN";0X.5F@R<
M;X7LU(TESM[$&0B(H<[.S#B<)A5B0<(:0IU1"6J:]LJ8AM"$59^>FV%0[YF*
M2?W0,;[K:C,J=EC@0\M[^N%*;`)1SI-TGB532#/CLN2=]1XKY.1;1C7'`]NG
M::7Q4RY`SA^%NS_QHB)-YKJ<JC1W%U_W=3OL4,XDB>"8VJ):#8,=I4?4?)>M
M+QRT,;PR7OC3P8_6>29R?VCJ.X<;<!_E)'$S!QX"."]X6B[5>*I?[YBXS">6
M1K1O190B#2Y)67;!*2?'ZB2?B!GL`&(EU$]8%H)T]S44[]T-D.N:%0**?&.F
M0(.16U##?[N63]F1D$\'SW0=A`/T]WRF<U'((YT7\XA/WBI<$8-,+<&*CO27
M')XQ?!^:!^9J8&991,T)V,?T'[Z[H[^H9RE*G.KM@,M1Q38LP%<`B#:B(P&;
ML2-G@LG\NZ3>;+I^6S,]:RD-3+"QZKD9]](9B8"S2#R1DF1>];Z1F:Q*9F$Z
MXU$7)`I!0#.U35@2A:QW(P*!)B=,[`5]1R6"(L_R0L^XMA#W4H@[6G5_D12X
MB,[FAR=KRV)*BDA>8T_@0X)\P[X^'&`=LN(.(,E?>])`0%LC_8*?'QN>[9OV
M_N1KG2/I+JO#>%C,JF(6;^;!)6P^RH`#C]^OZGDO7\W&?4B0:0\`E?$XX\=5
M^RA?5D@3]9/N*$D'K#3%69A*;X7#9MOC;<;O4(?SS-D[BCU@F%S`$]!(+MB3
M&PIFGDNJ'EC+>E`01&!FR3W!6>7@;-A10MJ^Y\06M&SOR7*X5UQ1L"L*<47A
M7%%,KBC(%<X)6#TP/SIP$7"/2Z=TKZ+$(`U?`)0#/D/LC&QBG*2"IN(>ADZ&
M!]PP"9YD8-T>\M"C?!ZE%6+NK3O![">1EH;S=FS<@M_X)<`CR$EBX`/*-JT?
M4UW/U-R=[3MTSY2:UU^5DWD\6T;XFLD>-*=#_7S%[=H9\`\T<,;Q*R!)[403
M&DN+8(+HCL,$!B[QXOHWWZ(O2#W4`C1OT!V&,)/'&;W_:I<F?<U$II59V;)S
MA=/W],[K/(4%]%3SUC1I\VW0%269F'+W3Z0XQ7WT9@L+X3F`Q:97ULV/36_'
MK_"\AX+2`4D<Y7DZ)XAF!B1_;ILGM%28KXD)&!3!04:/?_L[01->30,Y_!Q?
M4/,3(67C'8M$Y!B7U`6:+1,X7Z.AD4^J.'V=?)K_BWR>FB=[-C/S[LFMDS']
MH^7O8]>[=HJJR9E$$-/G.4;5A.C^=7VHVXT]G?ZTM]:=XV"X`HRJS.A7F;50
M_OI+^(+1EXE)_OW5=%6^Y`6":9<W^\:MIF?:-]CUO"^GE6='0+U;+E+J#0SW
M<MN&_P[\(E5WG5MC6*):XGK<RJ;>;GA5#G8],R'^1L/C#D/>W/'91SI[X,6#
M\RK6_EOY7<@U%_.#`N?=#3#[1"]('5]>@)58F6JQ[5[U=B?&]:(4A<LL0'2$
MF9QQ%^AG1X4S\O1,N+LO6>[O3*&(YS@]>Q;^>AY_V)LF>@X5KI7%B6<OM\(L
M*4K\^NQ'!W>#NF9*T\E\W6\OD@#$.DYGR86WJL@V57DBC70CH-J6&1Y?A#!'
MK?A)@E`1,C*`=[*S9[3:RCX$)(UR"4G!F4BAH\#!+X$L]K(HR4$JK-JQC$>1
M03KHO_J/-%#?%AV\RRE":DB+W_%#1<SF@ZVB\$,M<1D88T6W#<VDR1EH6;E7
M>[+?E7\1Q6EQ]C[@,O4^K7)'@(3]5=0G#`E"CQS#1"@6O:BH#;_R/HA-.H.!
M<I+J'AW\5D7`*R+I8?)JO#-^P,0OGBYQ56:G>`_NJ4)MK3[*]['OY./)/V.8
MFM7J)S<O?<D$HV)6,#UTY"EG"$5[>W2;^Y$NC?9,#M]UO7\<J0:7-X$3-;UK
MT1W=6U($T3,3TY0MM/WB927!`-OF'ON_%9E'0WE'S6D];A2RFH^X37_Y"@.'
MS_5<D-%>T.P9YCHXN8`)(+VJY)?F<+.CC'K7_3=CLZGO9.Y@N=0>933^B_%J
MYU$;",)]?H5+6P*$WW9Y!4VDI+E4$8TQW&')`<2"[OCO*3+??+/&F$A)@]F'
M9V=GU]\C.%@$44!B)`9M`!VRYTAS"(;P*";_UK(+`:BOC0U9P,9_D(ASXYQD
MR;'87ET\T7J]J&,IV835C:JTX)N_,5]5)/_)?/.1]3&<&E%?@6]0.%H_SX82
M7>@Z4)8NU#VFBW]0($\K&;"U\"2(/<OELAN8\P:J1:($3VA`Y$:H8TUX>`!&
M^PI*]3KIO7'@A(NZ6=QS.96C=0:784%*8OQON(#K0&_:\X8#RGG027A_!0AG
MD8Z'>6NSK<=)$F5H?7UGJS=#'FJ'#CZ3>7.U_NZ>:3?D?N[PKPJYY^`QT[ZQ
M>7((3@[AXJ)YI8S\*$J-`^-T`FNLO6A8;/)G!'7^$:5J65!'U^Y%[BK$;5RK
MFE'!$T7'^&\V1/\_Z57YS.,1WYGLC@>1OXYFP>D,H%?'`?74:`-$$'LI<#7*
MQ^^6L^12O'YTFI13!'<ZTUV8)Q]7/H[GVUW@-&VK"QPM**<P$E=XEXQ\6]=J
MA3VD=>JU<\>5!#F$V](E([_N3@RT$SB&G-](@IB6Z/B2@>)Q0X>/VO,6Y8,A
MFEO1GEQES=JE=5*,=$@J(6)Y67FB5CRIB"=R:SJG`OOX9@`/)N9+O8)J2TM7
MAS-:*/*Q.WG75,3%`R"D/H68&0C7BX_I87]@Q40`7QJY*UO$`>M>6.D(CDR@
M=@)CLL`R3^O1]<@M?N4U<;#2RG_RFN^[3:=,),9%*KN6[Q6N9QVM0YQ0+?\F
M%[!<5/DR'6VA*/T6RLR6P+=3J]9]3$^R*\NQ$_"[KS+_ZNJ3*4D^*+MF!/FK
M&75/V50CVZ399/D=L6<*Q_-,:I5DQ=/Q>X9,LM)J@X/R!S`+R)52?=$(4RTC
MB%%Z/T>39K$&LP:@A`33NP'<E8M\9DN`'LU>?Q5FRK#ED"`^V_MH>7_='E.J
M!F=Y_IF/)97LZ"Y^%\$*>R#[`UW/I)?!$J)/B>82./UJ]IA0J7C:"/I=3[NS
MX[0M1QX:)H"\:!'Q)EE-)63L/5^1FQHY`2QHBN#VW`Z84U`*EY3"A2I4)B3A
M0DA<:<&8R-`WY7EH7-')[\"[C"J7;O'EG?$Y``S!IG<'1@PV-QV6JZKF(`NO
MZL?BD.,,N^6<3=-K)R>B9'B2%A@-]*>J_+N*;;K-C&XS#AG8TCYRQY-]OG"%
M5E_CT&%&6:U[M@KL@K9QRJN_I%K("&G>6/O5CR]_!!@`Y--\9@H-"F5N9'-T
M<F5A;0UE;F1O8FH-,3,@,"!O8FH\/"]#<F]P0F]X6S`@,"`V,3(@-SDR72]0
M87)E;G0@-C8@,"!2+T-O;G1E;G1S(#$U(#`@4B]2;W1A=&4@,"]-961I84)O
M>%LP(#`@-C$R(#<Y,ETO4F5S;W5R8V5S(#$T(#`@4B]4>7!E+U!A9V4^/@UE
M;F1O8FH-,30@,"!O8FH\/"]#;VQO<E-P86-E/#PO0W,V(#<X(#`@4CX^+T9O
M;G0\/"]45#(@-S4@,"!2+U14-"`W-B`P(%(O5%0V(#<W(#`@4B]45#$P(#8Q
M(#`@4CX^+U!R;V-3971;+U!$1B]497AT72]%>'1'4W1A=&4\/"]'4S$@.#(@
M,"!2/CX^/@UE;F1O8FH-,34@,"!O8FH\/"],96YG=&@@,SDV,R]&:6QT97(O
M1FQA=&5$96-O9&4^/G-T<F5A;0T*2(F45]MRV\@1?>=7S.,@)<$8W/'HVR;>
MRJZ=$E-Y6.4!`H<BLQ2@`*2\_HV-/SBG+P.!E+V5%*M`8"[=/3UG3I]Y]><;
M9^ZGU9OUZM5ZG1IGUMM58Q+\&I,V25S4IBJ:V-4)NAY6K]Y.I>DF'I"8J>M7
MUTF<)$ECUMTJ,>O/JU_LVX\___#AW?N?UQ^BZS*N[.OH.K=_-=$_US^2DU*<
MU'&1LA%^<5D:9Z9*RS@KR4]"]JR)UO]:57$B`_DEJ_.X2A<C4Q?G=2'#>?SS
M.M(\3IO&8>KZW=*B2X))>7.NCFM35B6>L"B#$G-=PI6K2YHM;3F"3!O$"9]Y
MYK@CI8[WZ]6_5\[LS:K(&UH(1B:U@?6B:9K:N#1VJ1G]ZA^FIUQ?1D"S$&J#
MB?F<:_$)TW_3[<EE6=\)O\SBI)29M"6NY"W!`/CG?;GS5R8J[:8]1KGU$=9B
M-]2`A>#Y+BKBU/K./T0NLW?1-=9H_6C2*(]+F_#3)33R\\Y'-2;W,L9,4147
M]B1?W<ZTW'OB&1M^[N%PZ?2N/>"KY:^^\VIAQV.]IY'FSG<#1R)S)M,^M63F
M>>(=O6))GSGPG0;,OL<(J*ST0P-[9.L#/^?(3QT/T<DA\LT^<LDRX.BZHFY&
M,'#AXJRJ,MI]`7^NF4Y<HYEN#RVM"\F:=E@0OR!,6N-U!E/MX4`KC`!BA,1-
M6*R#OP0MYKCSIGUD=PY]`<+LS17!6R;.'G&\8/FP[]H[??7FIZCB;&!*;<=[
M:<=NOJ'(Y*N33H[R9J<C_#&695ZKX^LTKJHZYQ-$WJN`JJP2]^L=>>.=0[)R
MY+[`\YXRFI''MY3+H9\HI[&C7$H'H1#?>W[2ME2V-YC;V%M+^Y!CSS=^J]-Z
MOS'A52R8R?.H[LQ.SWBM;(Q$IM;Q^ZVEE9:VO8V"@YNCV!K$5O>KABF?/4^;
M(B?0743-'D<U=^%8@NXWXN/32;K-1WQFC+[*GL^XC3A5B$I:Q*$1[QJ*&KG3
MC"`++T'(^Y(%5)2I[`LB.D89+#&X<1AXEU):`P#!3W18VOTW&%?2J<+IHAGT
M1O"](>QR"QW0%&&<Y!/Q4/:%/MA1LW2T;3L91]N:B9_)>(X\39FN%W@.@1.)
M4^#]Z8'0X3=4-LR^Y[_)=\?]0*_R#3Z]M3P"6<3Y`1YN[9MVVD]FR\-&YC1_
M].,#;75NQ9`\[]F&X%P#DGRFESAW1:%AG6'\_@P)`$\>(/P_X5QW/J88/U#Z
M>,I.IQ@Q_J2?O6+@?)2:)0OBG5N),='Z*%\''B(A7X!U><:F3A8CG7?B?:.@
M%#1R_L\MP'$9@\!26]`[#ADMB6,)4:C_2]33,01LNN[$ML=)=F+]IW,DNUJ1
M#'-I.!$8[L]QW?8&.:>&W\AL&-SK(!2.K;PB#T!%F)MSICL!_*`6>FZ^-U0B
MPQ2.=7LQ3Z`,BG%%N<`RBK'&WB@[_N0)*R6H%5A)\<?G3<L#GR^J"Y6]DL4P
M\POO8P.3(E\:GPLZG9G9.#@=AY,.+:%C:=A,3#U<<DHN.8+XS$%QN1>(#^;=
M7,6\&=F"5,%'+KV=%%4^^7=?^$S0ZTG*ZYFVD,Y0ZUDQ2+E%P=])F9\$.O2J
MHL+\YT(G.BRNSC41G(?`&"[+)="_/\(O95D9"7GACWM*><-ECS'=RC?GB`>$
M'5"/05]AI\MDR5%SA7>9YN8KEV[B'D(;6,JT73>,FY;;>RGIH@`^[X^DB4IA
M0AJ.&NO<8C/RO%GN!KO,>96S=]UN$M1,7Q4=+/TTK^F?"SIY#17\.85P6C<X
M3>2<4CDOJYI5N^VP%A'/$'D\"PJJ2HL7XOG9+&G:HEJF:>9R`A.%_'Z[)>+F
MG7VB\)SHC7>R7X#'Z_O1>T&3/WZ61E)!$&E\&#Y%5)EXYGC<>X)T;<W%CB6\
MM+(LYE"R0-]Y&C`R8%=*.F'TAZ,_T/_#(ST/GHL+"T,,:?L-__OM5LXBQ#Q$
MT'*ELWVGY8&6^>1[/TV!,$@7R0&]M2]`#;E95FX!ZGQY@0*#5D+C)`<E.MK:
M_F+=>=PTWZ((A*6:_RO(%LM!41R%6TK[>!H?A\G/O%8AH<H1W-@/_;661ES-
MLEJQZ9X%+QEG-[FR'.4RAYE^TI?#?B,O6L=IS[9<>ZF-N(YU''UU\K5O#V8Z
M$BP8VP\L2;R.`9>IX2W]H>S]/#R=&1N/C)S]=,4;G+.P;:>):+`5DVHKA'/8
MBURN[?ZP)V1=NGA]Z`:=`[Y2;Z3;U;PX-G<Z;?A5VX.#L-Q%0&?:[?FL$^%R
M/M-,T:K+:[`\F@GD3Z:7%NR.I+NQVC))_:=7S7LSY[VQ$F^PI.J_(6Z21356
M+RC`Q732L3KH:(Z#E#K@M6J62"M"R`%I9()3]OL$W+,PD-*7"NTA$6]:_ES4
M*`-8ZB26#X:HG`=Q_`T73,&B1'!1M&;&*5UV7G!K\9I:N?)TW*1>KX",B*E`
MRT`'.6OH`@9_5$=K^P77,UPMB;I'5*HZ%/#4#FT7A&R9)]^DOS*0`E$"L0C(
M`2XI0]MQ>.`#N>^A/<)MDVOCO?FQ91#W)_D?OQAW95#M\9RU*ON\!%"B`$JR
M5-/`E\J&8LXH!\>=?/,!'_W!/\EWRW3:RP<$I@J4`^`SFDT8<YWPAM`26J9K
MZ6#2EM<OJ/ANZ>93RVQM0D,03'6-^\G,>B[458UZY.M&+5*OM%=\IQ(-2HJT
M/7"O/(U<,FIHB#9<N@8>^"BS67K3@+W:I+X^T#.CE3LZNKOIYL"*8_W*>)U.
MW2YD7D/_'OZ*0I=`2@0GBXF"L[WQ8(H""51\H=@=!^H32`ZB2?K-J3M*'22J
MQA\HH!4<X_#_;L(Q3)I""]$OEB3'J3\:&8<D$*IW8E`#&#VI$M5&TD-B11"M
M0[TARM=P0.&'/??22C;/IX\=OV"N4/!31;R0/..JDJM:)T5LYO<')O5`Z6!;
M%E!">#J/5OPM$5.F:<V5ODGR696(?$E?B)>\T;/Y1[*%UY#.2JO0>O8>P"CL
M;X0CX&/'^AV<2'_WW@`]#)V2H,.-AN3"C8X;_104/*1T_4)&SO*.61.[S=*0
M38APS4C@4;G'&7R+#=EOM+DE)25'&TC6K7&`=>,X+237=%'90DZD,6I\85U(
M:,B1B].\^/\$7C'O]_(&PH0]AXHHAQ`<X,57#0JNSE\&9]MOR,Z:6.P/HYK3
M>IE55><WQZ'[-03$4FJ,J%AS`L.A(X6)327`;3C[GT[\<>2/C\R,JL!H1=SW
M'>&9S'F?,Y2G&LN'7J4@XI"26$E))&Q=T4FG;C#&LMWOAL-&1TX$.$$4=`F)
MK^>EASM;5FH51C'%K`SG&*J3RQ<MAI4?J=[?.L_=C[Q'L,LL0RUTYL0);GS8
M@863+"PI4]!"4PK#@5T\9;2R3SY0EV^)-*G*W.^G(W?Z$5Y!/QGC7(#1Q'E=
M+)4E:@P4_+P*A'=#.>&R2W6+^%VN4J`KYM+*[GNPRE-[.(7T%&7:O$P/#"L[
M\^%]BZ`:^Q?)]`\&_0F2A;@Y$3M4G?[E+=3%35J[;YR%M*KX?O8<-%8K@%60
M%'&1EHNPW!Q6*!I?60'0;3+AVR0$W00MEE,5VQ!(Z6UC!OX_4>`@4!K$%9O>
M6M`H-`2TA$L@)7A@N&'B]N+JR\KEY.X75R[5Z^5>+AWR]+"'DHM(^-CPGS_P
MWQ<\J_^R735-JEI1<)]?P1*KYED*B-QDE:KWUDDE+UG-A@$<K1B<",Z\GY_N
MT^<BZFP4[N?AWNX^?:17;V?NQY3)F`"B1"/]%2==6-[=,OGEJFC8H84Z%1V:
MHIU.O:^PU\`.!U-H+U]!@5E9U6AID-RFM/,I9QYE&2.?%F<^MDE:9FC.ZGK1
MK!8I\QB_B,,^``P/J'O`1!Z66X+XBK<P4UTC?&F1TDP7TW7XK(=4:C+&XL]E
M5+-&'A*0?KJO_4H0<AT^J4FS*F13\;=,OIN0F0_#X<B:^P':5N:P6N]V\1:[
M][4-?=<,\$XL"\M5]:B_W#>:`##29/8BF861;KO1==B8"T_6=Q)=F!'^P<I8
M/\Q*;0\L$8SNIEW2#)BS?+U]0'(YZ7_I`M5V.Q&!3"(]^(^/]>L5/HOT8T%?
M]K3@?5,8_OH37QK2K\G:^%/:;Z6QBE).72VMDPSM@R78O=KQ\041KBX:/<H5
M-/<T=+,Y(O-.E/]Y$?&QND^6*R?JJBI<'9_3`Q28Q<N6@0'"`1_PND>U9D^G
M!1$C<7[W0:P[Z&K7:93\XD;R5]AR=J6;:<]8W4%U+W9W`9]T3N2@?:E,!:JD
MCZ\#CA2;DCN4VKU:'T6UN"=0])/5)IME<EQ3GDYHW1"M*S?XC[Q`PBG+S8P7
MQ;1H*"9>X`888?<?,$JXU3)51Q:\UA#9BOU"]HGQW4Z@R_R(6/R8M-CU?ONA
MM\9;:XBRNH&2-/F#H:O!AC^G*$':V0@`N*2X==Z8O,PZCZ>/Y\4O@F3?W@#G
M:@%7F?,RBU8$P(G((<Z)G`KG*.3PR7Q1E2I]"STV4.AA467HL=NNU86A3>TP
M`N=A'3Z3I"SWH]]_&;IQ/':M.1_6'>-9,M-+@H:="Y2T0WTOZCMVR=MEM`).
M!D8`^U2<$4Q!:S_#08C!^(7![Z$P0P)*?N/#!MEI)<4E6@]6`Q@:4)[=@:R`
MK[UQ`^5V)OV&KQ`A5(!U85L^R)9S+)_DNOO1G1MN&]*!2I.E+T=[ZY*=*14E
M8X,D"W]2&YM1\5ZLK1]M(/%<:XYI09#2;?C&QKW>.EL<V3FWBD]]VKBWY5XU
M(J[ZMZ]Y\>F\@5^G`#1EO#M_&+Q-J*J9CY?A3VZ]$7A<K.8EAH,V#]DV@I;`
MS\E0IG=C"3^!9-BIZV#WUE_;V^1@;\G0-<8SG%"":XAKO8`%SF_@(0\WV7@5
M:YSU)D;P%>E+F8NIA,ZAKZ.#%IM`4-5"/!LJU638B_RF@JHFW<C]`P_F$RP#
M5Y.FV0M@Q"-^7CQ9*CRI]:*_<;&.J40K^"1$V@WC\EH=6@1W265=1$W,71N^
M@T._VX?02B)1CX:.@_UVUC0D^P4M26V<@^-O[.'4-T=@#8&UG<S$DYEUGD2]
M&V<+G'$?&O(/+[/TU7M;]=4*",Q<Q^:Z;_2DB([V+#=,JW;TE;G>:QU[6^M]
MU\0&UF.TV/;:4*$KID1_W@-I4>=9U(HQQ_B_D`"HQ2@^N\2',@\%'[+DR]J^
M>LN?M_IL'Z/@ETDVR?2UYE$JJ2+@\CQ:Q[,E"\+!N-:,"5)K\B\^I60L3%"C
M84+#D.N'-Y^!L<(>W'*`-[IB;QVFC5R-1TM!%(N]'KHD[AU2&40]#RS"F)$L
M^:K7@<J7Y2*;ZHUOWW_Z7X`!`&I_#I\*#0IE;F1S=')E86T-96YD;V)J#3$V
M(#`@;V)J/#PO0W)O<$)O>%LP(#`@-C$R(#<Y,ETO4&%R96YT(#8V(#`@4B]#
M;VYT96YT<R`Q."`P(%(O4F]T871E(#`O365D:6%";WA;,"`P(#8Q,B`W.3)=
M+U)E<V]U<F-E<R`Q-R`P(%(O5'EP92]086=E/CX-96YD;V)J#3$W(#`@;V)J
M/#PO0V]L;W)3<&%C93P\+T-S-B`W."`P(%(^/B]&;VYT/#PO5%0R(#<U(#`@
M4B]45#0@-S8@,"!2+U14-B`W-R`P(%(O5%0Q,"`V,2`P(%(^/B]0<F]C4V5T
M6R]01$8O5&5X=%TO17AT1U-T871E/#PO1U,Q(#@R(#`@4CX^/CX-96YD;V)J
M#3$X(#`@;V)J/#PO3&5N9W1H(#0V-C0O1FEL=&5R+T9L871E1&5C;V1E/CYS
M=')E86T-"DB)C%=?<]NX$7_7I\`CV8D8`B`)LGWR14F;SIU[/>O:SL1]H$5:
M9D8B%9)2XL^1?.#N/U"TG(L['HLDL%@L%KO[^^WKO]YHM1T6/ZT7K]=KH[1:
MWR\*%<-?H4P11VFN7%I$.H]A:K]X_6;(U&8@@5@-FW:QC*,XC@NUWBQBM?Z\
M^!"\^<?UN_>KM]?K]^$RBUQP%2Z3X&<5_G?]=]PDXTWR*#6DA%ZT-9%5SF21
MS7"?&/4%*EQ_7+@H9D%ZL7D2.3.3-#I*\I3%2?Y\#I-$IB@T+%VOYAIU[%7R
MF]9YE*O,9?`+&EDH5LL,MM)YAJMY+`$C30%VPIZ)U31A<>+M>O%IH56C%FE2
MX$%`,LX5:$^+HLB5-I$VJJ\7_U8M^OK2`EP%IA:P,)E\S7N"ZG_*]8CG+A?G
M.5BELLQ$.=E/%^+HN'>WH;A$Q[PX!J',/'/)63M8FJ:.!?AN,Q2C5UOP#:_J
ML>[W35N.3=<JN.6@NU?C0ZU^J?LPBW2P#4V4!'5/<V^Z=F@JF8$EH8ORH`N7
M-LJ"=@J+1.Q32Q.Y+$[)0-A3T_;PEEO'NZ]AHSJ$0P=?PB7<1+"ACP?^*-LP
M`<7;6H59T)=CF`0-_'<\JP;8/9UD=S"#_^J.%2H4ETE2\.E(VCJOIH:#V:#%
MSU>T09C"=T="1]ZY8E45Z>(948LG-29*DZ28^5?G_H!.\P%IY[8N^WH8U5BW
MD#_@,5"2@:Z'4$<&CX-C1_H8RK;B[_&!GZ]4UZN&[J2OU2"CY6ZG6EDYXAYW
MM2KY`I;>+CBZ=9!@XGVCV3@-"<K&B5UPKI3.!0]T2@Y7R5\/X!(-!N+O,80C
M%F`@N`0DJC&$D`615Y,LS=.!'QH:VC[4)-S_W\I#.!D+S?2#PNZ.UY2LN&6]
ME;I[I.6J:ECZQ/.5B-'DEG6CFM]O(&1LL%*:9K*</"<Z+HYQ#:-.S#N5/<^R
MWB$T@6)5(@Y^)(OX!M9_XL3UT9!E&3O\7^7N6*O;8`RA1@00^U\O*FD:80S%
M4\(DDP96\#:T8!3E2A9L'D*LR9`E^(`L^2T$#_$<I&9!J?DT):$LQGG"&WP(
MOMV&?P&%8/8!SI50!L"-G'AM56/<X]L#ZX0$M!R\]CQ8J[=?,&GU)$4?+2DD
MF]!BO%0=\,*&?CN6AH"&S,4!_H6@EEWN2$--"]663:O%!*Q&6?#$CK+%(1.!
M7!'D_EAR(E)U8D'>OA+K*W(0%.940_IE*HLS\+:R*:)E'"4.2SX4^_OOEWKP
M9P)K7`1U6,JU3B?\Q+H"!7D)"$+@<Y&07"T^!/=8F"!+1DJ7%*Y!;&(P2PN#
MEAD7F>1%DS28%">P!@Y))BUG-L%,(F4?LI8J"03,B-4%W2D#$/H=OYU$`IQH
MP+QF4#=^44]YCO'L%\'LKAZ&L]Z6GYQW*WQD/!)#I4MG%M1>\FS!VR_\MIF4
M;64*\PUN]C?$*UDV>"&HB7=/Q<X:A^->R8)[Q"N?J\OOWXV9@#)+V6.WD'9I
M<!LJB+$,M.3JL*.X.B(.87T!?+P-'DF(:@>-C"2#00I&K!J.1'X0NCBL4A2.
M@;JJX/4C*\6!@1?O0VTE%1SA%8(?ZGY7;OBKZ]DF/A+CKH/(E,/$OHRD=!9"
MW:^75`$X2W*N/+&>L<!5<P+0QVH*1E]4%/L2"8DC&Z?),Q*"UDA1NZH^@@\1
M?,<0+"^"?=V."@_7]1>[06EQ138KD),NF[.R;W]$"_:A@_K1/J4%GQCMA1/H
M>$X*%`/^/8827.9M0"8*3X$X0(!Z0C`.<P91'3>D)"1"%6)H(.F@=3,#5K0K
M!H0G&VU%F44Y5Y(U:/YQVH>"5L,6#H@A1:VV9P(B&`\!/',NACU&TQY!TG)R
M)$'+PW`,9$L83WN1W(W-0=Z:NN(W0DI^?805!3JD:3`=>#`*,4;SL["L:TC]
MR7\@9LJ,F%&I2:UCM8_D)$%7DD1]UYTHP7*4S<N1OBQ'L")Z*16<_>-4L-K-
M4L&[U$'Y)9<"B\B(1:P0*#&=(3GDUA)"P*4)`.@O8K>XP'9?DYTNIM!E,"P"
M_H68U9@/%+9@:"G?W;$=66"*KK)]9!IW+1B.,(Q%F^0:^AU"HLT;FL'0`KKY
M0%?%\R=^4!P:0G`N3*BV8@*W8</`WW3>CG#X4,I"MJ"\YTUKVJ&G0/9A"[%@
M4_L\;#U3<JE04\]^:R5TF'@-1&NMJ#_A00@!:%.V(MJK*WGMZWKON?:(@2KO
M&U:R.XK2)HRQ<=EZ5CYMBE2".3ZPNR36YVLS4SAHRZ;&Y'%FE+%PS9?(XQ7-
M,S]MCUBD!"E7+.1Y++-*EJM8-R1'^624R&O7SNZ#AGH4-[)IQVM[):RZ^R[E
M%4"4(U^R%2FU.M;2O+VA:Y9N#$$*=J;WW=1=32U;JU;4O_$P7$DYJ*J^Q[E6
MFBQNKVC$-WCU9J8@BZCK3%GNUF_/&].69^';D#`8=CI`6%Q3#')=YML@L8%X
M"!21D@SHN=#73TRX^7R69&!1[_JRW0R*.U4Y/;>+)RG2HBX5!_"9Y7R^0>"X
M=Q),1DO<<Z2Z8.SXJ7Z_496\[W9E/RCY$#GJ)!T72L>!>\?O)3$(R)`I7W`>
MF-CK-W][IX:#Z!E#0K>^'.7^H7O4B74SP#;)9*54*D`ZUG<JFQV:C,Q@RP\%
MA#+AUS^'<6!C&<;`W".*TLJ?$>G)?3C95OY%0>."2%3#_?$!.U%/AT@)`W?E
M0#UO53YZY;[Q)=,O(U<JK3%.N!RZ!$IWP3B,]/`7[C9*O&-`6ZY:M:^_OMS^
M6O>-!/V\.%+/02%-;Q37*-5R):U40YMQ156L:]KYO(2\#UV)SO*9]]'G9+V-
MQ?MT]5#4@0&W'`X%L!2-%>RKH"26Z#-`%@R0J!^[')W.&)0'1&/R>9/Z#?R@
ML=9`8XMO!X+W#F\-L1=8`7[#[I:9A*'8QJ,@4/%U6!/EUMAGUV$]1XDEZ'\"
M+1EA'M3,CISN@CLH['C)O\)=D+\M4C&`]F%H6)+&*%%=4/)J=0,N#WKJ8%VP
MJ=61A2H:1G7W,K(9:0$+=BT-JJ]LR;OWL.5_HF]A_B*CMOH'C#K7<][K@<-Z
M'B&TNE+D<44T>$3N>T$<X,Z*?!X2<3ZI,F?JP%T--D'[&ILOZR'-$J1A<P:U
ML.-OZH$TD3AD6Y.4-&M@&H\@8R,N1]-8(0&PY%,QW^*%?D<_)^R00@(U9E`'
MBG/7!0369$7ZG`GXB@AGXZ/M?4D\\F/`"Y_`VE&[>II'NYO102J.LO!%3FA<
M]H/^*#43"P!!R143ZYCW#QUU+TA)KEIBJ.V1'N5.\46#1'O9/:$;<O<D2B9C
M<NOOEBHB=2<E^0(`28Z?>(*$B.:89E,G$\AH32@DJV2,+^5SXU7P=U\/!UFS
M&17CCY^[\'""'A[.,G?SO?P%9U$>@X^_RR*6OL7$\Y6'`T&C=$\GH0.*^(+O
MLE"@]D!^$L"^`/*249A_C[/^3VVEM1)D+J4AU-0+81F8J$.[%?@GL#;TB.E7
MLT)-'TQ%7H@G'9OB!TU&`BW(+*>-7V0%I+S3B2HB2SDW.<];"V#5=E;4]:3,
M7`01@4[9#MQ0P#%RC!I"N9X_M_(IS<4(/B...`VN`/0?)>H)4[(H30&<9H>Q
M_V.\2G;;.(+H/5\QQR$@,6S.GIMMR8@!QQ$@P=;!ES$Y7`"*)&9&E/4;23[8
M5>]5#YNT9>="]O2^5+UE6-\2A>?(J;9RN<>6G-$HB,@*+@:2R(-T0&E1LDT]
M6U&\-!@1]2KIJV.(385<,W>"(:%0E=LON?AG>[6)`-*=`%KAM5XMSD?"2Q[]
M"I%50ZD]H[,%E>#S,2"6I@IW%FC\$N9G\]PJ`@$YTU![#%O#V?17A<Z$2BZE
M*M"DOFN/>\.5<U/1OH7`9<)@B"E0&\X\F8=:&V\83/T*1]5]S40_J)>M?*.$
M&#)DM=OHVI2LG*;M_AG"_2REC8U$5QABJ9B2G-*D,@<RU7-\AH(6/)Y92-%T
MH5D7R43^B3[,I.#0YM^KY'ME<8V!N,AA7O0,+JG$RQ7QA<W,930!+6<L`UTY
M+K(T"Y)F.$?NS]%`\=?=8RM24(M"SA2!E>+0.9I78U><*.?CU92FW?Y33LSC
MIV:]-+/9PX,VYD@'`5]*&.HI`U-*O)410BD'*RO#*=AIUX<FLMJ%_KDA3XIQ
M)5KD14.7%SY)1VF8&4.<AI#X"R_UHVBR-CF9*&2KVUL((T[G@)H`O$\#EDO^
MC=^/NKTR9M5XI'+D(\KW;(CX]8FG8*C?C-3>PH"0.)9!7)_E\LG"KZ'4-T/"
M\1>\`75Z8Y2U",])ET@;*@]UXO<FF5<W!LNWC6A5D:G`.D7(E#B8Q?)]!T">
M4E+)E`,4_$K(B($H7R:>U%73,$9-<;G"^XNKFH))4-X\V`<SBP=K,2W@OQ3$
MS:)^1TVBY5WE\N_33#:9>FZ"Y)^"ERZBA9H*5>OU]ADE7$3!Q-=N(@@3Y+PF
MO)8N/(*NF+`1&(ICC461L!V][D=XO4\T8*]NH@5\V8Z3PR1T`E$%64\-W%&S
MYDZV_Z)FS2N3-(K>=H=0H*9@L>-H9I>Y/9@NA9WB17NMVV.8=:0HA^%EA=5O
M-G7;1;OML==1$W\Q):R.J9/'\N8RR;-0=4R'G=M;R-09S"2O,Q+I_ON;/]_J
MY._1MIWS3W]P57M\*XI)^K1U#ZYN]'(EN?;:UNI>A-D/^B$OL\;@I0B\*-72
M'QB;3#@E(<MV>@Y9_J;+RB!KK]E((_,>+JZ(YSO\;8'_#C3AX@>XV$;0=\'F
M-NK`0Y;N"0[C65=-3D`I<A<M<E,A(R5V%<`NG7-`KX(HDL2VLDW<8!4!DU2A
M1.IA<773!)%1$7-VP1'UMEC^9+Z:X\3<LN.!U3R9F=R")E>5E00T@813Z.\,
M&P\O9,<YV#R@%"Z9(,7[_?<UTNCMNWO+TDK&*RIN'[L+.3>O,[-LU9)D*[74
M7).NP@J9)6MJ/*`J1B?Q8WO[NO1$P8H5*YKH^BLZ7EYQR@/K.<?<.HU*4P."
M$[(89]`'D_Q=#*1ULE-9Z`,KX2BF^J3)<$*%<WFW6=VMD'NL/=BJ)^O9QN>-
MR#UMM=E(21H@(0EXAS>9>L`U']72B^""S&81V-3:>>]6+_JF16K.3_KTU.NL
M6Y#:O,%;0U/_)=%F1JV-7BW;IGEHS!CVZIV`$*)5LB(011X@7&&N9#[*E#.!
M`"[FFAD"N*`Z=9K,^I2^L@?<H@9NSE).GO6-?B5L0DJD>G"'-&&R%3%'KSG'
M%@^+*=AZ8;/;A`!*R?0DOD+VVFX.'(XWTSSQ(&.'/0,9.S./"[<U#I+D1=*=
MY.XG9L_)JP>PF_@Q(A<'SE4M`<[5@A(72];2X@R]/E@N]Z$@T0F5`>8_C1*H
M'7S<?*=*\TE:!@1<^<4GV9DYU*CQ)"QY(C<)9204'C^;)5'_Y;$1[<\7B,8]
MB=])HHFL#E;+AM4LV@5Y5SITBB,)ZXN8W3S"FDK"7D(:"R-&]:&Q7O)`9<PA
M,*<*"1)JL\9K9B]SH33.[:"]CV2;W?5.X4!C5PXM0A*XD%+,*M:M\:O9G[#/
M+<@88)2KJ.T086CR@M:1%%+$O(LYD9P!E)2R+RMM&JA:T;27T*^R#2F,96R%
MSWN5L12QE2H4Z%87+QNAN2=I6>D[E*H1B:12/-F5[2F:VUGV&_RKO76PM\P?
M!X=GVV/78+\\]I/NS*;I?N``J6LMGIW+C)??0KNJ:Q!,2^)9)\R[4THN28P)
MB#$',6Y`B&X@Q-:(4+M"0]^R)Z7R>AOI$V1C14E@UC0(<*97Y;=3FLYN9CU\
M921O?YEY6Z77W1C<HFP2D%W6])P[\+L-:T>*Z#MV?X`;#6;:^7FVP3HVFPI"
M;1,5SP*@<WLL#].<:$Y_N',AY'$95X^L:O2-U=5H&ATT6X1[>]29@#:N9(33
M:DE"'66.[A8M.W:3+\$.1JSZ3R$W_=YUI!J5S;+U[A%#9RO.\'^7&I,<?H&I
MR4\P52QMB*G#E213B\'KKR(8(++E,>?-%K+@W)\(A&73(IAGH+S$Y8$_<8I4
M^D(B8;<=($]%@4RH<?VT6L\D1B4S!\-1PG!<*L'!*FEK:^C5$2L+OFFP=C:L
M;6`9+=:XSK;K)93J><,L*JB.$D#A[;O[Z/9I+>EYC;3X:@X2YM%ZU5L!CP$G
M04?G23QU/J82._C3FD$I:?C(_S[R-4W4JK=)XN5J:-JQ%/5H&#K6^SV+F_6L
M_F)%Z)<,<E0['_R'WI>U-".ENJU]F>F]OOOMFP`#`&4!WQX*#0IE;F1S=')E
M86T-96YD;V)J#3$Y(#`@;V)J/#PO0W)O<$)O>%LP(#`@-C$R(#<Y,ETO4&%R
M96YT(#8V(#`@4B]#;VYT96YT<R`R,2`P(%(O4F]T871E(#`O365D:6%";WA;
M,"`P(#8Q,B`W.3)=+U)E<V]U<F-E<R`R,"`P(%(O5'EP92]086=E/CX-96YD
M;V)J#3(P(#`@;V)J/#PO0V]L;W)3<&%C93P\+T-S-B`W."`P(%(^/B]&;VYT
M/#PO5%0R(#<U(#`@4B]45#0@-S8@,"!2+U14-B`W-R`P(%(O5%0Q,"`V,2`P
M(%(^/B]0<F]C4V5T6R]01$8O5&5X=%TO17AT1U-T871E/#PO1U,Q(#@R(#`@
M4CX^/CX-96YD;V)J#3(Q(#`@;V)J/#PO3&5N9W1H(#,T.#4O1FEL=&5R+T9L
M871E1&5C;V1E/CYS=')E86T-"DB)C%?;<MO($7W75\PCD!)A#.YXE"UMXE36
MNXFXFU39>1@!(`F;`K0`*,G[&]X/SNGN&1"D'*_+97$`S'3W].V<?O776ZVV
MX\7K]<6K]3I26JTW%Z4*\:]441D&::'RM`QT$>+3_<6K-V.FJI$WA&JLNHM5
M&(1A6*IU=1&J]=/%>^_-3^]^>'M]\V[]UE]E0>Y=^:O$^X?R_[O^.RG)1$D1
MI!$+X86.HR!6>90%<49Z0I+G*7_]\2(/0MG(B[A(@CQ:[(QTD!2I;.?]QWM$
M21"5I<;1]?52H@Z=2%EI702%RO(,?R%1-H5JE4&5+C(Z+>\2&!F5L!,ZDUCS
MAX0^W*PO?KO0JE47:5+21;`S+!2DIV59%DI'@8[4T%S\6W7DZW,+Z!1,+7$P
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M?!D;-(D_!\&/T?6H4E`>A5=+#36#F?"A@%;ZVT-T,M<,OSK8C8&?PECU%C_:
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MD\>VVJEI,/9`:V5LE=U=B83J@-)[(8,Z]>W;_ZC;IW;DSS?/]I05;KJM+!H1
M8QLBFD@9)I$XEGK.]SI67#`[-F8$.[9M=.&A&>WQN2?ET+7`/^T<J),32&(/
MJGY`8,!4O,X,GY$R&25,Q*X$:Y#^#K009VP<:,BW&3DT$"4N3X"P<%HC"X1/
M[;2CXT9U/?2'R+K6IZSNS%X]$GH0(K[YVP^T"3`6TF]CJEUP3K!6H#^,3^3.
M(DF.2O.C4ZL/OO6+#IU?_P0=B,H`!A:7F#N@MAE]57\\C-,]H(>,_1%\`1!`
M\!M3BQVXN-$??0(-HA/$)*03G::YU%@6IL<@VS!%:6*+><TYI5'UT+-UPN5=
M)S^C9%F+FHJ]VFXGI;W=0&=&*\?L]^K.[J%VB59@ZH_T(J<&P_*FQDI1D]4$
M;L>V@XTR0V3OO/<V^P84ALD$#&PJVNUU_)>#FW!P$Z]2H,I>L]DTPGBX9CTD
M&I]$]JKQ@5;[=KK$2[P@:AT[:'):!9JB<VC2<V`JRJD(27DGK=(U57XXQ:?N
MDCMC[+JJ-/5Z>>YQ^2`H(9!G04&:]25YD3U4<=<6^#"C!:B-_%0OM<_HQI!O
M55I,;;JE.9=<!,\5V!;C@@4))1#D(%2N8Q&&.H*`%@=?I-]SP<K:FDDY6WJ#
MA2<'H)W(,M6IT23J21X<G#$P+_'H9:.!)0^<)CV=O]I7$"3$<=E88.BRH9U]
MG;@YN9XT@<6V8+'MZ)*26/%9JW3$CDQ0AM,+G/N14Y72&R\W$^K)96]M@!>R
M)B\`%!MDZAW5A#<I/C^0MV(N-.9?"3F.?]6;9=)++C="O[E*%YE,IBX260PN
M7":G>LGID0ET5;FK:NP[6-W4JG5/O67S!2Z!`KAOAJI%,QV:K;QM?>JR*.KA
M<L8R\JVFI+$GC7-D&45+3X9VV`C+W+IRY%(VU!`RA*0"<E#LCO7=/HHO!1(`
MF!H#XA&''-4.909X3W!J*+PPAN<P05T(A]/JPP"*K^3I@)2#0MZRX[5U:AP'
M88(6<-8>3B:'AV9H!6[ZVJ<1(F"F]@)48B(NW)8)/D^&1Z_^"I@4119]&TSF
MZR\<*D.4A<379FS%JQLX\EK\.LG/<-]VY`'!F!080]VM$7_/TRI]88S!O7H[
MI'P3:SCG7"2R/'=0`Y#ABFY\JKN!';6EAI(RPXVD011"Q0LW`Y32IU(W`Y3<
M,$IFR*G,`$],G0V+!5';#B(.:4P\]#-O5')V9V6IGXVH7(ILG(3-9)]YB^ID
ML65!O4A8GA/-)\9UW!_OS"A':V7-E<,@D_CZ:$VPRN6\M59H4"V?D/G6/^0R
ML;*3[3.=UD)7S@E9FMH\V*#=]N";;5?MN=T='"?;.JIF?/+^\*F95&4>Y.L$
M9?BR;W^7(J8YKCB9;IVBW#9D[DM\4[IG5_/OYL#O^,$0M486\(Z)B!F_)<_$
MWIXW4L=F!]RQ+.I`$$+X6TH#3+F%@?\THY)5K607LW+>03V(!CHL'WPMBY%Z
MO.8632G1#"(1KXOEI%J<--'07A&T2:X(VXBE_]APE8,WR2_))E9!$]D5DK!A
MO])-)W$[.S`*J"$OX,1Y,,HR$<]$*1*N%3''0;BW\F2[,;*`()Z:U7"H)GN"
M$81<P`:Z?0P;E#8KKGDK"%5>"8.+A.(!>6KWR8AH1AA2+C\!73"W%_QY:'N+
M3V(6&-JS/5]9>QQ'C.P9NWDC9LH[9Z>C^2OKH',0<QFMX]AF-#-6>#X3SZ.A
ML]/YS3UDQ^3X2^YE9!VH`7_B%J:I<>##Z]Y8"7;$R+,L?3G70*E%SEH`JJOY
MQK2>>07+0]$P>#.3`'B!MS7`+"8<-94#;ZNXMU%]U;*U&>P6>50;TPZ=O,(0
MV-MB[%KN*^(F:^L+L,_G638Z#D7"P*DTB"_)$[,FSMS^^-EME8'`K@<0D$[6
MG"J%397<#@*R[EX.49A8F)"<`EZ\0,XH0*:E7N1..NQ#SB?IGPQ2Z>D@E<V\
MS,;J[?W#OJ$YBH<5.UQ2V&Z@,_>>*1$0BYWI.(_T3*.",H4,LAJCWTNK/?,U
MJ(ZC^#NA^CA=L.&IF_L>'EPTEM,%1DIT80(XN@HON*T*P4`R7?MHYK)-SG#W
ME(TW>,$WU7Q3/H1^23]@^%?;QE+^HY+OF")+Z^C<8<L[)KX,A$S^J!ID(BQY
M(F1^C/5#+[]"+E'[,JI1PM]@_K`'I-41^O+@"2OM\WSJ@TW3XYXO9YFGP1O"
MY&NL/4]L$R>-%'GR`OQZ>NL\"&/$Y=@(8G?<7OD/D&9P8ZK+W.,^GWO(-H(5
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M_6\3V1AZ11)HT>HP.?(QR^P4>Q6S#+6*R[GA.*=^FU_Q!P\<&'6`F%:^@8G"
M`_L3>*^R:'=+SDM9M+%Z_T<5Y;>AB.Q%R/V1\?N)&AI?UJL--:P7;8+->SB$
MB#TC)_HGQ^82*:Y!5"](46<S%!5[Q+,-ZLY3..F/2JM_"</P"'OAK#<<NP3-
M@8^6SJA$NV9[:Q<,.NT6G_J8/:EQ-Y]&WN0R/Z@+&3SUP1QYVM,49P:U'V=9
MR(>.F*@A:2LE.SC)0G!_6N@2YH'B+7G@]E[Q6I-BT]&6=K2"B+8046-"^L5^
M\G@4HIVAWTEHJLK=1#[YT1H&_)1%B0OO&M:X$]EI?4JZ`^EQ#S+O\4DW"V-9
M1:D)MFUY:RS*I*](=&=SG:7&(KX`;O$H#M>LF[/50,HAH>\.>HNJ?\2;PW"Z
MA&1S?U/%M_<G'3SIW!,+3;*G;$DV*0I]Z_;*$974=E#:H3<_`YUJ1*=@C&B=
M9HG^Z2&(8IKG(5SF:,W&6I,=T\NGGO4VY?BV?./9KO!I4C_Z9L#5$?-)(J%W
M(S.]RY.YPM>T@S'_08_#E8I%(!G-U_EY[J9KEJ;,0E0;;&L^+]8UI6%TR/7K
MM&E,]<V]>+GN.JDNUW0^^SX<@_]+?[3NOR`7-&'!BQ383-I_8GI%;E@7A*)*
M868F4^H;[<LSVIBG5Q"TFWVS!D&=>E-7H\M0H(\*VZM8Z"0"A3B*F(D``5K%
MWBV365&EGP3),_!I3I<+I&`AE=QW('=!%7KQY?77EP`#`%K3$X,*#0IE;F1S
M=')E86T-96YD;V)J#3(R(#`@;V)J/#PO0W)O<$)O>%LP(#`@-C$R(#<Y,ETO
M4&%R96YT(#8V(#`@4B]#;VYT96YT<R`R-"`P(%(O4F]T871E(#`O365D:6%"
M;WA;,"`P(#8Q,B`W.3)=+U)E<V]U<F-E<R`R,R`P(%(O5'EP92]086=E/CX-
M96YD;V)J#3(S(#`@;V)J/#PO0V]L;W)3<&%C93P\+T-S-B`W."`P(%(^/B]&
M;VYT/#PO5%0R(#<U(#`@4B]45#0@-S8@,"!2+U14-B`W-R`P(%(O5%0Q,"`V
M,2`P(%(^/B]0<F]C4V5T6R]01$8O5&5X=%TO17AT1U-T871E/#PO1U,Q(#@R
M(#`@4CX^/CX-96YD;V)J#3(T(#`@;V)J/#PO3&5N9W1H(#0W,#DO1FEL=&5R
M+T9L871E1&5C;V1E/CYS=')E86T-"DB)C%?;;N2X$7WOK^!;),#6B+H+>7)L
M3S!!=A9!-Y`$XSS(DNQ6MBUY)-G>R6]L/CBG+E2KVPX2&'!39+%8K,NIPT]_
MW%KS.&W^L-M\VNTB8\WN85.:$'^EB<HP2`N3IV5@BQ!+3YM/UU-FZHD%0C/5
M_>8R#,(P+,VNWH1F][;YYEW__/7SEYO;K[LO_F46Y-Z5?YEX?S;^/W9_HD,R
M.:0(THB5\,#&41";/,J".*-S0M+G&7_WSTT>A"+(@[A(@CQ:248V2(I4Q%G^
M>(\H":*RM-BZNUEKM*%3*2-KBZ`P69[A/S2*4&@N,QQEBXQVRUP"(Z,2=N+,
M)+:\D-+"[6[S?6--9S9I4M)%(!D6!MK3LBP+8Z/`1F9L-W\U/?GZW`+:!5-+
M;$P67\N94/T7#8]Z[GQS4009S$^*H&3743QRONW]G:\>L:'L#8.BR*)W'CDJ
MAZ$6!K.`A#;BT&)D<XGO;3]W\Z%]:OO9^)DW/)BK0SWT9KNO1@ZRM8'-RVRM
MI"`E/(Q52^NG0>GM_21(O>'0M.-DJKXQ2!EO*VOS<HAF3B(F7CK]EU&09UG*
M=R'[8K'41FDI9^SVK6%58^?'R,1'G!;CS$N+CYFGC/P,,J?2K5]X=2M[7EL5
MT6VM^0E:(H]D1C^%3ID>S;5?!G`'G]%/LKO151:^M%XENF01/IO\'+I4=77@
M:?EO7FG3I%:R7?<_6+>1(Y[=P8O.4G2RK,@\T)E&%%9^Y+T9D>KUNNYF)#M,
M=""2M):]=+EF[9;]<.#-B!66)M_"<K,^A^.$NK%!G%,P7/`U+E&8)A*78[ZT
M$Z70G==6]?["5'X6)&1<3-?\[0PQD.VYC32MCEF.@)?%HA@66D^T0S$.H!_.
MK[,L*H+(IB<YFBUF:HK^FS.RAE&6$B1&=`^'MIZ[U_;PX\+,R*X/;(RR.%VI
MM4YK9DGK^NY[R7LMP,6NS(;%\9*V=`KB2,U"5:>PQ;SA)^7H(=[D1XH0+(@1
M-YJ3@%S&>5"$42)Q`78ZQ>D*LZ\H1TJ/0Y]ZL`^7+B0O4V0.G$7Y"_3P$#'Y
MGGD'LC[&[""23SZ0KI343#W1V?K1(MWQ_Z$/R-HE7U#&.460[<IM^?^81#7J
M*B?U1$8V,)348F-_8;AH4N0UG!6=&/,B>V6AEP\QL.<MCZ8RS[(J^O5:[2@'
MJ>)Z^%^WEG%C'E27'*N[#/"SU3WUJ9?,G7>>7VB3MLRSC_`9_4L<]WD8GT@K
M0>DMY^O0GR5_'L0I^MA12Z2E%.:2IIQE9H:M*==_YLU[&;<NJ\H@3;/R7;7;
M0HO2YJKI]E<0`(2NWLMOU3_*H"5/`#>NW'<OOS.;W@_KKT,U`V)I-",/D.H,
M/Y7N,`_=ZZG..S1FGL`U=F/5R$?GCC8WU8]);A*AJ1?QNB=2"Z$;D?'/:!T%
M0(GJWQOA$6`F?>_INR7'+`7M$]E!E4"?1[7M>F$2VF@%6@P(WY"FG,\H_\S[
M'5_)_-2V,RR\0#X@:G26NAH@722N@.-%DT;>)JG8"NAN@4VF[<A&\A%L*:@U
MX8ROPRM9B.XV=Y.:6XJYUFOY8_)#<=VAF^:VX>;>&Z<KIO(QVR]_H_GMF_C.
M!F69N,O96$NWFR8&37/[:\V:U1)$OD4\AA'`RK&4<[^S[I?NM3I0N^]?4!H6
M9][#<LWC421%6PL[427/\T0I63B<4V-6,"<)J6Z*\BAR?GI&XY%L0XUV.G@T
M\)$,*T96]A0=47I73P2LA!^@M(09Z`9`B[K2O>:F?9;1(#\3Y6'L=?,P_E`=
MV[TJYZZGJ1>"]JW`7HLGRDJU%<%@NM'YHE682Z)0A@YM!D(K<@+71N)`D8+U
ME4`R1=?_^\`RXR].E.T1Z:%FH9,EBEO!O84U5?R!X/'OG7^A8O*-UJU[)0QZ
MJ7=Q<#2@#/5NZNZ8W9V(N\715AR=B:.SQ=$Q.WJ0X=3-.H*+Q;E0I10T7?7A
M$Q)2%`J3+:B.GWN2"E1W\"1-8/J1\I]7&TI<S''UJ&)N4:SXV[&8<MA,#(^\
M@@K:MR<S72\2#P1BK8SK/?J+%CAZ=IS&)QUZ:<[H`2<,/92W1_@.<<%;G&,U
M%6$SH]TXTZ_UR+^R=(-$*KSM65M`3//0KM(Q<YKC8ND*`6?:#G=03IS@QI2#
MF734A%A`[-WKDH#VP.L/1"'8F_SY6L&PA%*;$QN]].J&6^1V<MDLW3+QS#V'
MJT"$B9@GH.6-M/9,,K_J]0.T(1'2@!8BSPD'0:2H4BU[%A`QV@'68-YTTC2#
M"$VF'\@(#1/(*=ZIYSS*,3S`L#W%X2/J<@BH5A;H+01Z(^)3'?4`HI-C^S!H
M_B9RQJK/I\LQRPLJ(^1IO[]4!Z!TSJR?<8FI*70RDA)6WDL/`)B209JT+I_/
M2/5Y5W$D?8!2Z1EOW20C6#Z]2".Y%X0_M-2V!/U?&-:1YDN2AP6>EN>XX"I3
M$OGD><#/`?93YBE;-M2.[?)&J.J:A8:QT<=#S3=_Z^:]V1+W8?%!Q'N#9A=\
MS#N7..*%JKW_2P\>2;%!?@_&T2I'J7!YHY'F>#87R@;XB]YA2+VS6`N%56H`
MH,RC)%L1CV]"7MGXBO8K%)TPB\8(TVA821F481*]#Q]NH6#0('X<#R2:&`7]
M_P*)I<>-K$ASKPX'%RHX/"KR-;<[>6\587*:Z91O:"?T]AKJ7_`F(/HZ=3S1
MJ-TCP5[BB>MZX]*\M-E)FL?N#*MGD.X'];V64[+@+N[V>T?"G,8DLRL,<\\Z
M&*T)W2M@QP+/H+3\P<_;DP"(]S&)PFQ<=RLE>]]UM^,[3_U>->3Y25KC\#)/
M7=/2'90Z04^2QQ\4.-Z?VJ$T3%SF'*M4B2<U702+O<]U3R'@@:YR-!@0$`VX
MYYJC01.-"BC,Y*O7YHG_887ZO^*(04G%W>O:+UPY,4VS].ZAKT/K0BM``=BD
ML(D,\SAQ(-`B+>R[UVBYX@0Q`354Q,H);K:35NVQ#2*IRHCTH(K*,#E>(#]V
MSOK.U]YI0]<\<6:Z*CE@^TEW!4"D`-CP-.=9<ZJ!W;;S?&B?6DYG\-4!U9-3
M;R/.:CZ/%:$.ET(_";$_:[,"/5F6'I]?6K2%>W;<$JFZ!))/_`-6P^RFY2]Z
ME:%ID8L;&K;"-57&^*ET@I1L.LXX%?6@(][[WZ29)R0X!70#[;1GV3N"^93:
M?(KF3"LBW"]6R>R%3*O"P;>+;?R*1'I6KRS>L3@;4J%0<M%44YWHAF9XX3/G
M"U/QX@]S+W=>Q&6H&T1CW:$E\@EO<H^5H#-E.8*Q`\O]TAC.8,\UJ,R]:!D_
M&)#1OO&@H8:S'QC_[ZNI)4YNNGE"\(YRU+ZH&<'H1U/-YGK@TLBI?(AB4OE(
M6T##+HH5"4O=\:G6"+03=KOG6>G8#3GVIW9DFA[1L2&S<E?^)9<_ESU1]&1=
M]7:YHH(DX)K*^8*X$+=_,*%5NW-)36]3>F&=<R*7T)$KFHJ081;:\#@B.I(X
MRU-O>:H24-#2^7M5#$>EQ5GZ`6KBI'+%5_#$7&N)CD!"07'8B:LXLE64'W4A
M:%6R9<;N<8^0HGI&0;?I>>@;>C;,:XHAU(OKK9U>#ORN4."#5)06[UR5+*Z7
MDQX80!#9.Z^M:GXJ[!E^S6]G$(@EXDS'3,D=72__PW>U[#9N!,%[OH)'*=@U
M1%)\'1=K!]A#-D;D#1+`%YH<280-4BN2L?8_\L'IKNJA*5G)19KAO'JFNZNK
M;"\%([%.J^YR#40*?A?CX@6[<J,+:!+,39.SJA1-YEE5^D=NKR)0/98L;H('
MW!:%1S7G';JGI;JSVI<B&E&?=P[+6DX;]!L=\;AHF$%G'I&YR:J8V^&E2&HD
M,=#%$YN=N%9(GE0L+`A(P76."LIL,2.CX7LNNO8OF%OQ$QA4!]QJ>H6B)#YJ
M">ZIJH04ZF@FMQG9L`%7LROUCPTQ*2/V9:`;']<$=NV5&'0!OI[XK=*V'V]W
M?IGGZ_$JN>:AK+#<M1I,+,`;/+D*SU\*.@I^]R`B.H5>.=$K\D:6#A)!\\?W
MY&8U$;_!M924P&H6/;"HIN-W&PY^E[1A4Y)'44O\#8=[-H7B?4D&X@LW].X%
M19:_03]6*M4DVWHY-"+Z9=1VD)(BBSI,4(8'"!1E*5P3RI*R+U830T2$OH_$
MH@`DR_B"6FFI0@H'VOZ(9![<\0OMJ3V-S'E>_[;^EZ/\ZMOHO`:_R,%8,*_!
M@9J#,6)';R+/LTS\[BWO>&'#!O#[1:;]:>U71F<SVZ</[DZ2^=/+2+/5NL"K
M'=]?#4/JDX>?E2PGB:795_>J2_[2)U,MELA!ST9U-KI%ON!0)1DO0SP7F@*3
M2B_7M+/#3(>9J):EQ,3A\()M&OQR&ZYZXBH.<Q6APJK?H>S[617,_9DN.)BU
M$KW*@9W#?G5O\V@QP@@1%)];:^O<'M-4%JB\4V$`OQI8S5^DYH9**;1D32]Y
M7ES#(IT+W`;R<G^C^SWL!<3Z\L6!Y>>$TQ`LOZNJ$4E<CT>M)A"&!W=4,B&!
M6%NP@3J(*_/UO+!/F12M/&X.^Z-SP<.QK(TQ*<"0^*6+V_)'/^/Z'4>D2*](
M]->>Z+,I_*#$?-O+Z<NE@@Y'6]+H]X)H`.UJ>6^&_E?>`]34VJ<?S(&OR%[F
MK<+Y+)\LW]FQE$&Y%!,BQ+ZHIU9N`W0H^[/D+Y^8PC^F=;7KN=5N/D^7UC8'
M&"D,*XWG0L)3-:!C%Y0*N))>C0-?RHP8"'X((+H>!?#0]2B6?2-6:)5V#('#
ML:G<%<$C]TP%XV>*YU+PU%<$3YZGT?\+GK#(KS$J[X.[DSM6#6O&O1BL`D#+
MW!#\=J`VO"IO5F_R9B(F:6$,^@LBPHKB&KCF_K:6#0W36#G,IFV&CLU*H?;9
MMOD,(+01VZ!7URFNI,1HK">MM57B@S_*E]%O+2GXX@12IG/]O&^;6YT;LILN
M56WE['Q@Z81W[TYFV;1^9UNCJ'S:75ZP]Q,ES=W)6XBWOBY%_$.&*\_&I&QI
M<>5O<#\.;(AGT##:9V)I;>F2:KJL/2['BXK+Q]HA#.OS40%-Y/*>7>$5,IH"
MD`7_=EQS9.:+(];^N)Z[U+9L/JT\LZY%,F#1Z*4L>9::.I98V=K-!KL13>M=
M=;%5=`.^'V([J:8\3_)"=WRT>?Q5#@NC'Q<;NZ/M6SW+1<+5`KH)`_X6$C\>
MV;SM,T_-J*2G9>$J3KP$JM5!EC6/RP^>#VT]-DRCGNKEH4?SU;1;S-U:*9U'
M`8Q.(H<(`^(KMDOX"`Y81!H,290N2C1;+Z16>7PM[>4$JQ3"W$G;(]+V!!&K
ML2J5JZQ$"=7E?+3"'5Z;8?^F>/(B?R<.)T$;>\D&+\:"A`U^S8N+2)XX,1_F
MZD.P(SGP$POT`>/\A>,2VZ!EAWNB#$@U;]D-C#S<CO,C-9B5-778;,L3]?GV
M&GT1<B?!BZ#>[WB`[EG(:@:2+#B4/S!1#@E*.[@;_<EGQJ'V3PMX"HI1H4AT
M-E/AQV'"=TP>2\Z;$39YU4E'&C)X<D:NQMY$D$HRI'/J53[AXYQO21J0LPZS
MB6"2B@_\:#"*]N@/4,J-!\CY``6>1ZKPIQ?C>;D!DZ1VL"'5TH"&BR?&Z.P(
M*3WD9@=^/\PLG:P_,WSSRN^"Y]8Z>P+C=G.&6;/3P%8A6IS/8T\2?"6IXOS5
MXY75LX/G)$81+SB[(F9D`B%A]"C2R^L66K8498J9D%"0*>:"P9,;"I:^?,]_
MMM=T!FVAJHLD8]9B[HP;YIX;9E;I)0VM.,J31_R_62J)"MG17%38DUPT':?0
MV7&P>K:50H(7GPW#!%^C:(XS4>JSW[2=G)?((_2*7F)[S>Y4J+6C.6NM^Y$-
M!4IK*1G5AD"JD::/L>1-&A7O0#DL/+<I[/2[DM5:LJD;V1CZ`>>M@0ZI)%S+
MSLXFWON)L`$M>[8"_N]M1X5*I<*-C96#))ZUZ[?I3VPJ28!PW0:>S!?KU!QV
MIB-6F7^Z+MB.$GBYV+B7<-IVQ\H!X-QVJYAJ+DA6Q=LVT42R$W-[P+*8J;K:
M+D&C5A"WZ^G7/KVB&F;,#K3V''!`LC"$6,A`<@;O"Z$)21*^]X4/A,SJ(\(H
ME4A&_I*$*93\ZHX[:T,'?;:)+?]Z9H5Z*N>SIG.:ES(EV3QR;XM=+O&SM%Z2
M@Z9&T33*!LR9;/&>B:(LF0=U/-TEXV60%8F68P"-\`D&<\Q`7UN@QV8JVVU`
M.HKO2D?I0"E-JSB='Y=,Q_E:K8L2I0":@4X`0H6%O)<^HXZ4+?\##'3'P'WG
M!RDF@>@5\U5\LX[#\+)B1Z"=.-I#Q;>-@-EM$*:R7[;(;\3ID4'CW<-/_PHP
M`(3M!5X*#0IE;F1S=')E86T-96YD;V)J#3(U(#`@;V)J/#PO0W)O<$)O>%LP
M(#`@-C$R(#<Y,ETO4&%R96YT(#8V(#`@4B]#;VYT96YT<R`R-R`P(%(O4F]T
M871E(#`O365D:6%";WA;,"`P(#8Q,B`W.3)=+U)E<V]U<F-E<R`R-B`P(%(O
M5'EP92]086=E/CX-96YD;V)J#3(V(#`@;V)J/#PO0V]L;W)3<&%C93P\+T-S
M-B`W."`P(%(^/B]&;VYT/#PO5%0R(#<U(#`@4B]45#0@-S8@,"!2+U14-B`W
M-R`P(%(O5%0Q,"`V,2`P(%(^/B]0<F]C4V5T6R]01$8O5&5X=%TO17AT1U-T
M871E/#PO1U,Q(#@R(#`@4CX^/CX-96YD;V)J#3(W(#`@;V)J/#PO3&5N9W1H
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M7>:XFOLR<-)4X"?LF5E-`SD.W&Y6OZ^TZM3*914>!&:FI0+KKJJJ4FF3:*-&
MO_J7ZC'6EQ[@*G"U@H79.=:\)YC^AZ1'(G>YN'3XF^<F*<E_3(C%T_X:F20N
M$A?9$'N=BHG$9,Z]"<S+'NBO*W@"93ASG-S-Z.OYP<>8V#Z&H2*:U;!3-WZ<
MZZY7G_>Q2VQ4CSQ%`02BF_K8S?5!U7VK;G\_=?,S@V%MDLH9K>!_41A'S@3?
M"4M1_246OX+G:5):8[_ON8:(OWAN#-E#PP6?`0&9Y-$A3A,3-4.\=O`?7:_Y
M<_23BO/HK_[0JNTS]V''':\;OM;CC)\NZLC$=,9V)D[2D?+\?"1MQ8<\UQ+'
MO5<?#K&%&#5Q&0T];H`>E-$8KW4$+LPTNH<6_*NYI>[B+*G0!9PXQQ7T=30R
MQ1K=W`]LM)W4!+DWY_7<S;^J'\0<;+KURC^A#V%F#UO8Z-ZWJB/[/?>_]L>K
M3S#-1#Z&>,4NNI=N_'ZGQ$:KIM/",NX6SCS0!,)+QGCYKL,48`BK3FR!P92P
MN@7MP#D:B`JFLO&XK(KX%UR$SA9W/\68M2/NX**!&CTWU`V<%?+`K8<8*K8*
M$Y=F9OKNZ'?H$[!Y26QK"Y[EA(`JS8*K:4%@W5X#=)F;/P)H?0:T"8`^-`/A
M%Z((A^)("WPYZ#A^':2INXAFHK-0*&>05IPPAPF#NL:,8HNRQA'9<ZAJ;KU9
M-8Q*<L/SGJD?B8-#R<L0PUD$H-E."+TJ:GDVSZDI`2,W8&.$.DU2T[Y>)EPQ
MI/=A1]R*X8RC(>$S+1:_&<Z9)'F\][1T1((K(X:S`V\R7FB7"Y?0A)LIY%M+
M,`LASCNL60S=.'>3Y$I-@^JFZ>1I``Z+H`,W2\8EM2!SO6_F#A(XT\">!_S(
MJQZQ::-NWBM`+>6`/#(F<54IN*'T9L&CD-YG.C)1-$3L-.&A-<<<8>U@EZW,
MN8.R)M*!"2,&H*2DE)0R&ZD333ORTH$:O=AAJ[L='&*Q[BN/\J!,]=/$NPX[
M^*<YTL(>>8CT.ASL(N`ZEZHH"CG>)TH79M1*1BUGM,`8BX,9[I+Q'I#^,VXL
MX28'W*AZ4BU]LZFI&7'UE@VVKTQ->,@LPB[(%]R^.1S#J"\178H?>7-(D^50
M90!8Q-S:4G<A._1HHUX8@C*98YV^>'F+A`TSI4,<EC-^B>E(P_7CS7&VW.;5
M\,0&OL6V1&&L]TP`-=$-`2-#8(!Z0:?A%X$!V:<K#<?P[)SO+(Q!"2`[[8&M
M,P(>41=!3BX+"AN/-L2V=!-?\"WHGJHT2\)=OS`NZXCF"NV2Y/@#"@CT7#A^
M**`[D@)2SH1<5`[K!?>NB7P9U)CF,OH6#R_$PALD?^B?"8!<'13T/"(5PA#!
M>#H9_2SP%:0309\S3*!"<@8PT95`CC$WVX!BV8MWV4G!T$S<:W[9CWDZ@\01
MX0!:C,V6RDO.42*&\!Q=/782H0=@7P0N8BQZ5N`?7LAK1ZH,3<*GJF=U0YT\
M^TCC'K@0/WJ:@M1_4%O\]FQ,S6--8]/.CZ-G2S-6@XX"A8BK"X!_XV:%#*/2
M,^"I@R-3LK?<\PQ!*`FF`W<<J<./-3F8D:;$RMT3RC_Y\9Y[_9A<TPR9KJZ+
M!H9P^Z>4@PL07I@3+./Q1(U_>`1`D`IKP=,IQDI5/XT@QR!%_>SIHP62SR'J
M.20GA4,H!#8.#'P#D8+]V'.?IYN\G[NOO%C]<JC[I5BZ)D*690NN0SP8_;L9
M=KL!.SD7$5$HHO+(+8`$1A8NP1B5H\SI^=\[]`Y8`V'RX1%..`$=SWL>]'`2
M]=^+9&BX>XHJ7]R<Y4)F8JRHE"!6!?'<ZQ/91140DH(0R"J1_O\#@L8[!;FP
MC'8=2R1NM7SQ=4&:IB@!\-V$,#O-U#WQOYH6]&V'L8#)]R1P>S(@MD?%4_?4
M"5H.KQZ\$_L6Y)"AWI1_C92&!HD!+[#%Y;I>RIG4.+?4G)!OE"$YIYJRS%2!
M,?9O0ZO!PB(X.IC59<9F/\:8N1P"W'BP&:.[9)B^`$.OHYUC7)<L?2;/4,$8
M[6G/+S>A"K[+.;;B[(E[CW`D_R0SQJ:;_)DBOX9U&*YI[GINW_,_3&A]/,K#
MLFMJV>;@<7L_SP<D(IK9D6SK6>K.^[,[.;G#22A8I7U+XN1.ZG?')#V2I$"R
M`9T&8&>EAG<`WI\7MX1(3X1-8/R)10$NJ4D:M)?L3P^WC/5\+J^`ZGRKH+VE
M:&KI*8>X$R5:IN7R8DBS<)!"#D*9\6J:QU,SGX"U<4M0Q_,>[@"R`F(]S<S2
MB#X;$4@*TVX%D7[7-7+CT"W!VF;T:PZR!>+1)G\59+%HM:"Q\8CJ':3?UPU8
M+:*]6CRVJ"IAU_$1D8)*OJ9)VQA4BR?F)]H/>MREU8*-7TI*KD=DN:&?6/^W
M0>;7I/UKOC9;#VS,X2#GTZMNCP_,45V/KQY8W#3#V+)O2(MP+G3]$1\-YV"8
MW+JW=>^"%K'5JR`?QZ'Q[0D?G(Z5[XQQ`H,=I+YB]G5OQ!H10%4M"]:&'3*I
MV%N@@"<F]'VW[6;0T?8+JD-0MFCU[2V2L_,OG!M,!N'QN$=T%RR*;,0-*%$-
MMSCJ#-!7J`X:ZL<2**)I+TU4#J3948$,/:_M48_CN0=8OV.K2OJP*N1!69'4
M+J@0"^0*'05'W%E5W<1X5$I\QM+G91891M664`WS;8L/)G>F+N[NUV?J,%60
M-HM$AFLHM5:JI3D`Z3E^\#F2[2D](KBEFAI9DSXQW?4S4AHV#S0/WHM';@^]
M3/-/0IDD>KB3L/*+;#2KGV4-2SA\^0$]AO*X8'*3G3T6DF"'@&\.8)1%'TF-
M-=[ZJ$:Y8\+*<;#'?.*.&:I`QIY9V]2J/]&VD+"J6E*3#H"W1@"/VK.*B,\=
MEBBR+*M"O(-A41G)&T#ZL";6Q1FF:VOA:%?8/)POD\?4MJ;WEQ;VE5=ECKC"
MA\.>6Q11H'DA>8VO+ASNZ!<YWH97EV8`5;SFG_6!IIS$SCO**VTD72.RMHU.
MO+:G(38N+@SBT&515XDM*W/E6K>Y%.#M4RAE0&T>43WC)0\5_;J4`=.FU-=H
MW@::3]0&.(AI&#GQAZ$FPA\Q[ZA3^4WP4/_'TS@V\'_O&S]-]?@<7@%P.>HB
MN\S+><,TT&G=_G::9N)4?&5@QOL9WE4#1A#Y$'0E7>HC:\UV.BM=P%>9EY;/
M`^1)2Y".Q=J16?[0`=V`);*"/,I?]P/?!?W]VQ<#\!&(U.R[SU[_IYZ]K]X,
MVH6'D/K\?\:K8,=M'(;>]RMTS!390>S9../C#KJ''F91H#WVXMA*8F#&-FS'
M0?Z^Y'N41W:WP%X,6:(HBJ0>'SM?JCWZ`-V+9S61(CL.0"+SQ^>Z]^78]C9)
M+XBMAR4#@),Q_"MX65CNJW]'*(]\5[X?]+E]\TW=]EA`(%^+ICBSR+\+25Q7
M@S_#<5%KL>CNLLQ>W+=BLA1!S=+'(SC6:K)G&RGK0/";)GV*]Y69B'<=U]JI
M%G30LBSE2;L,V>0YA<?[O-E*HF(GJ).VA+WO,.I50'0-/A1,E1^C8V":&<-5
MJ01Y\,)L)K;W3@$NWU`@B#>T2L5_V`TD)=1RQS\[]=>3O&MC*RN[E+P>+7*F
MT^YT[>T.M`MS)^X3W(4$E0YVJ#Q#]$Z,W(XO4&OU"AD/!\-@>>I`(\);#'4$
M)JVRB19E@-6-`@$V=:/KBL%6D9==7Y0Q;I9^:_E*NL\V[(>M\JOL@_T8<5((
M/W3SRRWM%"`<BHYWGKY$<$BXOP7#B<@*9"_BWT,`V(+*J@^$-B"O8Q@V(Y?0
MK/&/:X5:416QESBGB0H[VA/4;#G=^*7OJ,9.`DT"ZXGC%E6T@[6Z>4#.=X39
MD[6!0R6@74H@M)*2.RJ]21"H@S:I;_A%;@G`B&>D46FYJ0#\]-@&[S24ZAU7
M&HK=,>GLP-\?CR9#P$5OE6Q,E7HZFS<K&12]@C>S-DR,CN(G$[<.*39<IBY(
M%5D^>A\;:.;>V%X5=B&*5/]Y%WC\^R=6J'2N4$_A?:">9*PG$NEF8-N@#4KO
MT!'E!M8.#8:XKL2D=Y^E+MKVH[A%MCPE6Y?N=OGC'.B4B#K#=R#M2>!F5HXE
M*WW7*Z9EN(*27RV5VL8UK<,QB(BR@/<CHS`B$2\:IB=R%6I[>4!>ZVS15UOR
M1*F:R3[44]&IH>=9$+ROS^#?T93'49>MMEH\["S(4*5%9>LT=JI!`%O:0)@X
M:5]*[D`SUL!U"%QE?PA%S>*G<*/9<2V8)6Z9;25"WC84JO%M('&VQ.&*0Z0U
M#SO+8TH-1;S3`K\XX<CGQ>R51(`@-RF29H(`(]_!Q32[B4<SA1>6G2VQV!E`
M<W@>P5#Z^7;A#MY/F\./`___I:^8[/`U)*#<#!UF\:^XM"#U2?IL<7GU_3DP
M^JW3)&KNTL,:K?=&ZZ5^XK^4@B_7Q)CM@+<5R>W:ANAY;#=HW*PMR$K,,3AI
M,CYK%S+Z_CWL+]`4Z2@H7(E['MUQ5MNP?&,BLVU/L6U.'AW8C4W<W5BS[;)+
MF*$GT_+V9H-;W9AW%K@SIW>:FQNE=0T!6:8EDYS9MLK,UF(F;W&9<$7SVPQ<
M)=\8:>_MX,&%!"+"KC(C1;[L^,UGB-7?:EZ$;!+_L"HJOX\*3\#PLSTP=J%J
MC%^]`DOTJQW$V^#9K,S[`B5F>^D73V*:LUMM^?IP,.^*OQ;1"<&)";5V)]B6
M:E.F]SBHR5IC="!1%HKGU6R8KVW-M:D\I8R\[Q^?]]E31-Z3+!QE:<#,5[[Q
MI>&H]#88ZRFL?7TK;)(FC:W]'4W"Z-6\52A*92)UF`M[;G4X5/!YZ$Q#.;I9
M0B[;V_;!4ERJD_NPE4@>KK?F,G.-W5F-[:P?,&:[H,?PG[81B999@8L[5GW1
M([=2)%XJJ04:S!]G[+QR"\[NG9'IR?=L2U0?N;E1?3M-*KGGO&NO-EBR>B/M
M1MXG+E8Q(R_8G#AO.KNWEJ;;O^>-3'MQEER!#6S3?+-H5XK(HA/[(SK).HMU
MSQ$G[W[N6B5QW5!>]*VD,'9/8\F6<[PT\5[E^5L#RB;2V>#-G*BT!R_[MX62
M"30K!;4EDV;')P04W<6>5#IG(/8D(J3.\Z$/62#.*8ESNGE\R.PJ_WS_XZ<`
M`P"9V*])"@T*96YD<W1R96%M#65N9&]B:@TR."`P(&]B:CP\+T-R;W!";WA;
M,"`P(#8Q,B`W.3)=+U!A<F5N="`V-R`P(%(O0V]N=&5N=',@,S`@,"!2+U)O
M=&%T92`P+TUE9&EA0F]X6S`@,"`V,3(@-SDR72]297-O=7)C97,@,CD@,"!2
M+U1Y<&4O4&%G93X^#65N9&]B:@TR.2`P(&]B:CP\+T-O;&]R4W!A8V4\/"]#
M<S8@-S@@,"!2/CXO1F]N=#P\+U14,B`W-2`P(%(O5%0T(#<V(#`@4B]45#8@
M-S<@,"!2+U14."`X-"`P(%(O5%0Q,"`V,2`P(%(^/B]0<F]C4V5T6R]01$8O
M5&5X=%TO17AT1U-T871E/#PO1U,Q(#@R(#`@4CX^/CX-96YD;V)J#3,P(#`@
M;V)J/#PO3&5N9W1H(#0Q.#<O1FEL=&5R+T9L871E1&5C;V1E/CYS=')E86T-
M"DB)A%?);N-($KWK*_)(#DHL,KD?W=75C1K,>)82,(>N.=!4:BFH2#5)6?#?
M3T2\2(JRW=,P("<S8\M87W[\]6MB]N/JI\WJXV9C36(VNU5M8OJKC:WC**],
MF==14L5T]&/U\=-8F'84@MB,;;=:QU$<Q[79M*O8;*ZKWX)/_WC\Y<O/GQ\W
M7\)U$97!0[C.@K^9\+^;O[*2`DJJ*+<B1!9):J/4E+:(TH+UQ"PO,.'F^ZJ,
M8A#*(JVRJ+0+2IM$696#7.AO][!99.LZ(=;-STN)2>Q%8I4D5529HBSHER2"
M*#;K@E0E5<'<V,O(2%N3G:0S2Q,Y*/G@\V;U^RHQ1[/*LYHO0I1Q94AZ7M=U
M91(;)=8,;O4?T[&O7UO`7&1J38S9[&OH)-'_TO!DN-8?F%^DXCB*1E)*-*(D
M81=Q2!Y.(<D-VI[^E4%GVK"*LJ!_=O*_:_!/#B>A'`W^'\)U$J5!@R_CY8`=
M9V`S8UA&Q4P/.OP:4"BY2E+-RST76MH:3%@$1]FX.U5VTRP97Z";.#IW#7,^
MIW7;_PB3E'C.H'+=J!<X+D5U,W,_$&\6F">URNU`J+9"Y3"HZKU3\3"X4ZKK
MDN<PRVZZ%Z0^)11I+9.4TT:J)DD0ISC+<L1I2Z4B9K)]@VNG7MS18WL(URF;
M2>ICOE9(4K)`OYY`XP:CU#NE'EVWE$H2E:,!OY[JUU[%<.G.LMT=Y21RS&Y0
M14ID&CW72^#65)Y4,1EJ$+VBF&^-2S>[B:R>*'\JSI^4TLCQK;=8-V',2IWQ
M9V'!OG#]CHFNQ^D@BLB&I"Z+A:*D]HKR%)KZ"YM6!Y,A)EDY<QZ./=;BZNMP
MG"9XK`Y,V^MJ#+/`[TZXV3JE+D#=1:)*+8E[#&O-M/CJLE2M8NACF%/!<0J1
M\5.8TF6/\CN*.S\@SAFY&8<'\8FL9+?IS#&LZ5-2OPCHL(;#$N\P26/R/^1V
MJNM%V*7D-?6+X")[`X>5[@;FG3";)SFZ@&Y44;+'Z4Z=830M[.S&Y05@*V@Z
M?"`^LO0W@>FT?VY&)3HO;6E@YM(_K?M@O!G"WI[DZ[)5?^QQP3L5#C':_(5C
MDE06D6`Q)=W@TG2M7II_'T(.ZY4YJ0[(B<%V-#N.%V^5`0)10G8)7[/57!@V
M&(1RH"JP=-C0#@M_P7DS&"NK&+S)\N,#!R7HX4>RBRK`!E#%@CLLS17'=S88
M]1^OAJ;%$G3L+WRK^=36I!&=8?,@B4B=+MB:7G?6%'AN;\%2T(ZWC[,YVZ5+
M=<:@H-6[3]J-[R:'J'X]?GZBCN&[<(/>NZ48<PG[SFY^02]^PO%%>S!42+'8
M6-:)_@I71+W!!G._I8"4538W!*O]UMK<^KDH%2Z)3R('=QZ<]$O>F49I$[QL
M)JU/'(3<[_3(L68>6S.M%]B,U'LGYMLI(]5]<>,TQPXMDGIK4MM%Y[+Y;*@.
M<)+43D?8FHNM%LN((I-B^2V@0J0X?0NY3Z'\:$_6G\,USZK?+R`]DE.ID7'-
M)<&+>4!CN^)?0QZUG!3,N`7#R,)^U3XI:AJU97);<^F4C'H6NQ0?G?9)?[]%
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MRUZ.!T*U%&`>^!$><IX.\TBG07F;[L3S[,G6G+;C=%1Y>T.P`SI'XS<7K-1?
M9!77_AY*L[W9XVF2^+;W<&V&[3N0S[=**>S8IWRS'YR3_*&AU5$24BWQY#\X
M\X7F",V`*F(\;.GW&54@645NV1H<'KBV*[&8$*58@.1-(UO4.=*+-)%5[VH3
M:3>5$$Z5I]J@I(<2*2'G"UL5('T6N%817I)7E::/N*Z@9C&X+9;J<MHCA14B
M6P0SI,,79<T92\IB*J@;D7@9141;"3^V9@3F2S3/U<E^FLNPFX>Y#&ASYDGX
M9S/<CYOT?H#SRT#`41IL7V$$.J">3;_/3@9KQZ/>F=MT]\ID2&"2]Q<1I5^8
MO)UJ@L?]75]C3LR+&\CA[,#_9P9)E+.7YB3??!4GJNO@C*W^1;^=(`[.=$X3
M"CL7?+$X8*27^<$&4D:-5ER;`];6P<%`IYA.O:8Q8RO"#I"YO9SDW)FM@P5J
M*NA!)'B0/+85R0:2>Y7(<!HJ!5!;K_FXM!($W@@U3?9(<8-OAJM6Y!'<AF*P
M[:">\(2Z_N-F4QC"#[L5OZKBQ`JZJ./,QT"2[K?`1H3B\B#S3$D,+NH]6:ZU
M&#,IR=U\7XBUG*_E(HOU\1+'.F>^'AHRL>1D^#?^[X_CA!6/Y/)F:0:10$!%
MD<\R=>+&-M6WR2,@V;/"*T`W/&39C73[\=``O>&72G*OYR"F9H5O#]SP-;V2
M,3@S`-&]88=N95<,^1HQTN5AH:!!=^A/0(O<*P7+7`]"V9L[XSG5^%.EOK4=
M)FW5].O2=@6PYAF"\;5T4"<'>P.;L+<_Z,7?&0`+_"#+S+]*""BMJ0]2_Y6Q
MJ>[B/44+$FARU,2S4H%#G13V;<^[H7%M+V?TC]/<=Y8(O^\^F!%-Y^F[TU>$
M/"QOCP=\+9\^#P/V]+FAHD>=_%_"W#>M5CLNWAW]T-SIELW./ST#\RBO,&P_
MRR_WX6'),PKRC'PS5"<L8/X=K"QKQ5`/9XG4^;0(7MLL0TEO,*JC`NTL\\%&
M8-_/V^&>'VF*+,.'=!"=5:^261+VEM%"YS1_0;J%RD'3B&!H553I$H;Z2U:)
MCMA)&L&!H29-L`E*)(]X<78T$+H]4N@'UXZD!M,*TJ*DDT;N^1D!.VY^T^`:
MAOC'&<VK+6\2._,9F'AHT[;]L&WDR2,0."-@[P<\PPTY,0^#""8<6Y79\HJ%
M%\CO-KGBL3TASPBG$#/[G<12F9PIN41*&:7)G91DEI**E$`N2R(>^^=FF(YC
M)'UXG111$6?5FV32EQ@W?.12IQ'E\='JC#%?!<,<,&OD16O1I&3V.@$05PR?
M7AZ$&%N85Z?EU+H?=%O7XI0#">J[2?SD.DRM'0Y;_/.SOK^&_-#LW,#IG04'
M')^EJ&]:'H5*!ZK\-C(7WYNJW)44+H#H!0.Z>6[T-N_8J6-^QW[OX`6H5DE'
M!I=LI[MKFS>`@VF(KED@$-S+QVEH))YLU9$<(:W'"H29DZ_R>Y1\DGE,C(.!
M#Z@E1B:7[L5=6*0<T&6+J,QLOLQ)>[,C56A+":R)R?QS<N9(3HOD7&:='&KJ
MH9&IGC_,/2WQS4'*1\/U?Z#/JW1TB+X&9APOBL-F:%1KX\UE\-YE-NE#I[I!
M,F`YA!'46\5LHZKHEJ!-S7#F[]QV,L5<P_X.YQE-4#7YM"@,ZK^`CV"\QXKT
M*-,$Y*J2NKO@",KU0RM2Q)A7R-C!6O6&NNK<Z.D-<3Z]_-FC+HLKCZJ>\4;C
M*)O^?Z17RV[;.!3=SU=H*0/C(!+U\C)H7'2`F19(LNA@LE%L)57KR(&DO/Y^
MSCWWDI)3%QU,-S9)\7%)7IY']]:H#;7W8#"RV.%-/:`?9+5H``],$06?9P!L
MO4KFP):&59U!TP:;E6WVO=@M*8V[5[#1TDZ%+5@P!8?5W58;6C9T=UJ+KF/K
M+Q:,9R;&L+;Y(K5FN6EF=6?L9>XL2?A)B<)"GCWEHXC\3VR.4$*IY&:GBGUI
M%,:L-@0.J;O)$*Y?EN<M\][/X`?[<=+K'&06>7L),FPYV4/?FK7L)Y/Y#I.5
MWI?>(QNJV+PH&5.+%L#U8B$`=G+$*S!3CGD%LVMF&/+_8QC2`\,0"/C4SO5=
M,T@Z0TB-DO(5WW@V:2Z1\U<45CW#K[?:K>/.[R)?.Z6W$"#@AYJS2&KJ?%0Z
MJSCP8@7TT"E^8$A.\RD9/,:YRE3#V6CW(Z][_V"E3O]%PNRU>"OH"N"8.@L"
MM/TP1E=]O0W]M1"=UZ_1K0W=[:SPW/*5VN2^Z\C&,&W]8$'TQ!\;^J1_M<+7
MC@"A3:\+1=4PP>5S.PS1^\9B:G1(7^^88G(KI,+[IM^T:!06N6@LF)8``9Y[
M/<*,2V\/J023G.@3?[J];4%UU[&E2Z5G#RK*DSF7%<DL"]<?%DLAO@M9_>S-
MM:4G>9:MYJ(J\VL6YB.O%WHOF=X+?4.I9PC$C_3^LIC[P-.TJAV2]/AJPQ][
M^\:3A3J5C5@XMA-(AB3WF3_7GL:2]5TS]"HNU3@ATW'L;0>U</=F:Y6^S_"(
M@JY.O,[`SOA<*%C)#7\U(*_^=TAC>3`K029Y*RP(PKN8.`X7Q_X]'XGY(T5&
MA):Z[*W(46!<SE^P.`?EXL*>;<<R3M?(,HN#)E"&=/&S-/RM@_IOVO]R!/G&
M^XU5UR]"J<Y/4;/2D9(1/2+?27=9'!)3IL-&LWCPD>@HB4&:-:3'A2*U1+`]
MH3K_#@W3DR)-JP,T#!<7.\M7#X#0"BN[Y)]"7QE.KC`R_%.#HV'3_VZ1`-.$
M^$J5L1<X,\>(9^:NI_&JU0!B)"2+V,-HK\X0[$R?]L1?Z];;"J*^Y*R_8(5:
M)S)5"*(JX^T/!G/B@QGX",\9WJ494\V<&9V4:7Z,3IS22?+K=.+"F>:5/U-'
M9I;W/8SZ+^Q0X%SE?#3PC]B)RDG'G3K=:<ECXM`%50+9I/#R-/TO9&&2)RD+
M%X26H$6*)7(3U<A>:X*'?=3BH$<-"S4.D)/UL.^LSXW^[Y#D.:*V*B$:6G",
MFELE#='9D&?[:%/[.1LOS+*B3(XXSJ3T<C#H%(#?4I;Y:.K!E$I-*C;-9TV]
M94Z0(S=>"AG9<B(5/%#T]C$HG:4'V<)W';TG8$>"F)4AP5><$F@>2'OI-S83
MN\LI+\C8'OMM*1=O)#CHH\>MUO%\B(Y:BW3;R`K5MQ*D[M?I?A\[&]?TN]=V
M-NS).NGT8?#9^>4@\.SOP?E[8)P69I9F&J;8G$SH6\7KS4*LB.1E)*(E8UX#
MXTBX(\OZ>2LRA\BN5HG`FRKL7O[QV?"5=/.LP&@S#=$:B9W$+])]LY"SY4AD
M`P"G(67XB07:>\+"MM'_2&.0M6<WXOR-S!1`[HV`,=9]K<?U#90N^<)#'"0+
M$K$!D&=?Y)<$Q8](@))(R)KU!+UILVBIBB\%.L=/MY"L/>@.`&!W<KJ8'*NW
M0HF%7\-Z0Z/)Z%5\L`;2B%=YJL]^]J1*O\74<HZY49JD]\H.:F$WB?92KD-`
MM65;IVUWICG*2=E1_L::9(#EG3ZUDD).MSH-"5JN$?UF]V+QOJ'SD(&42]3C
M^WO"E/XV=#BJ^:#W6A%YN'(<Y2?"I,HXK/Z]`$I.5EDQRW5+`=+H^L/%F2'[
M)-_RTP/Y5@4'Y@Y$CNRR@H)+!`YTTU50;Q756]O-/F#,5QMDNJU2L$^.ZC:<
MC\O=7+<E1W5;(70L2D3$V\]UF^XI"73ELDF34K81+%2UF4-;7_WVKP`#`#Q3
M`X$*#0IE;F1S=')E86T-96YD;V)J#3,Q(#`@;V)J/#PO0W)O<$)O>%LP(#`@
M-C$R(#<Y,ETO4&%R96YT(#8W(#`@4B]#;VYT96YT<R`S,R`P(%(O4F]T871E
M(#`O365D:6%";WA;,"`P(#8Q,B`W.3)=+U)E<V]U<F-E<R`S,B`P(%(O5'EP
M92]086=E/CX-96YD;V)J#3,R(#`@;V)J/#PO0V]L;W)3<&%C93P\+T-S-B`W
M."`P(%(^/B]&;VYT/#PO5%0R(#<U(#`@4B]45#0@-S8@,"!2+U14-B`W-R`P
M(%(O5%0X(#@T(#`@4B]45#$P(#8Q(#`@4CX^+U!R;V-3971;+U!$1B]497AT
M72]%>'1'4W1A=&4\/"]'4S$@.#(@,"!2/CX^/@UE;F1O8FH-,S,@,"!O8FH\
M/"],96YG=&@@-#,W-2]&:6QT97(O1FQA=&5$96-O9&4^/G-T<F5A;0T*2(FD
M5]MNVT@2?==7]",)1`R;=SYZ;&<WBQD/=J3%(ICL`TU1,A.9U)!T//Z.S`?O
MJ4M3M!SLRT*`V.RNKJZNRZG#]W_;6',85S]M5^^WV\A8L]VO2A/B5YJH#(.T
M,'E:!K8(L?2X>G\]9J8>62`T8]VMUF$0AF%IMO4J--OGU>_>]:]W'S[>W-YM
M/_KK+,B]*W^=>#\;_S_;?]`AF1Q2!&G$2GA@XRB(31YE09S1.2'I\XR__;+*
M@U`$>1`729!'"\G(!DF1BCC+G^\1)4%4EA9;MS=+C39T*F5D;1$4)LLS_$.C
M"(5FG>$H6V2T6^82&!F5L!-G)K'EA8(6;K>K/U;6M&:5)B5=!))A8:`]+<NR
M,#8*;&2&9O5OTY&O+RV@73"UQ,9D]K6<"=7_U/"HYRXW%RG]9UD4%&P_!22F
MV_[NQ8&?!ZD7.=_;4%4$49*F;QQS/H/L37,5@#Z;DQ3'.HLDS#_[B=?Z,-<;
M)WEVOO4.IM_[:9!`X3KS[C",O1ZKN?>-_RM_;3$UZ);1MT'FF2N6N_%Q0.YM
M1AB-26=T(B8A(%&09V$Z&TWN31.QYJ[_5OF4;=`\FO&A.A[-T]B8=AKA]VK$
M`:77=R)S?VS,?3-.IMGO^V&213/UIJYH#Q^,O"JB+!87\,6CU!V:EW)HU?GK
M%/Y],7[FZ;BA"Q;>\_'%M./XI),[>9(<+)67"AZ(Q-ZKF\V(\U7H_I6F'ZEI
MV6(]T4P/NBR6KYWIY.D<Q:(QC-3\)%>?_0(#2AP3D=L.C5_0DV(02_0FK">(
M'IG4\$S%,B<8AK\4PBE>^V^R=6?V\D[+`\L?64/+_Q354G7*3(=D@9:.Y!<'
M/M"[J#1W\GPVG_KYO*^S_&;R40(PL?Y*1M[^6;,T*T!L4N_0F,].JVK\?H%#
M,:YK;;)(]6R!97>?<&3D;6XODC$*LBS)%\D!#9H<62%;__KLOS/52"'O]QPC
M,J,Q^]:'FY%\6-C)9"6)/S4L+'.=/#2D@,<RSS2B\3DEY5";6RW*9TH%KZWY
M8::AVO$[/"V:4Z^NGX;1])T(H!S8X9P\R,U/FUMZ[EGT>.1E'C^+.2W/\.:#
MY)UWKA=`1K%T23%;I^5R.@THTR,E>(+,?D'Q1YZZIH"BS3-RW7QH=CI!!8!4
MPHYKG)O"$MKP^-@,=8O)WYJ#"+:4_\BP:7B1B7,AL$V+0I!VY2K9<B5XO^[W
M;4VIHB!8:&H$-BE?!7G.#._V[[]=J?2<$FD:EDOITIWB0.JS;SBZI;>GQWQW
M%*%I.AGA#J;M%@M?I+CI[M9[DMG!)V30'0RID7<D^S5+]0*6^M3<`,DDN\CM
M+<>R0N'G4#8.S:'U8YPT3OQHAJ;U2PPZ>1\J1NS#1244<*V-ST>$KA!L;.=;
MNQK@)/NE&?A,2V!C<8%W9GRZ_]+4/#<1#O<4$`IQUT\H6T08X4%C61.$N.#"
M*Y&]!#D)+?L_E>,)/JNNIA,C+S"7/&0=RP6HN91D_,VY@:JCM(O&_U<7E<0K
M9NOB7)0CB5MJ0+BY#ULHW:>V[W!;Z:`H&&X1FX=J:,;_V127D!`6N!,?<(5V
MR"6L-0](.@U5/;5U=<]5#DC2<N^?6RGMM^#`.*+-FW"*V^E>(0#F45`%!\"1
MTGC9-V>3\E)#T@RBX.HP-,VC;RE]FVYZ9^;;C@^L#.B.V*;+HK+N?J$6%77Z
MT]"<X!Y3=0P=U!Y(_[[%Y9Z!MV0T=860EP11XP4VV/@M:A61=ODS/B%Y_Q5L
M`K-I`*+MU"(>52>+.W0?&=4/;N[@8(RJU%SW\OKXB*K**"TEG5L_#!3UJ:09
M$C^?#Y7-EUV+O)SDR[++%PF+=E5ZUQ>I@DJ+DP46:(H3W3QW+%.A.8$PX1]I
M.6DNCE,U29QRBA.ZA_G0#SIA/JP3\@PU6NZ^#6>/%BE0K@#*+JOT#*+?7Y=+
M**SZ;*$F3A0G:B&=:CX@+V-O[2/SK9=<W#)9=/-7"1/%F3U?$_8^M^)C2_<=
M3S)L:N`/YTNO:TZHF;D;O57(K\S3PM0I*L_);8/PO6Z43"[Y6V!I6#H;IF6A
M3"]1II<(T\N$Z26.Z?&RU)N,AT!-FTN'YYD!RW"DNLT\9L.4=.?PQ`&BD[P!
M4?6935WK)@HM[+F@>X&->,*A?6)M$6E4+BWXTG-RI-YI`@]>(LY1W!$AY^/7
M!"IU9Q:*C.K,]!P?PC#GF'FQ4N>\F%JG0!!T;D)ME=[(2$IE5PK5*CS5TLB;
M$)*4"<DK+V]NKXW+D[/3U/8WK$*1(\R*R'F-[(ZIC"FO>AFS?IY$%<F(:HE0
M@&I)A1C*1-SMTVU\!8OO*5$B;Z^44I',BG:.GD59^4,DS0H'R_412>P0%/&$
MU>VW1?H_R;C;`<#/=;%`PRM<4RM@3\>#O]I2WN-8V+`C9FS-I0NM([1QXM`=
MH:.0DG^H20AOVLF#[YYZ.\>SD7>RH.(G>7,Y*&\#&8;R<!V0YI#+U7["K=`Q
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M'AS62FW%8,24@YDWUU3,C3_W=+WQR8)!$R"F!#C)2!]'E[H8,FMNY!`P.;#V
M@VXS_2"MVXPH49D;7"ABFR<_@%_<0E-%*EHA=0#&HP"^_W1T#<ILOBIH_F6.
MU?/HN!?C9V,&E3LVRY6AT:;E5AF?03*XR^E9G6M:"0?-.9\-OFQ4CEJ6UCJR
MAN\6UO9$;:H0L&K!3#@/:`9]HNL:KB@J;EYZT"4V73LV4C=,HL7'4^ZH9YG)
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M.NPG8^#><UL$V,\.0"C`%LQ3YYH*`.MTDO$,4,P3<28@(I"+R"=K7B1OB5,:
MJIL_[M]Q/U=V1`\JC5P^E'CN1W0*6ZYU5@F5:C@VW!AB_L*273?`Q7=\?WI]
M,8WC4SHS<?G*N`;!&94(Q'-$$)"L*+)EOB3S18HE`R0@<PR00>WJ2`FI;WP]
ME!O(.>6&?O=&8?E?OJMDNW$;"-[S%;R%RI,=<9>.GKS)+;F,;C,76H26B2QJ
M2,H9_4:^.-75#9"2_7R1`!!+H]%=737=.B!=[L'GN3\TAYK/U0&IYQ(R]0DL
M&/ISYSCNI2XB9[5,WTK=8*T%CAADEQW#)-#O\0JQ^08U$X"2,UQ8M``W&K;Q
MEI^5U^:"\.SS$R[),$&0,'V"6`+NI,Q8\VZ1)N]5J,*3&?%AD`'&K0K/\,FN
MMB&-`#?'2V]I4,1A-!I8+`+C_],7/)4+PJ/G01#4.GE,2+'P'A1#E<CLH6X@
M79+G($Y!O4#R*.I:.:`?7-2X?D/0[W3ELY:`)M+NR2:#C=4&WN[4A);N&+6:
M01(3$E2"YV?[Y7(%>L?2X]>RXS<0?G5CW3Q4,G959^A*]=*;VJ0U[[8J"467
MT5!V?,4Q#XAGU[_=EI?$DNG43BO`5M_Y.M/GQ^%BJG1>ZVXZ48L.//)1^7&O
M6DJL+NCZ.3PH[$4\^:2%;&/E(ZIMNO2:CX^7%($W:BU%N@_JA,X^ZX&NL_+F
M;BLAG+[2^.2LZ#Q3.L:[MU89S[H4,,W_X^3TTPZXQ9;.V;^_[9?/!-<_9H0W
MN,H_A(*/1XI%8C$M0`,.)3!3QJH<X*-:J3.L8H0P*K4U"#IAAL<W5(#%HGPO
MNQ>948FS)Y":B4ZO;&D[D#B.V8^MAX]R^-$S&3MX4H)N+IA5=CS@1+#5<$22
M01[P"+$P0/D8@".8><-"XOC*6>(Z9LY2RVC*)^W@JL,93MAZ^EUEBV)Z?8_N
M7O<2RG&K3?OR`O<!RGB6@"E)*O1DY%V9@A=,2T6@99D!I:`@WG=%N$9$BBK8
M`B#DAJE61`EBL;V4IZ7QOGCD2,"WJB=8O"QR7^I^7,"("&)7VJBREU1FL#.)
MR/5[`=)3K2"-EO$E."E?%N_(Q<6RJL8@D8A#D#C3;8@,7'`P32?P'IOBT\"@
MLD)@,"RT.Q<'6#3IHK`"J]U/VWAZ`DF<=*`B\438[B$(%5I]7Q4\24NS0DU_
MP8-DQ-Q2,3>+Z0(2_A(:,E<-DQ"994B`9!G;5+:CNFDXCW@`>_N>12(C+JU(
MHTO%[R16L,[B6G?0>1+$KM.1FJ?8>OO;P8$(NLQO$K73\XA&*]+O,M8OKSI/
MES=3\ZT3/5]G2D0+_#X=.7&CBT_S8#[G;HYZ^*4Y:&.T9\\%3F4,#O]INWYT
M_>J=VWM*>D>-TC3`416XD8B,[<QDQ<8&3DHBI=E(R6-+D$(`GIVS_CE%;M#.
MD5S)N!:737OR769U><\M`5IF4>JE;LMT;1KPLYZUEZ"AS0N+.:*3VRV!;,5J
MFDIAMSP918.XZ\4R23`,4U-&I:F%SLL"*=D_+CH-.=\;O/Z^7I<1]MLB#^#L
M'&`J0+M:*-#R2#DMSF?K[S([6>AT!-.J4O/@`/UF.Z6/25K8-_HA#[7(+/^R
MKY$TE5"3]MBXCLW^O^@OIZ.#2JK#:=<#[[(`;/KB=Y4@"T9^C?-'K"_BQ-_-
M6PM-E!<&3+S41S:KNT-URX/-XCW$@]NWVA+3Q6J3C6(T_@;MPG@I'J8'2Y0G
M7?3JM_'SR-S#:^3F7MZRE,)PKVS3Q`K>VM2H\TQZ*>6<F3/HKI],V=:=%[V]
MK9%P[R_/VI&B*S#BL5)8[[#WYFETYRIE)_6O#/;8J^+YNIVL*D58/EFS<Z0#
M*M-D8#`)2WR1/[&T<T>DF1]`>K3:/%YLD>D`P51<L?)$0MB>70J)I4_#=3.A
M'K8?B0A`#V_UXJ`K;:>=9QAVMS=BR^N"I$A'M86SMUX"_6T#K_I7SPIUO=I:
M<4X=-?[K`R+;F>%5T%!H2NBPWTSZHERL25I4Q0?;UMFTR)9?9V3B%@5V$@WQ
M*[2<V\''<6-OVP'NJN)^TSGOZ!O[+CQ@&+>KK7$%"S>;;(1LHAXL?C`>R<."
M9-CAD\W'*5-(GS(6RT%$F)'81K!XVQZ/[;^27T99.#J0+NV5&;D`T9'DK7"F
M3I@=HI"(HR/]KY)Y`CHF7X$1R02W[/W3A:=X@QSZ+:Y[*#XP]Y5H.T>%`JEW
M4L[I-G"AY@P2*2^K">KP*I8M)S$Q?TR_S:*A_L?U+*[1^5AOW*-\6N\=W\EC
M'[278,`-2\G!JV[(;Z7/_JE%QD=*?T%D24BA7/=X%['Q=C*F=>J`;%)S1L;X
ME3XCP12\BY1DGY4H@T^_NDC/Z6W613]))/64'*AUHC0D(Z$Z#E;"'_QY]\^>
M9*%N+L=*1Y)PTG_ZV-IC:6;/-W`Q#T>9P)'$PXY8A&=)+%P1TU8'/Z]_^5^`
M`0#SLU.9"@T*96YD<W1R96%M#65N9&]B:@TS-"`P(&]B:CP\+T-R;W!";WA;
M,"`P(#8Q,B`W.3)=+U!A<F5N="`V-R`P(%(O0V]N=&5N=',@,S8@,"!2+U)O
M=&%T92`P+TUE9&EA0F]X6S`@,"`V,3(@-SDR72]297-O=7)C97,@,S4@,"!2
M+U1Y<&4O4&%G93X^#65N9&]B:@TS-2`P(&]B:CP\+T-O;&]R4W!A8V4\/"]#
M<S8@-S@@,"!2/CXO1F]N=#P\+U14,B`W-2`P(%(O5%0T(#<V(#`@4B]45#8@
M-S<@,"!2+U14,3`@-C$@,"!2/CXO4')O8U-E=%LO4$1&+U1E>'1=+T5X=$=3
M=&%T93P\+T=3,2`X,B`P(%(^/CX^#65N9&]B:@TS-B`P(&]B:CP\+TQE;F=T
M:"`T-3(V+T9I;'1E<B]&;&%T941E8V]D93X^<W1R96%M#0I(B9Q7R8[CR!&]
MZROR9M(8L<GDCCGU:HSA;H]1,GSH\H&B4A)G5&0-24FNWVC[@^?%DBJINNR#
M(4#,)3(B,I87D6_^=)>8W;1XMUJ\6:VL2<QJNZA-C%]M;!U'>67*O(Z2*L;6
MP^+-^ZDP[<0$L9G:?K&,HSB.:[-J%[%9G1=?@_=__?+IIP\?OZQ^"I=%5`9O
MPV46_,6$_US]F804(J2*<LM,>)"D-DI-:8LH+4A.3/P"$ZY^6911+(0\2*LL
M*NT5I4VBK,J%G.F?[V&SR-9U@J.K#]<<D]BSE%&25%%EBK+`/S@*46R6!40E
M54&G92V#DK:&GI"9I0EOU+3Q<;7X;9&8SBSRK*:+@#*N#+CG=5U7)K%18LWH
M%O\P/=GZI09T"JK6.)A=;"TRP?IOZAZUW,O#54[_16&CBO4GAZ1TVZ]!%H5E
ME`?6VSZ)E45DLSS_SC#/,DC?O!0"\7#!'L;()N+FNWTSNK"(DF`_'#9NY.'T
MS7QVLCJ'2QO50=?OS+`U81&\/;1#?PF#3`3!S#8JBSB_2$JRBZ1:)*WVB*`H
M"YQA%C(Q[P89-.-&5R:E:PX',QW7,GD(DSCHH$P>F/N@NP_-K&3=!%W'G?(>
MS=O=Z!R3.Y4QB[8VC>*LK,4:7X-&=[W8T1V:V?D9+CJZ274[')51IPO]9)K>
MDT(=T@<G&O,H:V.($`N4^#%,HL)/IG"9P)7-P<S#LZC=Z+69PS(0=9=>7QQ(
M2R0+.9E<6(EA;9%9,>RFF]I]PR$R[IR90T0AR;/XP$S.M,<1/J;]?B;%S788
M82':A\&0WH&?D1*YGZV%A1LG=CW;$"EC.>.]-O:B327:D,!+F+P;&D11#8.`
M51)L:`?"6:MM%U8P3-_T+=-T,,J3:T9C8P3X/)C&&T*%BB%2+SHI572*7&;1
M$\=R!3/N0R1],!SP@519&Z=O8:X&?X`UDL"YF0DZ_J<(YV/;$!%<!'(+!!+V
M*%YIB];\L*')IA$6(L(H)W)R"HJVY65A.PK;3<-KO6PY<Y8SPD;T-G[";)3U
M=.2]]23SWX[R[866='EL1N&]T^\CG]C3WKT7X,R_7T!X%D=9F297*)%<E0'R
M(R&_IOS24U]%Y?(Z$.*2`/T:6?)G9,D566;`R0L$J:,JKK+GP$I2S\\CU7_N
MPS`/(O,%%ZF#X80[!N,<IKABQ_\3$LT2?C0'GLN_.8&>DS'!3.A="+J!U^$5
M6*]MCI-D3AG(NEF[_W9R8TAT+\M/0BVQ0A2MG._-'2Y<B!-+P)N;B&CM>O@M
MV(K&K7QN]%6&PYD)-\J>;:\VN@&$I$@T\=9TDF,PC2I6MP*;D93U,5D$2C/P
MAP.]OCU!1DPUVC)$F^QMY+1,FI!R>>Q@K2K`M615!9BMR#OQ^4$61\Z;+=(O
MH>`F\KWL.-,\AIG&:B8Y4@>BWDE(V#J5I-[63,C<-#C*5LNBE)7AW$?Q0MJ3
M9G(#D28J#H3;:I@76HC_Z!A7MP+1&TI9$J9[9;KA52<6F/X@CEG]44*VUI#-
MZUQ<\AG4E<),RC"#P-C]*#Y]Y#@>811<[-01T*3`J@VS1+^0Y!4*@,G1OQ2%
M27/NM)!\U(F@!]F^UH$D=1KE!<X4D;7417!N^M0LTDSTXN*)*C3##`7#)69L
MA(%&ZS`)#MU.2#I>ZKGR"C4O$/&)!CR3#6>ZWN]MF],P7CANJ;!(FJ!<,K&6
M<)(K]1NC<7FIPCGY<^+#5'XAHGL6SE(F>+"6=B'G9J$752BB\.6_0PB+!4^:
M/V64%<GWT&4O4(->B>W#UR!]64/"8.-..M(MF&Y/]KL0^)JG)]_IU3'FUB;7
MZX^L2@)KI'EZ!7>^,2M].KMV0)6B6DQ"-Q/7;ZH,G!V%##E^LTO\9IP1"EG`
M;"&\X_*JI!+0*5>:@BNDU$<@(0-4/Q!?,$<#I6P805+.4!09"MA4=3AY\=>Z
M,+&AT,\Y4=)`CNQT7V8<&CKTA=Y;A1V4/!=Z,4W"CI*T(L\WH8=E$DKCL>,)
M`P;4?H\/771IJ=E#6702?PU?=..VA&"P$L)-89-,MJ02XEKA*XNX+-DR,`7^
M(H(H:L8O0W2`7&COPIBA*>/.*9BHY2JY4-.W%XXD^O_6?T())$G2;NZ;B3UK
M!O09)()$2Z=7HD@)LU%Z#R>DC\3L]G(G7I),I9(@;0[Y([[IN#0^;:X8<MX#
MUKC70@\YP9$UH7(:M'M#/1^8?$8FC]3548?Y?M_T<$"SW4+\9+Z@?H\S>G>`
M!`*7>TL\MHJ\OLH)CUO6=[I<6RWU(B2..ME[OD6A_S`/5-8:H[6WHLL1^49H
MJ%<>&7IW?INL0_W@(`L'ICO*9%;V-65+;Y1'R%*X2%*?3/^_4(N;J7$+KX*R
M!#;Y9E9O^1*$$FWKXRS7R_*+H**>G(2=S0/KT,A4+0M<Y?ZT(9N>.WD35?[Y
M\J@<VMGX'3<Z=-;K&]8`FDZ%[?3\K\!2[?>+,KY^05I?Y+)"L_',D%>ST/63
M(F)-SSQ!O8-D23O(>L]//O:?X").-LIB<W4:W+XHX4GIN62/-+$!Q<XS(UGC
MYT6S50)ZVOCW`U_B.Y/;RQ.U]&\7NC^EPT8&C>@^LSI^$]&$EY8;MM$E3VQ4
MENC,7H)YFE>^BR9L%M#LJ61ETMC@;1GR$[*AYI8;+V"]`FZO\-N%'LI/-"2L
M%0(:T0KB4NJ"T/^OPJ"]C9SG;JM4Q*8.!YB_47RF$,^#;Q['G9>%5Y+@IR\$
M7*`>9[W*DY0<D#R."$H]U#9KVI1J8-;'60`7XOP=Y7[^!C?P<^4P'WM5J3E"
M59E2V?7RG0VU#Z.&.T&$?,U\'G3$)<#*1'!TH[0DW`9/Z!&WS$/>+BK@>\+9
M-TRTU@LBG)6\`PKZ!*KS*GD&M4LS5N6)#SIF]&D884IN9#\M,]-ID6H/J-@;
MXZ1M0'-LK7VE;:A2#6'&5S8[K'NZB@)?;#4(U=+25AQEUFIGH$[`&0XE;0\T
MFU(;515N<?,*0<M;B_P--]@U^]H*"FKOD7.@68DZ@`^L?$5)VED6BMB!(2P;
MFG:>.`+I/=;LA,JYC8"-[+PBP_S<"*GL=5>"IA^0;FL^"?>W3#[PM#_)X=Z]
MRI+?=W5P<X)[J\H32F]EN;?*J;<B>DDHRPF5(:&X_O,CPETKA[PB@_>W5^+<
M,V33FB_`BO@WA^1$[K'&UM<@QMT]@F@^HRA?,@10]F0T_/,@A@'>'64\==P@
M*)43'TV3E,X/PJ.1560(-U&3'FU5(%T`B?/`L<O!C^8[2S7XOTKZ%,*[#K92
M<PK&TX3Z%9UK\M*K[.\8H,NB6+B+S)UKC[(S=G.'A^?'?\FTU0.-<MC="&((
M)$:MS&>#9R0>2IE0_<!X)H5"];T-[6<3VU1-W&B``JNI>>10$MN8+3M[D("0
M")!_B9BS>ILG.Z$R&W>XBH33*\FBD0[%;R/37+,[R636[M*^"']@/[W(<AE2
MXF>2^.1!75?N0+\7>0P;O9#,!Y!FKV08-WROY7"#&Y=</-V/\GJ[#UH$X0WM
MKTB_O?"3G+D$O.]!DSK7AP`>CHZ;S9&Z+Z#;VQUX\\H#%$22]?/OI%=-C^,V
M#+WOK]"I2(#9:>S$<7R<KP(+M'O8S*$+[,5C*Q-O/;9KV9EF?WW)1\I1YJ,H
ML)=$EBB*$LG'QPO#"`O1WGR1Q:XENX&H5,O35180G(F(Q9$2',-$DQO,5MC1
M0#Q?V<#$H=#JEBI0C$^V"64=4<R_1YFI&,Z5@!WG7$BH9CV;_"!3>553L;1F
MI[IZX[E90.>J5N=.BM()&3[Z.[TJGRMMI.+-6OM<8HT.%T%CN&]E2$1`DG4E
M.91R;TAP4MO<>2I)%:8'EBP7\DD9``_HQEPV'A5!.IGM(5/I.51CVPDIXBQ;
MA3S3=WUQMCSA&B.%AMY5+8PR8A36);Z#C'2I)F\O9Z5N1.7K'9$:PMZJ>91I
M=J^.OLU*BD;GM9'+AYS"D0<30L#.%PCABWKDB60.'SF^G_6X&K,/QYZCF]X2
ME.]"KD+UB(Z5=J:`.'URKN\)2;M<`C4CBADG`9&8'BA5(M'G*$:/^M]I4C]7
M9#Y5S\[V.^(8%D@+E<1--IO@S8-KK'SH%T7;EWE36+079M`"1_6`:3+#/9,6
M+F\?UZ<07%([NUXD[R"IZ":4L17J6B.8<F'./@L!Q1'04<J<ASM\/"HQP)\B
MF:`1)V.C8&9";%6@J13;2@4UA>L+VL;-H(=>1O+#^<&`;9/S`9XMC%J6SY!?
MZ<Q+S`09!XMXFT`$!ULFY)D0"`%K(>-"'+*`.%RRV7CW7^_OUX:B8?>!>]$L
M16.2+:0QX:>?)?/[[RP6+41N`3&$`.F0-541T,S%DC<C1E;:T7QJN`5],C<M
MO4,Z:_)F</,P`LCQ!*#HC"AL5=$R\']R">X9><N]211-J\0'.HQ^:1@%:!+V
MI(OUU,A%06'HR1Y*ZJNQK(;I?59Z;UC&(3JA8^J)5*9*[@%TJ>]%#_+%['_6
M#\+/KUN=[$L9")A@!&<7*M#HY#79I$U#N,OI48PTWQE]EEZF0KW2[4-]-'DG
MX\X+-(.YZU7`<1Q1U3&_\/%?5634U4=OHU,0I[M5J%QOGQEQCVGR46;5UFIH
M&;=55=$V?I6E5;3@-QJ@Y=U>;C7Y[(RW<K>2CUI$JD$H3SJ;UMBS.NY!W9P=
M^`94+X%IE-[I(NBWXE/HKC5TJ?2SD7O0%.Z3Y($7L):F\GE&.;B8B=CE'+PN
M2J1]^D.2<TX-$5$/$317Q9GLJV2,J`JM-!M\.KZ=#?'/9T,$M;/?*\<USDN_
M'_?*=Z)TG?G49K<V`=N08>/KR:#<A]X>=<XLJ7#I>;JB:4`C[/EB=:$2/C3T
M.:M%Z2?.ET1!83L9M-3*S["[D<YU,]NQIQ+5^UGF#CE\&I/Z%6I1RK[<[K'(
MH)H(D28,)B*#;]%9OE"CH@DJ2:@P8H57M^"46T=<AT7,W@8;F/PFN@$5*J:*
MIK1![X@D8/]XDN,+[L9?E1&CX62,9\I#8H#";NQUNO+3)M>9(Q5TKNQ4%$AX
MX,D-.%8BEIP)EVC;>-1U*M(/\@K"41'>;@"66RE+I>J@-'O0(R70`8HP4:O>
M4&&?4S8NH>+W4F7M5'\A^H$C+^Y2(X[DZ]%1_I-J<?@K($&T*/9'`'!^0CAS
M+<Y<(MG9*?!APD%!)!$K.D'ARR*HP`PPVT](]#_9XNTS=G*G66"/2HGJ!N<\
M6C:>1Z7Y+!3@G:.O;K?.B'&-Z-&3I=G]_'5[9U1SZ0<B=X2(V;&R6I4V]#@P
M[Z0#68>![YC>*8\%,?D>I(Y=>D2#M+V[N7P%7$$5_V_<6OX4;IW(IW`,]>1-
MVY2C$&(4`@;GZ]%5C75.:OO_KNK1)E;T_ZW7VL7Y0DD]A%6^#&K\8(U?0LFW
M;,':ESA?D:LZT'`35G?1K]6ZM@JC)RIPF],)U`:XX&"<M#NK^9@JM0M,/>:J
M*K.6P>6<NXO$,P]I*F[>-&3.=2ZPYMN<^Y"`J9R1D7>23G&+V&"L$=4V`+X2
MOZ/0D(+I+T5CA3_YX%R(A+1/<HS7T4RDV+>ZH9%5PVQW+:E']0@9Q"1YQ=Q8
M)7/20`!VQ)(I1&3LB<FGV@YX`^7\*K!%[+(T)C*M%C^')N]%:Y<[7>W4@H^\
M/==;R@Y**;&%4IB#Q=FW;@\PS.7:K1K_4(L=2$GKC[([W%-^6WF"7G6=9[GV
M5I?Q8KU60@6/)MS6_D,-)>GM9*+G]HV>TMG^8#6RJ.#134PU4,?Y4LH+F(=1
M1L[OL0`\Q["F>V*&;?G(N>1N9BK*E3^;_>"ZKS,71*+(MB/9]I=7AQU6+3#Y
M0355=?X@PQIJK"8=-U5\"SVBL),E.[$>%VIW2"GJNJB5NIB>[8SU;S)]-4L]
MXI+\TA'0LGN.8':6B4,S%Z:KS!?_C1M%<,`OP_:*PX@_3EOHFC^P0G=5_3D]
M%9"<QHCTY:3BU0(UI76P)G(BT38<1A2D\MG)%SO[N0KLVJNB<(Z#D42+$38Z
MF91;/2$T\5I.ECO]A9HZ,,#"I![,2#5.MR8K6CW?XOH]P&X_%Y#EC0=_46U0
M8"4\='?_X5\!!@`!KX5-"@T*96YD<W1R96%M#65N9&]B:@TS-R`P(&]B:CP\
M+T-R;W!";WA;,"`P(#8Q,B`W.3)=+U!A<F5N="`V-R`P(%(O0V]N=&5N=',@
M,SD@,"!2+U)O=&%T92`P+TUE9&EA0F]X6S`@,"`V,3(@-SDR72]297-O=7)C
M97,@,S@@,"!2+U1Y<&4O4&%G93X^#65N9&]B:@TS."`P(&]B:CP\+T-O;&]R
M4W!A8V4\/"]#<S8@-S@@,"!2/CXO1F]N=#P\+U14,B`W-2`P(%(O5%0T(#<V
M(#`@4B]45#8@-S<@,"!2+U14,3`@-C$@,"!2/CXO4')O8U-E=%LO4$1&+U1E
M>'1=+T5X=$=3=&%T93P\+T=3,2`X,B`P(%(^/CX^#65N9&]B:@TS.2`P(&]B
M:CP\+TQE;F=T:"`T.3(V+T9I;'1E<B]&;&%T941E8V]D93X^<W1R96%M#0I(
MB7Q72W/CN!&^^U?@2*8L#@'PF3EY7ZE));.IC*IR6.=`49#$A$-J06H<[:]/
MOT!1MG?+518!-+H;C>ZO/WSXRQ>MCM/#=]N'#]NM45IM#P^U2N&O5J9.D[Q2
M95XGNDIAZ>O#A^^G0K43":1J:H>'39JD:5JK;?N0JNW+PR_1]S]__NG3#S]^
MWGZ*-T521D_Q)HO^IN)_;_^*1@HV4B6Y(27TH:U)K"I-D=@"[:2H+U+Q]C\/
M99*R('W8*DM*LY(T.LFJG,5)_G8.DR6FKC5LW?ZPUJC3H)*_M*Z22A5E`?]!
M(PNE:E.`*5T5N)OG,IV4:5JH$FQF5N,"'5^3;IV*^8S-;X+XIDK2&@*YB%<4
MK<1D5<4AF[HC!"FIHH%_NCA-BNC0M8U,S#2A=A<>3IW,NWBC$QU-D_*N;^9N
ME/DISF#ZM-9V#BNPHX;S%-%+-XN$ZN8$9_X%BZG(SW$!_T5@%,.SZKNO<0T+
M7;S)DTP<DX$8/ZJ@UZ'28W`U`[OW?ONF[^:K&GGR@#\ZNM]]&+T3#6,X#CH6
M;,4Z,=&C<O_C<>O.(6(HI9J)$P^N4R>V+.WM%G*^!:U3N076D4=G[Z:IOZIV
MY/'`/ZBQ1L\A3R(,0LTQS:,>@E!'S>SV/%8[_KV"<S#BC2>>ZR;U=^>//'!>
M/1V]<ZS-!4./[#.DMLW`8\[?1*=9S8Z&BROD7N"R%+@5A5E'H[/O1J]>?#?/
MK!G"@?/M*"-*A3(*B[,:#^KS^(U'3;S!0_D9''Z.7DY=>V*O-L$M#JA9`FHX
MGFEJ<W83XP?1F]``G$I-)_QM^EX-(\_L\`<3HXS4A:2\:Z9Q:&@!PYI%5X7'
M/;$DVHSZ_7/\J)YZ.@C$]Z:7PV:2JLPD;'S5BVNF9->&$8(\T/V:R&.>32<>
MH)IN5F?GO\8`#P9SF_,)$TUQ09I(DM9`TAJ\XVZ>U'39\=S$?G9['G:-[]RD
MYE'MQQ!#\7$50W)/BZ/&6G9T]'&.!7IV,8!4A$Y9S*(YSCBU\&?DNU([%E)[
MV*.C<9!A,UQI0L'_&H3Q^X!;3%!PHCFG#F1,U/4QY_;*PDN',8$[/=*&1S4U
M9.*;8]T'5NX7M;1+W.AH3@YP[IU\N8&%&P@DAIF*A(T.XO&!?_>NY85)ULG8
MP$8FM5;S7SX0&0Y:))*^6=N0./#`T5Z.GMI!]6J"HW?.0K>X_9.D5[:DEQ2H
MY&8&Z:N^H^H?>=3XO4S'7*`\@H#)%U@K&2HRQC^1IW(LHYGF1!93SP:XS!!9
M8(WQQ(GU>5EM9M5XIR8W"ZJ&!5(8G'W5I$W)C>Y62D45SEI)AOX(J%E#3$!=
M26$E33OYG7$1@IC'&PM"20S-T$8VV)%6"8"30VFFH0ZX0S*U$#/JA*%'@,#[
M,!@#+,@_<Y&^=GP#?()Z[L8D95EE0;%=>$K4/,?2KW7*F]*DLL:^H0LW-W52
M%%FY!I8E&J%>&XR"CKA'.FE2^Z7+3NH)$+7M`0Y>-3V\NFF2R;;#7GY'"0"$
M96(^.:_NNG-@":IYU^[7T$WR"JYOY;U=HFR-M$#::2-P%%O%R*,#7IYTC[=G
MN*V'`]C5`2S4GW>'WK5S-QQY9M6L+&9Y:"ODWRM(U(6$6)=27%"K0'@NS=!R
M,1R@%4`68%]37T*KU51LF#(6X)C:,.X;>$69-,8FI^E_*I,7&@U[WD4@%E3Q
ME/H$-A&N(L1!1+U_`#QB^'$C-J6?`3N@H7"Q'AO:-:#AWQK>EG'BHB?<9;&$
M48GZ9VP)7W#B>"&]RY:!2ANZ.4(Y-?)Q1@\@$\"@O>$11:R^%4^VZB(%.U20
M0[")7,(V1?^AZ?8Q7PZ`SMB2Y(4PV@I&6TS"%]"$:)B)LT7$2R=F=(Z:Z>Y*
MZRIL)SE_=*24HI-!\V`;(_/":>Q7WNQ9V^(A%+D-DAP*.A"'`:T[GGA!W;DH
MP7L'%@EUCDL?Y72O@,(D65TR3)@\)%U:WG!B]QY.5(7Y8YQ`4GFK-'D?)=IF
MFF_D.>J>8]5!'F/M0"BAESID,%1T../QQT2KF9GR^"0;J)OYEVYR:N_Z[IM,
M^\<['89@X1(4E*3`(#NXL]+])F6H@8CJU*Q\-X$GVUS(TTS]%$D7]DPY!'XC
M#N%OBZ=I>B<WQ=@T\MK]9KSF*@HBW.7OENA@-!8A(%X'_GI4P=Y5X1N3*`NX
MK`D)&%3"<5YS588^Z!RV$.">7'MA0`+"C'0M7N#/!_@KWDH!^D!-WH#0()"L
MR*!E,HAUC'UASW/,"!F6(5\A/:3U&9L*$C\&@LG$4]BIH^KSTM5-%.@H%&8#
M#6T%K&:YF;5<RT\#PLQ6#`057X).[Z:`R>S<:T@N!9)S*QEQOA"']Q,<$E"C
M(;@0ZJ09\:#TG@BK7A@<&RS8+-IC$\&]%Q;B'5BYA7PW%-.!A/;TOZ/YX2@[
M!U$_AS>OIJZR;W@"02=#^N#Y"](GQ+TP]8USI(%[YWF@'!?H!=@&*BX[@_4E
M/:!C\*\HZ^6]!DA4%FF^KIW`#/.R6I!X0\^=YPC?.,B4`%]X:C[QS*VD,BFI
M#"\.:3#=BH4#&IN]N18I5&!F8NSI!0$?^M&>:;,ZC/2!9[)4A<1Z\;%SH,8E
MRWA#2!LTGACC#TD"#EQ9O/'</O-(\P\@.6\<@)BC7KP^I'ZAH<%V'L!3+F8@
MLJ%-0V,^+\0=GDXB>/9-RY^\`R&%QVP*WCJJ.9_%7_+]FZ/#[J55(L^_[3_P
MF3KQB05W?*+?8?,Z$\(Q+WS\CM>_H?1=6/K)[8374S>_!`J/Z>^OC\KP1$I9
MKGF@:0!5[R$U.FP.S<+B@P%(!F%RR#Q7:18\SG/V^*IF>+\2Y#+!M/QR):BD
MPL\C&MXP+4=$N_(6+UM6*QVSO;?J%O*&+KV!V3?\>&&]&F]Y!905`R7<E[!6
MQDAD',)R'7.".0R%:1"@">_E,K30TO4;GDN!DL+P0D2Q6\J-(E!GR8+Y?2=0
MO>:QHU]UA9D`/9!83*^"V_%S_)&6WE`-#>VMNGN2;%Z3C?8=LD'$Y(_(1FFR
M8O5V$A@P19TO7(/2'G.J_952_L(S\"!DA!AH-I3#!OOP7?FO:]GSWJ97S03/
MR57%8X#N2O+,E>992-2/4OWN!D.$`\$3!@4(M/0T-A?F[[:XA0M".8N<0)X8
M:\?+&M,F=@BQ=,>!8$4`7#5N=A.VL$SN+N6$QOR1V$JE:8DLY@ZV3#R^IB@7
M\CW3MZ,T'WC`X(=MK>:GFR;.4T3G9A*),VGS0GY;GN5=V``\L^KGB'YW)+S#
M6P6?:S$,CRT:_7KIR(YW>Y)CL(/?EI9'&HAG/ICB9KQX((J/PM(<:_Y*3T\G
M>\4J.SG(H=R!/#PX-B:GDV`I'DH`Z`JQ5W,!H_A=\&_];6G0NI9G#?7T`I2,
MAX^"^HR=DCG(J!]5[YH)ND??0=_&CWTW8=!'_$]=%>(JC```M%PQ`KKM7RAC
M\:4"YN`**SHTTDRG9M\,T\'QNZPFMDY@I#6][5(\NX"2G"7]_7>MQZ=>0V]!
M*JQ)\.;,;SPN)HO%E$7\"GPD-VZL(+?F-5G+%N)!K]EWGK;-H-#PP*.[1Z\:
MV?2>!/@UZ_]/>M4TJ8XCP?O^"A\A@I[`-OZ*=YK8V.N<]C@7`P(<2P-C0_?K
MGSS_8BLS2\;0_=Y,Q%RZD50JE>2LK"QO0%GR3>OU@Y)0"54JH59(*-NBXP:V
M'0.[%]`MUS3$:6IY(1F9(M;63F)(F!RK*`B@HTT,T2W"LY<RP/\Q/1D&O32F
MCM^ZI[5''KX_GC^Y_5X640_P.T74C9V"W0!H+6+:0%@A$KME30\I4H7T67B:
M\/9*DD)G-4@2RP^M6FHD^G70XI@5.5LA)A717A'M(]CGJ(1KG@D=R2[*4,]M
M^KO`4PA2.GYO<E5+&C,KF/>I\CXCX'%!.Y$NWZ6IN_$FP:-U>TN">37;S56E
M*W9T:NBF#[F*W%DX))$TU#6>-.A56S:G\%X3&*G*38W$P#\36=-%3>JO'K.V
M]L--F3@IJ6XUNR!42_A>1GZRUG`_@36%*N1<-.@3>5,4?*QM@N>IU=<87'Z5
MQ4;.3HD<?=?J)EPX??68;FR2<J&U9-%+!8DRVNA?].YPJR/<:L*--WMXWY$>
M^=)\W[UPF`J'@[T=@"/<$4*&NH,8%.U22*:$RM[FDX:Q7JRIIA+F6<%LOU`P
M=5UF/U4P9;JL/RL8ZR^=&A\DP,8K^@)7V&O0]@_JP>6*$U@$-#4'Q^Q!8VL@
M[<*,6X?-V76/M`X_?C24%%IK*MR;J8>C77?$B#'8AK6.#]N3],=@K=BTX>+9
M_MNET[LW*2Y[/*KS*4215OKFJ9IJ)FH*M-Z,,?Q(T,1FA_!ALT.('3Q;/$$$
MMZURX-3VGAP;@E<F*`0<^I:=GI@WDX%<#NXD*`WP^.HFV.@PYCKF@[5`8H7S
M[31)HN<]1+(B>B`.WSPD,3/];.V?FCJGP-.[;!Z>82+27+&-N1AIX9NO_56Z
M?%+\X9\I_I>[4#%JK:M8H_J`?#;VZB(X<_NWN5&JF!8*)]0<NPJ&Y`BC<0A_
M`U3H.XA[C>Y*Q%O/U=A<$4!5/+IPUB'KKHB*2JR;LQ![50;+H=1\<!V)B9'@
MFR[546$+OVZ%1%I%@LRI3NXF0F<5_6X[.:!064FH5+$#&*VB7&&0]^Z5MWH6
MG+P;7[C(=+GUC9T"`X)JL7X!Z,K-O]"5&KI*I_*4E7LE=*4J<^\RTLQ!3A+'
M5HH&(%>HK`T;S6J+,/9%6_DE)6?Y'6*[+R!6EJOJIQ"K<W/Q!<16\3M;1;&/
M9N7X;%`II6N`L8_D7G<R6%$<]::4]U+"1D=I,7$=%5:ZB@H+FY=X77.)[WVU
M[_Z";WC0N+T:@C7CECX"4F72(QC4[ZOO"=)!IN`-`;V+<NM#JO(AD\98"H]E
MN/8=9>1&!13Y,HK\G"*_C"G3A^'"TBI4&1LV)O,GE/OR((12``QG_'I$(_D2
M!4?KOS]T&7)ISERP$(;;6I.#>+[;:MBU?1<&DX2^Q_+IH%_V6L@!_CZ:>/,-
M"X#/"+K=X3O^V[>]7MPP7#N?.CW:'SN\.5X<M8=\KP,]2!]BR0,(;"+T\G-T
MI'A3>Z8NWOE^X<^=WR/ZRMS1]]I.WYSXV]BGL)"2W\YO;7_M!NH#/JW+Y2>8
MJFLQ`=1%<C.`%$7ZW`#R6&_1`K([!:UE4ISJ!]]\G&CYMAXTO]6\O@V7$H^C
M$8.8$(U[--QLW'`X@Q'9=KKS/FA\ML[6$>8!/_%66H^\M?3`=R#E8@9Q@\LG
MX;1O]^1+JPU[%^MX))HEFVAXD<`/X-T,G1+MD[C3VX666M%''_)VG.YP+R/S
MVA%KFMVT,KB=T:FI@FJV^#LGF#,=<M;TIIU&Z5^=IJ3^(I9WK,KR\!/OE\#)
M7@&=3]\4T-]CWPGY[K_2PR.W_D@/C^S\,BVRRZIPE?;[K#,46&F^'L-"%WU1
MD<O0]_CH0J'C`_(%,'KUB7&[TJ\"<QN@SSY:S#-VD[?NNO!4K0!T_`MHF(9K
MM]>PG>YB=DDD^4&;$+;ZU5F*5@"<`GB*>W-LP2H6\JO56%L7@\%_T@V))EL<
M[;D_WN0'XK;T9\OR.A+M?*4^K9R=)"!+BD[PU8K"L,"5D;_&<13?*P"*VC]'
M+VIT-D"&^,S_Z"+PMWD<DECCTJ::%I;8G&5E;,Z2]P/"!R6S_>"`))K[S7'O
M/AR-Z09=-<[;-[1R&DM8GEI%N0NR+)ZTBA5,.J*<0;E`*IMD,5"CF=!\H%"V
M#W;DL/79+=I!NUY#&=/,UA],&HJN3!HE'154]4NQ;#[Q=CKVI%DY`A?([6)E
M'TL\H=JQ)_`2[BNM"O?QR+6/Y+WMWKRD+_`\H1W"J$_M.:I577Q1T04'OOPP
MJ*+O6<WM9S-+QG+^`ET8:TNW/UR]>`"<;O3-*]TS%:3E+YGQ\3,93-7^X2LV
MJ,OLYVR0+NNOV*!(G0UB=EI&7F^NA$(BCH!>:94ZP<T`ZR6UTW3VFDQST5Y`
MR]%WZWJ@FIT^9>\..^XL,B>D&LE_3!V9]F[\P2\=0K*.7%)$EZ257<<G?]C:
MGA9)^![9Y!(#1KI!3_SAE^[Z2#1J.R?G)<?V??%7/%$6SA,HTEMFMKCB(B)`
MVH,!O+;LO'^B27(*[PDR*4<>F8VF<<]P"L3;+O),0HOVA$\4I]8!/ZVVFL^;
M$U/H!S1%*G`KC\5)B1QTT.^6'A[);3BT&!_EF^<GL@/$&R[@Q+5<A!YK?A7\
MM#.KL4-:?I(8KF&S//>L@H*%AGM3[X(34Q7>AMU.#;?X=W"#9'?FAI[L`WV3
M_!8&V1SY]T]C5?1$0:U5/=.&4W+1>LLS3O(GN6>(N+11S*5I\Y`W98RY])A[
MP_S.JPPB&@2M4IS3S/JQL-FC[%3.2J:-W0;!'O\D[-.EO@OMWKOHL(M;KZ;H
MZMEXS"C>&.`S9V:%H[%IZOBT^&3%[/6UNUZ!<`HHDYXO$(JOX8B#,&=UXM*'
M-PTZ:'[\&.;HA([HRS31A[N3.;#@_CVC:3*G,+I.5M9^AF0$G/&9;9"5^1?/
MO&RR)JIFJR7HF:[^@DK]DJFY&E\2%NTI/N/8$Y54(LV,Z_%)K>D,XSL;<GZ?
MM5#%\*#G_<]___5_`08`M[D'6`H-"F5N9'-T<F5A;0UE;F1O8FH--#`@,"!O
M8FH\/"]#<F]P0F]X6S`@,"`V,3(@-SDR72]087)E;G0@-C<@,"!2+T-O;G1E
M;G1S(#0R(#`@4B]2;W1A=&4@,"]-961I84)O>%LP(#`@-C$R(#<Y,ETO4F5S
M;W5R8V5S(#0Q(#`@4B]4>7!E+U!A9V4^/@UE;F1O8FH--#$@,"!O8FH\/"]#
M;VQO<E-P86-E/#PO0W,V(#<X(#`@4CX^+T9O;G0\/"]45#(@-S4@,"!2+U14
M-"`W-B`P(%(O5%0V(#<W(#`@4B]45#$P(#8Q(#`@4CX^+U!R;V-3971;+U!$
M1B]497AT72]%>'1'4W1A=&4\/"]'4S$@.#(@,"!2/CX^/@UE;F1O8FH--#(@
M,"!O8FH\/"],96YG=&@@,S@X-"]&:6QT97(O1FQA=&5$96-O9&4^/G-T<F5A
M;0T*2(FL5]N.V\@1?9^OZ$=R,:+9O!/[Y'B=P$'B&(C>[#Q05$MBEB(5DIK9
M^?N<NI#B6(Z]0!8"Q+Y45U=7GZI3_>8O_[3F.#[\:?OP9KN-C#7;PT-I0OQ*
M$Y5AD!8F3\O`%B&FS@]OWHV9J4<6",U8=P^;,`C#L#3;^B$TV^>'S]Z[?WS\
M\X=?WG_<?O`W69![;_U-XOW-^/_:_I4VR623(D@C5L(-&T=!;/(H"^*,]@E)
MGV?\[;\?\B`406[$11+DT4HRLD%2I"+.\K=S1$D0E:7%TNTO:XTVG%5*R]HB
M*$R69_B'1A$*S2;#5K;(:+6,)3;(PS`S.?9,8DL3?'S+NJW5[1/9?A.7013"
MRDT1A"4<25:0=,[."FR4IN*QP^"<7P2)M_&A+_/&R4\"ZU4=/KFW;[@GG:._
ML4$,<]*@]-ZV/%/W/-69BVCIQL;'R:S7B["L-)=6M3[*ZGZ0[Q</G\3;B?`7
MW\A^!QXUU7$V;J];/\N\V'A:V_-1#'FJ6'X0"9$>?8N#/9K*?(1H[,V2WQ"Z
M/T8GZI<#\%H8*DH&<9JINA>2QTD9:KA`6);G\>V:!*6X<AHDQY^KR0U-U9JF
M`TBQQ5X^C0_D>T_KCLY<Y5/1L2.O->[LEYB]R'#+HKUT8`VL/3M5/?'<HQF=
MZG6B8ZA4H':/ICZI?AT[SJ))4'AD)9T,D&=<ALO)(CK89\_4?3<-V#Z%97+'
MU!Y(2<RSU!W]6`X"J:GAH:-<,YTE\1P/3>:+K)Y.].\&(XV*9X&1C*[(M^KM
MS6R4.#U:P)XJV),X%Y]/O#WC!FI-/\#0B$!>8KBKAA><%1O4P$`D"$YA+(WQ
M11?>Z(R?>?V!_G<R`Z20THX[SH^P<AP-QT7*.*)90E>BVXM,)QU2]"PRKXPS
MEVJ\25R&2FR2(9&OW1?_9Q%!.'W14?G_XHN]QO&R3I2N]Q_,;+=.E7)EO#G!
MF3V!O3OW;%H6K5C73DXVF'[M&+F)[4^:DZVBW9:9>+[NV];54_/DS*X:CE73
M-1UN'C>9$=!BH)5!8"FB73?1D5BE12*-K`*.=<>+[DAOU0V\,/>:#D%%UIOQ
M6I^,^ZV!R3F\'Y+O>$?!VJS9IFO--ZL3T0Q#'J&E=I?)5*,9W'^NS>!@=$$Q
M&9'K=R^FK9YG(")WQ+E=1_\*B*)308>%XF+Q_(+)5W>$8]$FHWD-W,&M`7KX
M><')?"6\P5>D!W.3,C?XY'F1W,(W80)I@!AA$!N*//*:#8L[`KMQC`V*(HM6
MF2!1<@%-Z<T`'#GEF@17L*$T`I-S7$C[)%^>>B2JCBA%R.#YW.#ZI<T*<&FK
M'J^!GWJS5R%#>8$:+Z8_\`)*%XM^<^AO"X^Z!EB01D#X_8:WTJ#(BIC=58;)
M?)/QZB+3P,_A[61>.3L.B34!NW[#<:H[(OK-5XX3M9^]MUW77[O:G9UDN&G$
M368WV]3Q(5N5A>F"KTP371XKJ[\'9H&1V+N`XSS%+L"14>ZE5`32D]`EOY#@
M7L8%EL1H%_X2[[%P7>VH2<!$.K\UCQ6US2!:$!_@080RD!NK1$<FC!30LVX:
M.,E^[FXE]\Y^_M7J@R:E3/F>ZA2OKW\ULN`W45>?*NYV+'GD?S6Y[W3UBJ#M
MC:#GX+=QK`3]?&IJSD\GX,F!.Z5WU6S53(T3NRCR/DDJ&Z87<T)\`ITZ0&F"
MC@F9MADGMT="J4"U3*;1.@,M^VOP&-:9L\[Q5+6MN0S]4R/U$/FM&OL.M^*$
M(60"\(Z1FREO]U-3<YS`>O`F5TJ2I73;%5V^<D$4IFI"3TOY&#"&[!#RHP1[
M&1QH#OW!M;#$<<*&'===V]204"3/YRQLDJP0;Y-YJRQ=4JU60HRF\2)-<(;I
MI7F0>YQ.TFU&\W<W'%6,-W\KR1TP<JII63R\7NQNKF#+OJX<DCF3D4_FRJ&0
MB*$*::QJ&6GXG_(N%8U"^XF0>^$YSM\%!1%U*QW=,T0X&!+F;D$VM8D,"L0&
MVPB3@3/H/#/CJ+)KU\Q.3?+8KM/(DG\CO;\:6W+]U1`NJ$Z7#^IH\@0WYP;#
M2.<=526C.4M-Z_R0T@--($;Q7SURRJ6!_9T6`@I%QJ@CR`^<\H%$?U,N)?)F
MMG_M^MG^7$%!<>=^FP@;!'<I*SL)BUU+(,0]<)1B'XH$E)GC5=@]#?(X3%?L
M'BW:-<#;B=X3!>`]G3@HC>*]I.JH,\>^WYM#!5=13[3&099&^4IKMG!>.?/[
MG@K6GBRN<?08^0/NU,+#1HQT)&0)S-D991`7"/R[D)R+G=`6^E[KI=BQ*.>G
MYCQ748E<'?(X%^)NX0ZI5;DDXH&KB.&P&L%\+-R0C;([+'$SUITUT!_-78P+
M2K1HVV0HJ,>Z[<?KX(+[*L0&80&5/R;6]/\GUD1Q](Y@T4[5I$FR8[?`TO?G
M2]N_."?0^MU$"^;0O+`EA#+9,5/V0E&.F(%;!^'8U1LUDS=JS&]4IE9Z''#1
MS;-[D7U+ZFI9H&]0(@$,,M_NA/8,K9=U!Y$=^(G+_+F_J:Q96K7QOVQZ)673
M0N:Z]VY-M(O1=_8JTS+Q[E<KU'39YQ'@M*]9][OXIM0O#X7VY9'BKJIKA-0K
MC-=.GTV,W2@(4=%^-P\B@F%^8*("G$&<=53"J*=[A")S)$EI?P="LS^@]+NS
M=7MJACUE4=@'PO"8=-^U57,>.0UEA.:.7`084QZG(<HD8$-?'U.X?&K_$,_1
M7'/DNOF'`U\K$X7U7GQZB#H>&$8<F;(OUP`3,]1)IXQV:<UJ^7I8))D<>+!9
M*`[/,SQ>1?NU9C$^TL7-6\(*UC<:6<6=NJ6TDWC7/:9U_$CK=E?90>@LY5>2
MIT/M:F^$R-*>5M;LU6Q>1X77(+:?>MT1Z7V4QU8JX8TPK,PG3O45J]`SDOOP
MK$H7SOM.U5G.C]FA:D9DCYHNG/)\3$\G>:%LB$6JIALGVH\\20'(40)OS$_:
MU*Y(S\:S_ESCZ[JGDB7G+!`36HC0S8Y[5^E-+&!00$JC]87Z-Q%G%AMQ+UXD
MX3>J`_@I)B.]JJW8Z#/S,S^_=/5.YA&$R,.RY*1#:HIJ0!2DG%MB9C*U?0#Z
M?2HE>KV)X6LEPJJS.[[..AB2H,,33[QRKKA@3'&!D"B\H_2<],[8K)P[*CCY
M5`E*><DXH-).[^5%*]F4'K7:TH_$K4YR$I.25'ISVRVE+=H#B)Z+DA/GW5N%
M=>WVL\A4_?K*8BZV6.OA*HT6Y=*H[<M%9X?)S`??SP:WO%<_(O_.AI$SMS\]
MO$K8::H,6/>;'K%:38ZRD80*0077SS45IPMDBER**BF/9K2F=`/WQ52:%'/9
M3?'/3RBS=QQB!_ET>RJ?&GET]&-#;@TXI[?P.<7MO`>7&ZN,FRXGT(H-+RMY
M+^&--TVH(N=J*9%J*:5J20.2+YTNK;].<^V&"C)''K]#V:V$BN;C\/TR0!$7
MBHV<(MS2PT"[^FC)"54X]\?^2;J53S?6C/>4%4M6^3%CY7\`8Z4+8XGJMV?7
M[<]4<3*$>X,;`(8B?HL2\LT']B57"A'(FR<[HGANF4\M'E0L\C\(*TMO3ITO
M+TMD]_?_);T*=MS&8>A]OT)'!Y@I8J=.[..TW0(]=X]S<1)EQT#JN'(\6?]]
M^?@H1YE)L0OL);9DB:(8\O&]?Q"DG8=>E'0!%P&[]CJM%!<Z`0-/K`X_".,M
M@BK^GOU>P[S%[R101I&8Z$O@E$E+%5[YA[JH4N&5SWF[B6+6C/.?!"N34-3J
M6?`_1TZV08\&;]I.KNGY;@]AV,W67KT[-I<'Q-7,F7D""-+W<9ZS%8"G:I9:
MYO&[[E-9=[!8-H<SI,L+P<R[/5\4$Z6'>G?BA**=-$<$65?N1KX0VQ0)`>QF
M:(ZDKB7Q2L(I);59YPD*Q)ZUJNH8SK-0A/9Y(>3DL<RT+T)P*`2X;Z)!-)LD
MD2(C+,ME_5[ZY2LSV`"'=+-<6,V!$#^6YCCJGY%;20(7HNQ2D9HVD*(VBT\7
M$)\B"VA6I5`5:M41?4F8.Q]<TDD70S_I_M:E;ERP/Q@**\:#Q1?LIL!]]H1O
M.MEQ">ZL7UO]?;6->@("D9S'3P]TZ=DV\%?H"?L%AX/6SZ#,:#2++EJ!$Q-=
M[OQ%C$D&/.GC`B.U-FM9N>=^_,VCW8INA?D^J:]O;L7#[EWM[JTLSA8O"V4\
M3\IB+@+VKSI6J/S%5"R@LB2R`@U15G5\'%I31T[%';+&-!9%W;![H=PCYU89
M2"$EZ4K#5$=>*7(<W0BG](/7>!:,9\5XBBA37(WR[G9];XX?=.7I*OX:=4,J
MPYDB;8(KEOJ:\_'@HKH<KJ+N*@4[O3=E%H-@A\[AO`]]!E\-4T*H:G^#@(WP
MGYTGHZDB6#D#.L]-`H5]8-.3N0B1;Y!4"$=[:*\`RN?$!L`^NT9`C]9EHQH2
M+*QJT5H)>L^49FUW^*1G"9L/>[X8GY.7KWX;1OL*;\6AR16<6.8Y7P2H@"]2
M:BU`RZRA.>79"P=>^UVX"-EGK\)<V&$X8[;Z>1]YTB2.&JW0UE;,=3,,?&[!
M:,842D[Z&YAE7,3/9BZ6+7%'T@&U.X!T7ZN2-E0-"K=89VM*(B/#Y*#_7NUS
MH0,0!<'%1JSR[D.J8/\#TYE)3O6_2$[:&.7-4H)YM`;F?8&W1?;:[CUG]@NT
MQ]]PEV7Y+M&*%1R&U:_!<D,Y21X3=\7>FR29]-XY<9AUWG9J+UX;#EIF6K*>
MVV-B\//M43U'1R\]^V:7^R)4WII%Y-+FBS`-6W23TK:XDY1/ET:Z<K6LR_K;
M>Y@[;50B(FC=FZNUYP'J,D+/\AV/R6O[NS:E!99*1W)_:/=\:YL`S03<*>E^
M+8X//=^.[5GQ4`>0>V6VM7T=G][9U[``5Q<:)XI`2NPPF>-2/?.5:Q2&HHW4
M3KDI4[2)U&'ST:C#=Q-]C9!5P(:D?=1U<D3`?R'LQ$N`[#+HA0MC>B4!L5*H
M[J.&18U-L[2;G&UK5=J]Q@&P-AJ,9<FZU\YZ"A&*[!)OH>BCW:2*M.J$:J[8
M37.!C'VKXX'3`7539=N10XY.BB#/6>01`I#^K%\4-]9HG5P)3)(4V#7#B_QO
MJ@%M2</CV#P00UUI8^D_R8B?>C.=[J-3$P^1J]-HQY4VO3LIP%;(#4SS>K:F
MB==::6/#ALY90.Z<Y[GD(/TAWD\7N:"A`.KFV=`3=$%+N=PNQ5/X"9U;BNLV
M),'ZR)]__?%+@`$`>>UCA0H-"F5N9'-T<F5A;0UE;F1O8FH--#,@,"!O8FH\
M/"]#<F]P0F]X6S`@,"`V,3(@-SDR72]087)E;G0@-C<@,"!2+T-O;G1E;G1S
M(#0U(#`@4B]2;W1A=&4@,"]-961I84)O>%LP(#`@-C$R(#<Y,ETO4F5S;W5R
M8V5S(#0T(#`@4B]4>7!E+U!A9V4^/@UE;F1O8FH--#0@,"!O8FH\/"]#;VQO
M<E-P86-E/#PO0W,V(#<X(#`@4CX^+T9O;G0\/"]45#(@-S4@,"!2+U14-"`W
M-B`P(%(O5%0V(#<W(#`@4B]45#$P(#8Q(#`@4CX^+U!R;V-3971;+U!$1B]4
M97AT72]%>'1'4W1A=&4\/"]'4S$@.#(@,"!2/CX^/@UE;F1O8FH--#4@,"!O
M8FH\/"],96YG=&@@-#@U-R]&:6QT97(O1FQA=&5$96-O9&4^/G-T<F5A;0T*
M2(F<5UF3V\81?M]?,8]`BH0PN/&XEAR75++LBEG)0Y2'(3A8PDL!#`#N+O^&
MK1^<O@;'4G%<*581<_1T]_3YS9L??M'J8;C[;G?W9K>+E%:[^JY4(?Q*%95A
MD!8J3\M`%R%L?;E[\W;(5#400:B&JKW;AD$8AJ7:57>AVCW?_=-[^].GO[Y_
M]_VGW7M_FP6Y=^]O$^^C\O^U^X!",A92!&E$3&B@XRB(51YE09RAG!#Y><K?
M_7J7!R$3TB`NDB"/%I21#I(B97*BG^\1)4%4EAJ.[MXM.>K0L>21UD50J"S/
MX!\X,E&HMAF(TD6&IWDMT4$>AIG*0682:]R@ZVOBK2,1G[#XK2/?%D%8@B%1
M"Z".R%:!#O.8#5:9<^,G0>*-]&_\"*QVHK&R+Y7U"YB?>5/YF5=W?NKU.#KP
MN2?^')BRA=V#O]7>@"1=[Z>PJ+K1A]LFWM$N3P[,M6]X<W_A.6^BF';P\Z#T
MU-E<869(P)YULVJ/:\J(5)!(\V<0F'E'&'9,R/^TU_%F:P\X8]Z7/7_E$LBG
M61BBYX/P5_M@[9A,<,\\*U)Q0_=$F_!5*=+`?SJ(<[0QFUTG8G==EFSWWAZL
M_>+K*"B\C>KM^<+&J.!"VCN:P8)86D'!)=DP!MJC)8(>[@*:XLK@@RPPB*G^
M?>&5_N9L#<IIKP;S,Y>.U(3PC:,REAA%-<M)S835!,U`'KC,\A<TCD':I'$)
M&A\-;:'&O;@Z1E>3M9]1A92,&I.JQ:0JT8&NIKT2)T6&C;V*V'6TUO(.J;MU
M^K)QHSD%"E8[3'7$:@^VND#FHRV:L;$<C+(`.@#'/Z"H\:,AMEJ>7U=[=+H9
M!S5<]KPV0-1@"!UXVI@>^`5PFVHR<U8FV63F)-6L9:N@2($%SG@0@LV//#O8
MEF<@`7>-3`_JV?2]66^./M:X(Z^94<FNI3`>,=M0"5EUNQW%2[_B?ITM3*K>
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MIU++IO<H'4QZBA1\IK#<#80>+^`QM3J8)07J?>2=GC]4>G,/K9IZKW$(1%.<
M:RAH<+8,$U>&XP6@`7_D<+)T)W7(1W40)6EZ`R]FWA$D:YK/M5VX8HQ*D>3`
M1B>KCU`#'_R8@A.5\<:&M6_5KK\0S>"'$,=PV?D6@C5"TC_+TJE<1"(KRK3`
MC'NN,R=@HCW*IQ2CN\?E#(R')CR[&=5`W(>B8B"@F-:G9D*5#H,``D3HS4R-
MF9Q2"B#YA2=GN(5]X3%5?2+&@H"#%G/<G6M<:A.M\*>>SY(?_)`*->L)_1O0
MJ3=I.[&!DB(T(FU`JP+&0E:06+0UDBW<";Z2^OU5A"20.7FL%V[,%L'A/#AU
M2$=.]5M/\(-!(L*^6'Q/#C?@<8V60"]#@!;>!3#9VKE9`.A1Y',KR!RO1*#,
M5TCVNN-+]6B20BHRF^["PQ;J#B$L=CCBD5XJ+\P95U7"I96`9/=*[<ZX=C-3
MB,IA5/="TK,K"L\*R:A$D&$$-$X*F;G3`YB%I-7$[X-H>;JJG$<;V`.[1J'F
M>3@+WU^EMV3>=$\ROQCKIGLZU%T4D@Z$'"+N?ZDW/EM6//*<'62ZX6Q$K7^0
MYH\YF,-_QY-^[IH1E+W=4=:_8%6&O@,'`R3Y^62&Q[74<<-J1]$BQEAA/2DL
M\?*A8U!DJ$#_(U`_-J<3]#Y*3T)+'X5"YI;17_/KH^Q_"-3?2)-W5OV]@2O$
M[$_M/1*FVI!K&(5$BRA>V-&]7L(8@Q#5HC"P`#$^>P!W;K(',B,)E\DS,UC6
M0(HV:DT/1K+A,D`^0&Y`B$$AS[#5?K'MZ^30X/NT6!19G8J`R.'\K\`W@G:(
M-H>V.QS-";*N]/@?NOD3Q#YF\)X0=D1OF8!:4RP-/J*W!;HTHY=*3+B8J(Q0
M'1!NTK#"=@CO$E73F0O3]4QW9!$]H_H(*BY_!\I-O!]2\6SC3V$=0;B417$;
MU]D4)H(*9XR:3<7[3]0!`818^M5(A>CH<G]1(K`3T9``-_0H]7,OB7Q>L[M"
M/'"B3W*H#-1-NYH[[1J2Z<K+?RM*\U6^79W4;5&:ZA'B(4$D:T"=)9E[$&+*
M.NCIT*G["MI4:!#H&-Z$6$?;TSE':&Y1\QJISV#772U9UMMO<1##)VQXJ!P0
MQD)[.JG]"LNKLW'HWTEV*-U/Z=TQ@?1[A/#5*UG8Y1NGH[N4JAM$^Q;<FBXL
MN0+<A7NR[GIS$$S:/E#!,?R^%.1;"TP^+=#C,T-)?FT^"#Z=\2J]0055$[Z$
M[HXH&2P?3SBT70'W"5-##H#:HA`J7V"C^B;69_&=@\?"O;NTLL^Z.CB]ZZG$
M7A9W$SI(BS,_#WI>X?MC\:$++>^O]E;)[46GH^6=`^NQH?<`76&^%]8S6EZZ
M8JJNH4-]]J6RYQ$+^V!',#RH0P95^()8EVI`FTF1+BJI=LQ"\>OW+\=FWT";
MQP`$6(R7+U\59,BU+,EOT!*.I!YO(`$8';8=('UL0V#GB*R,2)!RV"_9B!9+
MR='U)9T&2::7[229+JSG=P5@S;,%QAK>0OR%AUB'#P7K@J%I^'W$JG"-+8(B
M3^+;&ENXCN*,RLE1S`6QX+Q$E&-G=%-`H&B*VXG>);R4NF)=RXHI\PNN96O>
M]+01.@JG)V$KX=KTO7V2XY79\P#Q?N9=U;-I'/E!1!O1X:JJDVD0!6,^E52`
MNQN:6K3![B"MI("2"8VLX4,BT.TPLA@L;X*.Y`_'`Y7:K&,WG5S)5CXTP_[2
M#Q3\%@Q)B$I31\8)!@NU481B]07<BG:O0>,K12AF+\5,'"3E$EJ%N1,4"03!
MR!M4W7<$V?`-N<T(S8"[V)DQ/4L9LC,^X5(*.XC8@YMGI8:PSM(_\Z[4X>W#
M<I&(_^MAN5VG:D2]S'O7]+8:NW[XC0+^)SP/=@KC;&F(R>)BA[IN*HMGWK?#
M!5`$7)[`:D:P>)WG6V%'#\]P?GAJ9]TX%C]^ZI[<HQ%A$#SPT+S<OW+J7QT/
M]_P9Z85GFM:M8RAY:GF@,A>>#)Q2+<_8;Z!N#C[3]&*%A<[Q-8VC.R\8-T+/
M*\RBH\];6<0(SCTY<[*2HKDGW#88'A'+LG4-=F_DPI;6H'C)`7CL>.K_X/H[
MW\DTIZ^01N**</G$7"&:,`T+-KWKWN1-'E8,$JPZ2]L_-54#16MN^<I0/2!,
M(W"##38AC-[!$P<S7,6;,<Z`<.%%MJ_6]%06:R<3<8>,G_%$X2']*Z3UEM"V
MD)$ZHL9DK1FT+-4?U<F:85S@K,'0<0>0JM>PB&]E'NS*M-P#5GTU3255,*L,
MU:-,RH<A;0<(WO^07@4[CA-!]+Y?T1>D1)H=Q7:<..*T(+BQ0F*/7#Q.3\:0
MM8.=#)K?X(MY[U6UXTQ`0D(C3>QV=W5U=56]]]"*`[M'HY$+!23ZH8N8SE[5
MS$^]!]\Z%\ERZ]-4O!)`?W$!R0@[G,1B-M=4DV..T3V*&!"/BU8E']M:N?/4
M'EL@::O"UDC7^&EQACS/-C-037UA73ED>^.MU7C;CI44]^'IS8KO04G*7?UX
M99(M10%ZC8[P/IR>J'F9._6.=?."JAZC+A)=G6<O>-_D>B@IXK=G96:02/(1
MZJ$=6W#,_B+J8("@(!7`Z_6\V65IS]27CK60[,SUL!Y?H]X[YF-&[21NT#?-
MQ<,TMU9,UIP3X'X1D0B&%>D&686!R/+*TCX6:WGUGF'D'O!\O2O-&IM$B3A^
M55!/]N)IS\?.?L0)2PL[WQN6*S#_LK?WEID-U#WX])O)*@,9\P%VKCY]G%2`
MWM(#U(XZ"9_'E(UB35?:N$F'22E9-^"UI*T@XZ,P+Y#6DYOS`U47KAJ45S1\
MH<Q:FM!3X,$5JNH&N*JTQ=8;W1EF18[42L;P$^QG5MA0HP<;CX/DY"')0HY!
M%GZ;+@>)N\EW[Y-U#MFGP<%B@]ZQ4NS9!-E9V,SW,O3#%^0*N&3(*SB1AP+!
MJ@($PW:WJY"?'YX_?/>%IT)76>'/GK(2K)YKP)8J)NO7V]Q8;4LOQNDRD&-M
MNJ[.[Q)I[#?E7TPI:CJ`\[-/\TFDD;EA\I,OLPQBH(;XQ\73:(C[E`B]W0G$
M0I;/>D96)#>]08:XK```E"JGV%WE#.&+28@:&47=7FRT/BX)'/:?PI2_36^Z
M#H3>+<$H^R`MU%1VDV@LV&AGAL))@X!XYD&%2N+-M?IV(1G=^E!B__ECOBG*
MN]J<%$99>JX]RW5&X\(<0J=%Z^I?H_"CI:]-M.^SQEZL5M^P0T%^69JNQ:M`
M48Z$JKKK+JF<RG*SFP4V\:FRV'HY41QFNJ+3H`Q4!6&HU0>=3IJ*8^%4V["B
M3[7YYB3WD]E1C,EN#9^-!8VJIXLM:80G+[[>K'7VEN9I%0ACU-3P++=ZFV,^
MAK/6N968HN['?5=S"6[76V\AC"],8Q/[V0<H0]@%`Y3$ZI?LB:6_A=-`+]<:
M'K2S>;/PYQ=E1=@O60*Y.*<1`3Z'ESA$KGQF^RC89+73GWSEVG)AUG'OM:*\
M%@706+!/[L<8?10Y<V;8L=QG='*G#L?9SC9Y[LL0]M%FV*I7.9Z",#N1G>XS
MW7ZM+5+GV3KWI]<MSV.@J3<Z+%<E3WU62HQ]F:1Q63`ZRQVO`4%_AK%?EX_(
MXVIQIX`*PX7_(("R_R^`5I,`RIQ1_'@9`+Z#(#U\&D%[]%@;NG=6HM6=K%G]
MNZ#9>?_]Y>*"XC?VQ,+8R5Q$/)"KN=(`ANJ3BY?>=0LH:OL5GV0@R9*#K[E9
M$8,/1Z7X]#C4(G23LH"2>0BD44D*J9ODCXA]/@M4/AW&>0L!09)+&>$`4+!J
MXD")0D)-*&&V)<ZPZ/32&AU!ZT">*\5E@3W0G@C$D>A;"GM3GY5+=QPH`4BU
M]1O\E**R<JE&)ACI4^;H5BS.#PYIA4%:(4A;I^D$-MT%OP0W>!2M;GR9&W*4
M+$Q>]CW;BTS4C`<L@9G:<B=%6&+1UJ,;.\NT#T9;Z79F?ESL=P06X41L+_.=
MIFDW'M5I40QI_]@FT\MI%]]S/$VIV;Y.WFPG2N6E/H&V\H(Q'Y';:_DFIB^T
M=-BV%[1+R#\]0K><17OZA.M`@C'^NER2)VB*8WNT!8.Q"H/]DW\"'C:P:?-M
MWJM_`E>J;7+?H:<MGH[:+H)FCS9?)..9C0R(D_P8[-M[[\Z3_[]S5>BO_`#A
MQ0A\Y[C-2ZN>9F/36A"/&[:"8Y'C7D\`GON@42<^DG:V(<7!]0X@O!S5<<.\
MVR5):6^WB,T!4>KN7;0MJX7]]XDO-K'52V<OAZGA%XL'$27%L9]0AZGV9&;>
M#)TZ0QSTQ+$>;.Q!_$F%M!*^\N4T(1-(M52.:/;^U1P8[=5M1Z*-?3!GS27P
MD<'>P\7VW4<M&_[I3+[F)X7.-S[X?)PMN^;S3:]>E[FW-V/[EC==ZKVU/Z4F
M79].WAK:IO;F?HR\M&/]YTC.:_-4A6N1#O+F&+[W+[9!,F(R3:3*`8&@DR_N
M]FW^9;G#@AK?K241REG+1S-`G,\)*YC,@TLT^5DW5U_&F]I/B%FL-E7B6-V9
M3!*4#&JL/DN'80/OXNC@GPY&_G'XU6Y&_E>;R9:'74'/$*(.'?K<A[YI+D@7
M$>*Q1V+4[@W84U'N9O(Q(11L;9/HXBEP,<?X`&QIH&[;[A!(GW=0&,!K)%MS
M.7-0-;=/4`-VL:EV]Y0^M;UUHM0@62T(?*O$DC(L%H?`QDN6L#&B7Y#P]6?-
M`;,(-5(+/K`@/G*20D=H.J/XFPA5]6P&&\1RI.OH6HGC%_ENCLI5\FCCC7A0
MOZ=LJ:RMNV>ERDE$=#1@QL`^['M[:M*R>#?W.OV-8?H99?@6!H[`9_0'_U@_
MV>_Q+7RMW^QY1M;I]QUTN_-Y8NNN'($04*@*D1B$"S\^#LO,ZH"$PR0'LJ2I
MAP&41FN-4R528D(7*-Q=Z4KB):%NC)4872'TH9!'XR*)!JVVV6Y&*.EMZ=ZR
MA.39Z3*<^E'$<)><E6(S-UB1E5HK3HW.,Q6%TF!K:5!8&JR9!H^06$TBAE2Q
M9EFFF%L3(9)S[R102M(L*UUVBM`N&:K#4"_5$G)K9PT[-P/XN7_E%Z0>\@U8
M_AL(@)490KDNLEF999-YSSBN9RAX>>V0&@&SF;KU%U()R@<OVCS?EO=%"VN9
M6=L^9N2!30U0PW+6I?K2^&QU.]!Y!!'?NK[[*+,_?/GPMP`#`+1`EOD*#0IE
M;F1S=')E86T-96YD;V)J#30V(#`@;V)J/#PO0W)O<$)O>%LP(#`@-C$R(#<Y
M,ETO4&%R96YT(#8W(#`@4B]#;VYT96YT<R`T."`P(%(O4F]T871E(#`O365D
M:6%";WA;,"`P(#8Q,B`W.3)=+U)E<V]U<F-E<R`T-R`P(%(O5'EP92]086=E
M/CX-96YD;V)J#30W(#`@;V)J/#PO0V]L;W)3<&%C93P\+T-S-B`W."`P(%(^
M/B]&;VYT/#PO5%0R(#<U(#`@4B]45#0@-S8@,"!2+U14-B`W-R`P(%(O5%0Q
M,"`V,2`P(%(^/B]0<F]C4V5T6R]01$8O5&5X=%TO17AT1U-T871E/#PO1U,Q
M(#@R(#`@4CX^/CX-96YD;V)J#30X(#`@;V)J/#PO3&5N9W1H(#,X-#$O1FEL
M=&5R+T9L871E1&5C;V1E/CYS=')E86T-"DB)E%=;;]O8$7[WKSA8H"A91`P/
M[WQTG=TB19,6B+!]J/M`4T<2LS*I)2G'_AMI?W"_N9"B%*?;(@Y%GLO<YYN9
MMW_Z9,UNN/GC^N;M>AT9:];;F]*$^%>:J`R#M#!Y6@:V"+'U>//V;LA,/?"!
MT`QU>[,*@S`,2[.N;T*S_G+S#^_NKQ]_>O_NQX_K]_XJ"W+OUE\EWE^,_\_U
MGXE))DR*((V8"+_8.`IBDT=9$&?$)R1ZGO'7GV_R()2#_!(729!'BY.1#9(B
ME>-\_JQ'E`1165I<7;];4K3A1%+>K"V"PF1YAB<HRJ'0K#*PLD5&MV4ML4$>
MAIG)P3.)+6VP^I9IVUC9)\)^-1U?%4%8PI#S<1:76%NQV!$6"E+OY%L\'^3C
MT-2F:>5]V\EO_^B70>E58Z,+NO_&7\6>&7715(?#XNI\R5^E@?6NKIK>5<.\
M1/RK28`7[/UZ8K?!R%F6Y&))UB&:54A%AZ9W&W#PS,.+^=C1VQ,]*A]&]/JQ
M&4@^HI4':9Z4"U*VF&G%0LL<>\<V*;RJ=V;<R[M3K0IO=#MYZ>G'LD5TRW1;
M<WNH._G2Q=^S%(._RND$B[&*RB"*R]2L;!#G><PQ0J',TK!@J8KS<!H:V#`B
M:A%^W#`$?AK$%'"70;V*@R)/8H-C>1DF$\UXD1UIX,,"GHVFJS:4NP@6"N3K
M8#T3CP(;I4L?A%,<D3>(]J<OS3"8OS?C?N^3VC!"3)X$Q]*#=RR$;]J=6?MD
MA^IY%E\C-F3!LRP]^R96%G&4"X^/W1/9-(9GTR`1SPY[74+@^1GBF+\&8IB0
MU\;!/,B:XTO#:-Q6@CH&!80&!+*>+IA.#X^5^!M+H/JE&97-<C4.IP"UZ60<
M%CR9!->0VE0OL`EX@Q6N;GN?LJ%[]&U$,3'Z<)VW)Y$SB+RI9,'YL#H8I3#@
MWO7.+^C2EN^:2F]5?.A93@G=$_,Z\';#3YA=KBECX?0=]G`D+\";&JRJ'P>K
MG8/59J*EM:6ZYR>W(2%AUNK@)YY9P\NWX!B)_Q/B"`MBJZ7',.+15_2DSZXU
M-1(I@1!;'P&0\VHOK^>;.T,7]D*P8G:TL%QUYEB]\`W7\AZA3PG371ZZ8VSJ
MVDD`X;WC)]D^]N3VSZS-:;H&Q]\^^KG7G?AD.W/OY,0ED]N#;T-O4DPL&FK>
M1]\$#,,Y9].^8G>S^J7G]NS33IRZD5#H!Y+E5]XYB?>JI=>W<K=9!--@*OSQ
M;;,A7"F\IV9)L]TP.0T7#12)FNLX`>^CA)KL'[M!:)B.5Y4]KI57U\X1MN*;
MMQJ)KI?UNFKIV+M.5:/G@]P_+#-C+9H\R\^X4!VQ1#B3S/;3E)(T##A99E\`
M=O(B^0;9;&HUKM<=RH`SSL\0RL^":R-"BX0<]]7(NQ\<TT-5+R*@[P(ILYE>
M(?3Z'9%BYT8DR)<&V-6[@7']1/2AZ(B"@RS?`8=,PYC9RHYI`1R$L$U;'<Q3
M)6RS(`W+,P2=F=(;,3V<G+D'`F54[.L]R4ZTWY@F<`$YB5P4<<Q6Y`_$MVB(
MM&$]W00'P+"HC*_A(-08CJ()K:O=#J!%X+HCRHC.T;'PUIZE)['.'#Z-H@UZ
M@*RXJ-/I1#U1?;1OJ,G!A?>+=A1W73LT&_EP_5R:L7-`Y=1JCBVCRTI%VI2I
M;X%@(@;J19A'"ZM&LXZE2#$KT+6.2W]K*'4S!N,51:E[<V4^<,HS>P$!<XGV
M_G59=D/I]50`2PVE%L)'MA]!4R'I3R@)$1Y]:GO9=^\YS%O9JJG7<E<U%W;.
MPJ18**@EUY:%QNJ_@73W/E3QWE"8X\M(I:>2N.\.&ZKI8X7U9[,Y<7K#!B.D
MRB6@2*J/XG1"=%J`2+1=^=9C%4XL-Q^0H&-#P?IADI>_C97OV_H"*Z&GD4J[
MOT!%>9H'AX:`T53!BV_!?0(C+:]NS)%_I;PJ1`HU-)F"D1_]5&D\5?V$/H1U
M`WK9&/:J)EI7R%DIWI&R(I.(JTCWV=6Z+#^*PM*'\,H%/2T-2WQ4244:KIC2
M*C!:HF.Z-`CHPB:[I36Z1;LRN(T1R<0DXI[U'R[1+9P'BJJNNY["`DW\O=<$
M8`*G^`@J+S!HZA&V8V<J1L"C0-JQ[YX;&(4R&2"!BS:%:)*$B.\LMTM`M1-+
MJUCP.Q#+N/NF$.5W"CF"TT8*>34%FE1O2PZ2)&DU,^@6!SH5"#HF_Z]Z;/1"
M85$6%TWV.7LSS=ZIK4;ZEMH7_G9#7<Z]?ZQJ_5R1>4J,8YMF?)%WHVM3:-UU
M\OUX/#A".TV>6+"9:UN4OC8+9#H+?#L*1$GZOXX"$S03P1^W6P1NPWCT1$.A
M:P&Y6FJYC(AS@"`?7,\O.S[6LU-0*V3WT4T0\%^'@QD&)BA>,[:CE1N(_DX^
M)N+R!18499!,OD>='I)I>GC06X*96@5BX#TB;3%_3H-)&"M*.M&=IDX:-,SI
MV,EKRP.(>]:-^B0O4I?H+2#W%:\'&Q7U,I)@*Y)7)SKUXBL#W?_AQ=49^ODU
MF4:ZT\/@?@7*G6`PM#Q2Q<T'I&C?,)A0I5QEWMV^:G=N^([7PCG^),9I9"!M
M&+NW".B<VFBIEB^,%H8!DL8\@C'B!D8UF/#NCK/XWJNX_]TXOK]M6C>Y*T.D
MO.(N:W--K(W8WIQ:?4,\KK@_K_1E#(S-]91$T\4QBJEZ?'/M,6ILRFC1,%#'
MQZS#7+/DAP_("+08(_^0'1,TE31AX,?<[;E?@J+<-KD?KBR*W$I3NZ`_JZ;V
MO/=-5Z,<RD"0TXQ`58!K+GUSJTJ=.UIUKV\Z:O=C;P*-)`BC9%EP+QOB<@*F
M!S=^<=(.4ZW/`VX>8VZL+KID!#R#$B>_)J8<X.Y(XEY2'P8N/*X!)8UM*)X;
M$2N*T0?893,83?*D6G)(J0-%)2H+"`G>T$M-6L<>IYW7BQA,%"8IL^2U("E*
M-27:%O(V>I*G.2J@`L4[H0;%P[3N]IKN!ZYJFRE.!BDG7R?[0N.XB+_I:-2^
M81HKE#UR`^G<R/'>\!-EG*IR*B5:FX-2F@`8&NF(^+D]\&(M)WF*DDDRFJ[Q
M))G*)%G*U(>]X:OYP`7EBB>?W6$VX6-;1Y/>F10O;D0`%4<8F^5U,T@_,Q'M
M6*Q$<O@3-$4GHR).P@E)%7&IH'(>OK(<D\PH\9$>N+38@().!]_XX>OV^ALU
M;N5\0R@-5QW.C/;3_%91P'*/:R7N$0D\!+YP;P6HDGY7^QN$Q8M`$U`YS=-O
MYPE)9"+-X46M]9RH?5>[@<-J@"5'L^UZ[-)LJ%,&"<YP-8^@:9#;:(F`4P8S
MP_,$>LY"@!GU:FU].'%#7_'N49+XV#<#+;I*QL8.HO73-`,9\M!^@QFVG$MD
MLIC72F]+/[!\U<KWBW%/\N9T99S&M)*L6O7.4(/6Z6[U(+_H$0_-+WH3'Z/2
MQYSGKW*"U(TNS#N5XDGXO>&274VR2H5#S;G3>1'E30='"<![G[I[G3-EOM.#
M9$?R7W>2A=$<>_?YI$>;VJD\FA>-?DQ]VR3<-404$T24"L%Y`!?%2*-[C[(@
MY\S3SC_RI*IL2=A4/VJ4G&3>ZMJ!YQUPWDP]<4Q9U&[F-SG_'[ZKIK=M*PC>
M^RO>I8`,.`))41+=G!PC.?10%&V.N<CTLZU$%0W2:J!_W]F978GZ0"\2R?>Y
MN[.SL];,+-',_(6WTE>_O&HLZ:_3H6FTR6WZO5L;F5>J/):97/%'?N%%N_%7
M+X+(OOG)%Y^TY8IO-RANJ^V>+VG5GIJ#J_`T;?(C0WAQQ$]/+8T]V="'LH:N
MGDLDG=+!);(#K;G/%GE'6QL(]V)4DQ"%W1L+R_X@.(UX=,OW54!:-T2O>4@&
MU*/.4V6EZ3WKT6+RJ8M.J9D#PJ.\/_++TJFK9[B[/OCE?M/">9_(96PE*IL#
M=`^"=88A0T[D,_.N;OZ8IP[8.)2=1E,?<RJ.KHKE6)_#WV3=->3BZD5?R*8^
M2B+UB7N7YQ7E^7JK9Z3F6ZPSF;!/D:Y*[PL-%IU"V;A<2`\@S:5*P<)RFY[8
M>4N5Z8L^66DP:3ZU+"H91N-8"B8K%)B#XE):$V/;^#*;?$="15TQG,),25?;
M'">MN:E>DT[PB^3@`+>`'&"%X9Q3F])IO`U<#?Z`3C&8,P?_;<U+`TK'D,XX
M.*^/T&50]N<S_H$1\T!OGX_$?,"VNYP7/;H\@K\,EY?%KXFMH$DP&+V0T1`1
MTOH+:GV<\2-K./V[VO!A%_-BN7_7+S51A4FU%W^(+OV!GM=\V(JRM$T:J*S]
M<!07BE?C.$2X>[XY&O4AK#JGXD/C6;AMPZX-*6!AA"<%!05WSTC?.HA^HH]Z
MY1?AH"607N6$ANQ5AA,:.<%@M`N$V/5G!^1N.$N_R$D>&UME2V9$:MCU&GCR
MZ^EV9O),W&01N2,,J:;2TTJG"^2:0J2CC\TR=<>IFB9#I.IBX@FN-<$/C/RA
MAUY.DX:]`'<&(X09V[,L/.VX3%XQ2*"?NZ*.($FR*3R+*7PVG\QB95EXLS:M
MT$PY:&T^-O_Z?;0WK(=<NZ!3/M:N%!XZP.Q]335I-=7DVY]$:H_Z;`U0?K)N
MQKZ_=R1=]D`:3>FLORMHR,+TVEE?`IN:.%*]AN4F%28;CTPI88];;ULE11^]
M<_7@#SN]/WZW?R0^A-\[U:6O9HIS!92F[[WI?IK^:SO?^DE_:VOM].B-#@6K
MOD1GU&:?G7WJ^V\VZSR.Q;2N[TI5D6I^&<;)"E)>T8GX08?-JMFU^(4SIVCQ
MRK'.B]2=5>[+^S>6$@`.6)]-5%]K)!9;Q1NK$42P.E<-@BN]8UV@B%C'ZM(5
M">&R%E4DF?/[O`DBKB<']=D457VE/#FB^CQT)TFOY(PL0SEQ;HBDO<H,*DWH
M2[45.E*-']@!>$%_I&\=<^XYLM!P<2]2:34T4J>\_(7:;PX@=2OD!QP<HJ61
M:"DI6CY>I#$T)H(U5A%,N.41`(_7`-`LJO\'0%E4XP3V9"H7LWF(DIS^_OR0
M7J5WGG*[L:*PL!"J=[.<Y7OZTO7>UNGZT+IW=3$&6!7;S[U`?_E0I_S\;$(?
M7@`=W!(A<_B%>3:A\N`%[(TNFDUXE:UE'Q!%23A7`B.Y??W>!+#2SSH<Y/7P
MQFDFYR7,_'8C%5&,6#%N9;8MC3.0H</P$4062/W\]9?_!!@`PG;>P`H-"F5N
M9'-T<F5A;0UE;F1O8FH--#D@,"!O8FH\/"]#<F]P0F]X6S`@,"`V,3(@-SDR
M72]087)E;G0@-C<@,"!2+T-O;G1E;G1S(#4Q(#`@4B]2;W1A=&4@,"]-961I
M84)O>%LP(#`@-C$R(#<Y,ETO4F5S;W5R8V5S(#4P(#`@4B]4>7!E+U!A9V4^
M/@UE;F1O8FH--3`@,"!O8FH\/"]#;VQO<E-P86-E/#PO0W,V(#<X(#`@4CX^
M+T9O;G0\/"]45#(@-S4@,"!2+U14-"`W-B`P(%(O5%0V(#<W(#`@4B]45#$P
M(#8Q(#`@4CX^+U!R;V-3971;+U!$1B]497AT72]%>'1'4W1A=&4\/"]'4S$@
M.#(@,"!2/CX^/@UE;F1O8FH--3$@,"!O8FH\/"],96YG=&@@,S@U."]&:6QT
M97(O1FQA=&5$96-O9&4^/G-T<F5A;0T*2(FT5UEOX\@1?O>O:.P3&5@<=C=/
MY,EC3X()=KV+M1+D<!XHJB5Q(I$&26G6^1G9_.#4U10E&[M`@D``U6?=]57U
MA]\_:;4=;CXN;SXLET9IM=S<E"J&7ZE,&4=IH?*TC'01P];AYL/]D*EZH`.Q
M&NKV9A%'<1R7:EG?Q&KY]>9OP?WWC[_[_/#I<?DY7&11'MR%BR3X5H5_7_X!
MF63,I(A20T1HH*V)K,I-%MD,^<1(+U#A\LM-'L5\D`:V2*+<S$X:'25%RL?I
M_%D/DT2F+#5<73[,*>K8D^21UD54J"S/X`L4^5"L%AFPTD6&MWDMT5$>QYG*
M@6=B-6Z0^IIHZT38BX8+.&Y2G:I%$>E8%]/Q.*?S]7,H%W3,-^(HSTWZ1EXX
MD?`!#>(FO,^4+-D]BJW.V?AW+R]]=ZKVJMNH<>?4T^<_JT]A&A7!3^'"1C:H
MPRQ*@AU/JG;K5-6NZ2B<*H/'OSQ]XKOD+P,B%<F<)>K!+*UAED[MFV%L6G`S
ML-FJC@<;_-,!D.?YJPJS0,8N7&C8^[I_5<TP'&5QS?_J42B<^*\*$Q"L'YM!
M/>UDJ7<#RBT72-2%EQ5(VUS;LY&T2)R7"4O\"!8",V1,].[A:;A50)',](*6
MT8&KQ^;D]J^WJFF5JVHZOE-U-3@:XG)5\W+7>UME99+-;94*YR(NF#-)G()*
M:638&&E0B^F_-N..5]2`[#O9YUT[GSP'WTXF3\'D8@K8_A$D(OO&Z`M>;,(8
M[@QC7P%17FK1QY/92&PR&Z36F]@BE\_,EGA?R"1<&#""H\F`C).`8@K<?7D#
M%M#6SZ&J5MW)_187Z.`E,H`@>9F!'PVD0Y%0,DQ90Q@3K-])G:+(S"^D#IA`
MQ_X`*I6+>DF>>_50('!F"@*O75B@W*KK51,"3FAT%Y@H^!)B6!_;>J1!0]\.
MOCE8%0CLJI/#_Q4M.=<J/@)QSC373$>M7ND$6T'&6_H#XS#W]A!JBL;0P+1E
MCM4^Y,0Z\GS'=WIFPVM"#H2O5$VT.N8J!%]XYOBT$\JJ[HYTL4<W9D)+>39T
MI9+%9]$<O$G^B]\$D#$^@*Q8&+ABW/>AAA#L=CQK5O(_#H@Z-"8#UAU/#F$)
M7[F[=Q3#DC[X1V@%06:"Z?)WKM_*N$?\0?DT9&IAWLU.C'1*3N0*>C6@$X2K
MD_3:2,[TM:N(5!:EF2GG,.PQ,39":K5WB!!`[PG2^I^NWX<Y&+1"NT(DK:,W
M06^@!F5P':.^C*>HM[/"FD5`)`T2?]7'/I29)'VW;`AQ$VF3YF_J!@T3,Q6.
M?5,C0K3@AXXJPGUW.+B>$KANH*9`/0]^Y$3?`O[(UJ2*SS32(8O3<R2P>6P,
M5B-F2W05.*IZ0;<&PAB'Z%1$$8,Q!N;;0`B/OF3A%8C5'JH&G>-X";R@)"/(
M1V!L(V/R])SO9R%BB496`</GK\#`!L<0[@3;6V0+O@,#P'(9$.83,FP(P?9U
MU]ZJBO9:ND)Q0Q64`5587]<A7X:LD3)TCX$5G"7',,L9NRUA-Z281E`5,3^"
M(/M;TCUAW1/0G<0C2ALNZE`_L7)2D<D)>6]9,@,]5@("O9,"UGMFD!)4[?=J
MQ4,I)FK3[)TO,[+U2ID,#H)D(X2@\UA+7V2,9=0O_U#UXZOR%4@HC=.M?85Z
MCITO=&Q,D7D&+B2X+TZ)T2QX5]>(718@>PT89<F2B`ZT"*8A(,-E`C+857=[
MFM=\I%5/7.1YNX(Z$+A=MP?TR:$<]`,DGPG^I;Z#TP`LCHDU]&VWPJ=_C\]9
MGD+0ZF+[D?J;CJ<G(E.!Y/V<P0"&!F6&'70^0&5'ISJ6'V3#`#R$&=6;*[EZ
MMW&H"JD38K#R`9:7K;S\S65)S%))$89X*7S4E<QK'N%;$A'V:BIY4I'4Y3WJ
M^ZA&R0)7MY/4(-Z3FR_]O*#V4GO\Q9$KL90B"#2JU:[V1?O,<"UUBBNGVM"^
MD"%SO51<(WV%]260_#.K=RRK,C&=UO2-A<\C4+4BZ@F">V:<@?!>W;%R_#U*
M!97Z_<`G3])>K+E?X$J_EM;@[)W$=_C/WC:W8N8-%^LKL7OG^PX(G0P[,M\3
MR#G?X#R*_/2MB/V5)G0?8&:GUE<BB^^\W=>N9MTJILV"N37W5>JEFE3E\]5F
M[J1>S?L9-YD\YD[RVLI$283S9C[.;$O[)Q;X+.BU66<0F`H$8GZ4;,<TJ'BF
MOB+_-#CN:4H:K=#"EJH`':UY[T@'U[P&NC<`(-,9=4$<H,%M9)])\3:/(;^8
MZ48`^!NP:AK\$6=E\$2-_@-/4%^\<F)BK&Y*Z@+//U5>,N;ZS>VEX)2@U/RZ
M$^8!*8PITHL@1*87V;OW->D=]IG&;_?TPA$K"`*6Y&@C=9V)TK%+AY13;Y))
MH>1<+3E7K>0JYOF"&X3A2-NU!*AEMUMNXAE\2I8%^U5@F0719>OBNS#+)?O7
MF[#T?VK"J"%)\!1V`0>@2"TYUGUN<"V"`-7O7^RNR%X9![`NH><@$9_0'!"?
M7PBO&379+PF!.!C%(MYB@@N*9V@/'5AHZ^\IA#HBT=)WS5?Q]/D6/>=^`*\[
M(K>FD^A?2^\4@J.)*4FPXXFC"IH&?*_?RC]JG[-W;'`;8O*J^W/`)>1\?K<D
M`62Y\)JI,9!CA`L"`1U3T!@0!S9*K[QF[TGF"X<0Y_<`SGUS=_'*B<\/TI\O
M?1U'26+US->E@`P%E?1^J-OAQ?L;LS'&7'BH&`G<E>/SR-KTHGE+/-%"2L._
M\>$2YMQ;@7)?=SQH:AG(FP;\V#=NF)^ECI^'V$[S:-94;X52")@[\H.J?".0
MG@02+:$SH6X5G>F;0HU-H;1YW..O9#SNJ$5$R7:\0N\EZ!0<-YQPU;6^,82<
MT;9X\^JT>H(/+5(<*HC@C.K,`@M-A+2@:OSWV9_]7YY@2]<?FA9>0A"OU%[A
MBV/!3PM\TOKWUMVV=_P*.P`4_CI`2*]L8C`7,?K$W>%E']I/9=9RF>4VLCQW
MG\_!ZE6`%_+$U=*:-K-^LN5]:J+*]YI<H0[-Z#OM[4>89+X3KOHUG09(6'"<
M=#T_P"Z[]N<`B*WXCHBW1HP++L5KY0EW)=<=R>5)MB!".1<!2*\AJ:;V&AMS
M;X,9'LQ?>=)/&/(`]1/D5GE6C6YZ\30#>56>/ZR;S-"_"ZSO!P)C)[='U6QF
M#Z;:/Z7D5=8@DO#*,+WX-&0'AQW4483K-4<_TX3@DE2D!A)9[F1_$BY#X3AW
M80A>QU.;QA.2#,_X?=!T?I9%5D;32XYDN4[8V`AJY#;S'>Y]UZY1&]"#2LP:
MXYP@2C(!9``K@6<J&H'[+?8>)]Y0N^HD@&T0BDL]3SP]\1,'M=VH5H@L`^3>
M@)JIU:OZOAZ[E:,G8:_T+;K'(,0]4S[^?(4=NN`.\LS'HW.>"PQ]"W;&)QE^
MU=-(,[*J+_(+"UUSD5Z_=4TR`R"H#OB2>5,=S*S8>`4G`,2Z`&T_=H\[\.6X
MJUI5#2&^"@"6R9_#<3_Z#-GQDMI4]']DN`=P3.T%W&>>#V(N\@$2?)]P_!4"
MPOV#8Z"!ERCF`80S)*:$2"7QF@6R$*$;M;>&3IDCPEE>)&>^/F"LD8!94LP:
MB%GBH;&.,A,S,3&!++"(/)84!)MPYAG,/"'@_D-Z%2NW;L3`/E]QI33C>$32
M%,4RDTF32;K7Q<V9HB0F'-'#$Y_BO\\"6%"4[3A%*E%W((C#`8M=VE]"HG7L
M^Q#[1'>!=X"ZSK=%N4Q,Y0%Z8AP`*@4`\3-V1ULXV<]E+?0';5NBWR.-]UX=
MN)<7>^[]O6CM$<<N=6>NA6&BM]LA*SGDW($:Z;OZ\G`Q3IG/WV<R]T2"-HLY
M'4@_*4D[F@QM;=](K%'S3`E<;L97DV!WZM3&VIU>52>ZWO[=V+_7I0RE&JIF
MN?O,#8'GA3<Q&5(;)E.$>X^^=/=)6?'";PJ5L-]<V:_:_2R$,IF5*<SG]8-;
M5;"R!+R^]@M'37SI%VHV_!:O:J4?C=2?=THG=XC8E*R37Z=1G*$=2:KUJ+;4
MK`NF<<>5P;;/&C/&I'+FB!;+<&YEM@;G-Q_):"U3</,C#FXZH%YM<<9OK7H:
MU:TJ+[<_1W_[1QG;'*WJY&!!V#X_+82_U"MFNVS+O/H41VIOEUM';JTC!3;F
MB267<>68(K65Z<,'Z:[&I]#%L6;B^$(D$I^//&&?OH-@ZL4T$Y'*M^!Q[B`-
M_ET'D2(^0KN2RD&5-FAT7$-[.("-2(,#QE8/P-UP;05(DE1P)R/L_!::/G;(
M<:9<2%M'=.T^<BV"=A^9/Y1C\727/\?#?$,=D(0G1(*P@Y><K\16$R=;23;!
M!<F^Q$_YQ67_)XK2Q^BY8J#O"=(\&)$M"U?YK)Q4X$-&+U(?P\O8QN9DW^D2
M[@US73^CTPABI"KNQOI<13FKJ%5).PKGKU?&KHPW2SD_:4$!)\<0T<>==&\;
M^GA]_*`*,G1$A:&ZE`4WY5>1Y[L2`-^H>3L?-,`BW%PO#5#;I0;E@-LI);GM
M8`^31>W(O1`FG(2S,/EC59DFR?Z_)LGH$?3KT`GGZJ)<:H&I@T+Z2F?<-7)>
M;.\&\U:YJG?D>K/LY9ESN.%YV:C'P=M85)%FYIXQ)"/J!D"Z<A`.47]-9O\=
M6J1EV?^V$XV'7RY*R.O5F,"8>DQQ-YLC'UM'E0?2&(>2II_V-QH4N?KVB8+P
MKC#V4)*?[@?(&<$P1>&"0[;0T02:)B$_*711@L%AACR4+F30!'PSVHMF"-S&
MJ#U%]7U6%T=0WT[Z?W83[(V3;G?+SX[MT5X=]R&A`G<VRC.DC#B_V^9+OIB7
M?K":C2^XJ@`LS=W*V_![0=]K>K7C`9/-8,]2DS0]VZ_4IZ(!QDRU^103BQU+
ML0\O!E!O%OX-\P0FNS8]A#31Y$^#/)F2E=(8:\+BL2SR^H.`F3]5D&Y+'4CH
M$B6NN6^/\A"-Z/3!9"S2-\DR:DG-QS>G>:61O)+45=4<7<+B=1R^:QXL8866
M&96.EM'F@Q3=2-0^EDQ1"JI+@\V"T7XX&.U+Q^&[:U-N4XU:2[@FC9AE$Y]/
MP]A)+F6T<;^1N;-;L04@4I5@<)-R%U<\C1?<`"<'3_(^T=EN%AP%!UW;3'97
M_*YE519Z56[12M*.M9/N98.C`M)%3;C5F.5?Z`DNG.PW&KO>6;Y!")_7G!&_
M?/OA'P$&`%7-1@`*#0IE;F1S=')E86T-96YD;V)J#34R(#`@;V)J/#PO0W)O
M<$)O>%LP(#`@-C$R(#<Y,ETO4&%R96YT(#8W(#`@4B]#;VYT96YT<R`U-"`P
M(%(O4F]T871E(#`O365D:6%";WA;,"`P(#8Q,B`W.3)=+U)E<V]U<F-E<R`U
M,R`P(%(O5'EP92]086=E/CX-96YD;V)J#34S(#`@;V)J/#PO0V]L;W)3<&%C
M93P\+T-S-B`W."`P(%(^/B]&;VYT/#PO5%0R(#<U(#`@4B]45#0@-S8@,"!2
M+U14-B`W-R`P(%(O5%0Q,"`V,2`P(%(^/B]0<F]C4V5T6R]01$8O5&5X=%TO
M17AT1U-T871E/#PO1U,Q(#@R(#`@4CX^/CX-96YD;V)J#34T(#`@;V)J/#PO
M3&5N9W1H(#(U.34O1FEL=&5R+T9L871E1&5C;V1E/CYS=')E86T-"DB)M%=;
M;]O8$7[WKSB/9%=B>'AGWASG@BPV[J)1T0*;/M#DL<6L3*HD)=7]&?N+.S/?
M4)+E)EAT40@0SV7N9ZZO/GRVYF&\>K.Z>K5:1<::U?U5:4+ZE28JPR`M3)Z6
M@2U"NGJ\>G4S9J8>!2`T8]U=+<,@#,/2K.JKT*P.5[]X-W^^??_Q[;O;U4=_
MF06Y=^TO$^\GX_]C]2,SR<"D"-)(B,C"QE$0FSS*@CAC/B'3\XR_^GJ5!R$`
M91$729!'9Y"1#9(B!;C`G_2(DB`J2TNHJ[?G%&TXD\3*VB(H3)9G]$\4`12:
M94:L;)$Q-LX2&^1AF)F<>":QY0M1WPIMFRI[U7"9I$&8V](LB\#:N!`I"#IF
MZ%^\//#S(/6BV2XV!)H-HB1-7PA]HAL%-DIS`,#Z"2C>]E-;N]%/B>S1W`F0
M2)THR+,PG:6PA3Q9$*9EAG>[[I[\)"@(-?,Z6?7^DJ3Q)MI$7BO_M5N8P?GT
M:-X_=_B.N%^87I`&GX1*A4J/FS7@!@A6]X^D>.0]^C:FSZY3PM4YF[YC_!W$
M:)RB*CE(!<#1IS?QS">?GC+WG!\QHX>9X5&2ZP?(YIRR=1V(F7%=;62%?P:^
M<_S?.%"!M*XQ>P4$XP92X$@-]]"R&)&W=YU:DA^!3&^#.">O/3Y8JK:/TA*V
MWVU9XS0H2<3:M=L)F[LG,ZV=^;GR,R([3+3M<7-8DQF)6>F9=@(?2^Z6V%(]
MA]GDRL86!=BTH_&7C%XUS>#&T9%NB=<LS';H]VVC6Y]<):;W7/<'G.SQ&1:$
MG9$[4#Z@5Q">I'U(@1A^1[=J8A'7U:@Z.=>1I<A&IB6R)?G:,I9G$KV&=FJ[
M!U-U#;1:1B4"`D:,C_Z;*!\)/^8S\IO&ZL!W_"2)!U^U'KT,WXP`$'^R_*9D
MPX@.*O(;ZP%F`QK]8&8:1.Y>$*IZ;!7C'-8)M@%M<3HR<#<^TJ/-@..(+[TR
MP"2T,D8J:;?&3OSNOM^<T>Y%A`.P.]D\*&HEFC5RUJA&X_A:3:">1T&?%\D+
MCPA#]8B/]P;OV>/5)5@V=4]4<J][K9Z5!['-*9,$26BC8V*2?(_LM)Q!EDE@
M\S@_Y<R7N&<50Y:QY!_AVBW,QZX.Y@1L`YN4^?'%XZ/P$83/(E(^]D+YMVP6
M2@6?R>R9V"WV=I/HL6:MWI.)/.<.U9-<G<6F32`P<OE)L$@3X_LI,'^C(L9Y
MB=*-Y3=.)"]R>EGSIO06Y`3T*!P@J[^;'(>9C;%(EA$685D^XUSF+R-G5N^O
M73N1CWZ>JLF-DD_OS;5&O1O:NOHO.EP^S$LV4712,%8%Q;';C1/Q.TX1K*I\
M`HY.,NL/%GM3X&M)^<++]3#-L"B$0I[JN>JZ^I/:-ILUC#5FKZ>I8\-DWFOS
MP>G2B2\/U89UONEQN-/+T6TDKGZ'[B>GI*J0LL=]R](2!9R+^CD7951-]]C,
MR;<=_W_A8*.C1#E$$O;L9974/F9OKC]\RW=B5>2GMA9_C+UIG(:*,KR)TXM'
M.";.2!-TPAB)%_(C2L)[4[&5\V_'B#WI^_G03O]VPT82]HNP/?4O,_OH&,5Q
M<>E]XGDQ/"^&YR&;_Y#@R)K,8L6G<81U8O)"E]DW13YFOME4L^OE['I#C^6.
MXCOVMM@P#W5*;BV6\,D;S2^`UUMXY87%RM_ME<]<("E40BI!G)LS%`NRQ+BK
MQ4O7ND>+%1/$VLG%8*H&W<F`@W$T!VE%%*45:*5B*NXL!`]4GK0%HA"6,I>1
M\UFZ/CM?5WMGZCE6F.2CV$/AN9L3#A4H4OK"8E9!Q<7.J0:E:##P[N?JN2P@
MUREV!<YU/_B<3!L<5W,;P9O:F0.0GK%BVL\.`#/R\UTT:O;48V3'5)D=FXR:
M&D?N`;F64P^?4:J*S!?OUD?23(0S(*@9_^('EY,/>;4PX=I<ALFSL4!'*)T-
MXC\^&Z0E9H,;GZ80":V"W6+B+W7/WQT3D"OG>"U2+8?OJGJ-EC21EI0Z:%EO
M-N;.50,U>Z/I#QTU^B.MOI"-M3NED<F>=:?1D;#:EKP[@U^.8E9335,_=.X)
MV]^X0^%3RC1W5?>K$^@!I^-OTCLY-\Y]*;7"T8LA2=AIAN6GN1$9IS7UJ*Q$
M3.3H=<@QO_:M7Z`U3;QI\V3:KMX-@SOK2HN4;'/9VD?VF&?47&2`'2<G2V&7
MP/]248/Y8NT,"VZHO)].OO98M1V^DXC'2E9*KE$`LM$7GUX!VTJ>P;B]$E)T
MTF"&I\(=>_MYPU3UQHE\NI'LFPG#_]V!DS_DP!*"Z2D$0?H3QUCJ-1S`I7>/
M3UW)X81=WTF+,+*K:+-`J>OZD6>!R.N:1_G2N#`N?.W9_M)2%BJ]A_4D<:R#
MCO9!EEL"0E=J"S_TS(\]>'62]R?N^HG/K7L002"CG@*P`IT)C%3$[\;?L[IE
M<RV7[_Y5LQZ)M^4)%HXT.EW?]Y0^J4&D^<RT<B1I,>;$F\C4)CMGMI70X+$A
MD?&'YHH!9UL_D9ZYY<G7<F:/Q3D8IFDK$'(;^3P)+#D<MCW('Q9D>;G1>ZTH
M3*=O(-<]/K72:\_Q@3OZ.B&=W2Q,+W<R9='EH0+B7O4Z4TKB"1JI#528+>YI
MX!74D;3,9OX==M^J!W,.B1*MT)@+%SK4Z1BG(Y^T$N:33!N80H<'&=9T_#37
M-)#H,#<XIX/E<8C%^+C#_3A/MBGY#H7WL[FU<>9\/J2*G\YC*,Z!K#`/.C@"
MN#&L<4RB\ZXZ'STYC>!2A;@3F*^<<"EZ:A4)$VS_;"C=8K<5!&C;[Y6XZO`$
M68&MAG.XN\70NP>MX5QZ->H;&>L`5@W-L^<Z2\;(^;),M,9(F\JQO79&)D[S
MIB<*P9$$A5]>)"^:LG)N`%9KA^E`^I/]W*[,[825B$1#TC#@]08-$>")'2F<
MSNU0I7W,.'<VOW9^HFU$Y!T8*/)`P$DGAN[N0?YQ(N40#'%,K@1E(DK3"3GO
MJ08>E2EU\$/AXQ+A/1&1)3_V(PF8H&YXS2.^DYFX''D*:QP-%KAHJ2.>R*&7
M-CSB&H&]QQPBC1?7)J\=N>FPWEQ!5;RS&$.G7D!*&\Y]P2='@2-]&O6(U[KD
MB$%O3OXMU8]74OT4EJUGN6G&_NXK%[:$'5>TD;ZOVF*Q'?1DKW2`+!.HTGOR
M^3&D0@MY<WN)DD@G37/:&[TAQYK[2RK;*NQ\-$G??*0V.^,EYA=VV85INQGM
MB/'2Z4\%,Z3Q,M<QHJ9I3GH+*4-KE"%FB,J)4M5)3!5SM:L&J7V-U,?=%C6M
M,X.KI70JU*-T8/CG^L"UM0*;N1!+AW^/FGHAP,>N04'>:EU&7=?K#M#F+2@-
MG&^D<$(R&L-4W/Q"$,!/9__.+23F#VMM%H3=6MC!BC2<:N-"?/J9&J580KY4
M"?)!6/8[_E:P)?Y-IRT`ZCW.[J`CFV.'^\%5G%UYCJCD[@[H3RH7R7NNRGI-
M-;:<AYZ4NE>Q0W#LS]ZMKOXCP`#\<.M7"@T*96YD<W1R96%M#65N9&]B:@TU
M-2`P(&]B:CP\+T-R;W!";WA;,"`P(#8Q,B`W.3)=+U!A<F5N="`V-R`P(%(O
M0V]N=&5N=',@-3<@,"!2+U)O=&%T92`P+TUE9&EA0F]X6S`@,"`V,3(@-SDR
M72]297-O=7)C97,@-38@,"!2+U1Y<&4O4&%G93X^#65N9&]B:@TU-B`P(&]B
M:CP\+T-O;&]R4W!A8V4\/"]#<S8@-S@@,"!2/CXO1F]N=#P\+U14,B`W-2`P
M(%(O5%0T(#<V(#`@4B]45#8@-S<@,"!2+U14."`X-"`P(%(O5%0Q,"`V,2`P
M(%(^/B]0<F]C4V5T6R]01$8O5&5X=%TO17AT1U-T871E/#PO1U,Q(#@R(#`@
M4CX^/CX-96YD;V)J#34W(#`@;V)J/#PO3&5N9W1H(#,S,C4O1FEL=&5R+T9L
M871E1&5C;V1E/CYS=')E86T-"DB)I%=)K]O($;Z_7]%',I!H=G,_.IY)X,&,
M$\`ZC2>'%M62:/"1`I>G47[]U-84)<<(DL%[$'NMKO6KJG=__ZS5:7SYZ^[E
MW6YGE%:[XTNE8OBKE*GB*"M5D561+F/8>GUY]V',53W2@5B-=?>RC:,XCBNU
MJU]BM;N^?`D^_./3WS[^\..GW<=PFT=%\#[<IL'/*OS7[B=\).='RB@S1(0&
M.C%1H@J31TF.[\1(+U#A[NM+$<5\D`9)F4:%69TT.DK+C(_3^;L<)HU,56FX
MNOMA35''GB2/M"ZC4N5%#K]`D0_%:IO#4[K,\3:OI3HJXCA7!;R9)AHW2'Q-
MM'4NSZ?\_-8?WY:1CG5Y/YZ2MB*M\X)5MCN#CJ(T<.J?=I@:-RI[&IQ3DZS;
M:1FZF_K:\[#I^#NU-R5#%\(+17"2$U-C)W?@L;*='UT&=R%S&!-EN:E80U\"
M.RR'_7/-J'YQPTFH#RK,@_?(VFNHX\!Y!H`VCYZOKQC_AA(RL/4<;'64%#HA
M2Z&*-*LH3DW"*GI_"M-(!_PT7(+'IS"!KQK/-BRB,FAIRK^JZV47&-X[5=.)
MGDAT(V\-,"N#&43&5=`X?6U#F_Z08MH=[=WX)-J(-F4N9$.0H0J45VP*/LV*
MY1`Q7B+T6Y1H"LO(!*"=!#X.&3T-_=P=1O6P`RH<PPR,.O.\/@,#88X"3/06
M.'%F\FKU5K)H+\_XK1O8/-QFJ/F+]:.#ZF6(CQ\P6D'!O&*/_`7W(0OBEA.;
M0:Q6*3@]V0R"<1$Q6:'`:,%.&F^%,=")PBWJ\1D%0"(R^]9$116GWOQ$Z$M0
M1*#\+,C\)1WS+1V9-,N^B>L[61-IDQ4KC1C-%#^[-Y0+N0+NTV"P/-TW;3/=
M%NXD@F/B*T<E$E]9D;)P/]H:=,+>=<'!$$*L!ST2!T=O^@Z<`H9'6B8%9O<`
MR-#]W].`W+E"8W0XG="9VU;MZ1"RF`2JX2WG'4OG>BV:SL78F8#)<,$8RX'V
M!&Y2,B94')HYDZ,!\#[./*[/LH;,E('E&W)0/BY$10T2SSGZ90/_(])QQZ.K
MI^9-3GJHX4?>;-N@E@VR`,Z:!_?8)UF>8[\0>(P+B909PZ\(#@[B`FRF[(7F
MEY8"KZ'?VNYID==<:-"M>6)I<HW4QR-P=J-C&`_HWSW-WEC53&D$H^4R!D."
M!/T10A*G9SJ]/J9^"5DY^,1P0L,"W20XT4E^@S<1MQ)DK6-:9&H:\:\"F)H[
M%K$[,G-#[2PM[%O`6PK!?E"-X`UQ;M=*.(C+@)?CINM8T[&$:O(4#^@T6A""
M?!0EGOE[DOE&C;)2RPJHKI<H(E>7U5&VT7\1=!_BC)T8YXNG9(PHH%T>RX$6
MX"(!O)ID&?V-'!]SKD_FCRB7&9'!*?<[0]6$\40#3H@8CC@55".9<I$)OZCY
MSA]!%^T?T!#,L.<%P8GM\PD0\(T7('C0W&TC@(KGK="6)=$/82HDDGM`B(PK
M8*6`R"0@LB7$W07S7!78VE&N.*@]^C4BTI;"&L>0*=`]\%Q#O^0><L;2O8Y7
M#O>[;KV.;FA04IR(,QIT1J3F.(8,Q5#&,93)2Q@<J8QYNU/7,\]KSF[*TGN#
MLR.@/#A[]TR=[F'PFH`2;A6L9+3UM)*L.]%B`_!5>>;5B5_F7R_[T?(-OGV6
MU2L?FEO1$S^#1MG]A5,,9M-*X+_NN[$Y0*Q/%)R@GP2A4Z/,E%"28`+EVU'5
M;3\Z*,]@>.G'L=FW6-2Y$.MB=!F`Q@/%P."=O"SS==E@%G0W_#:>GBE6<DX:
M\#WV_!W83W'8HM\;LA$':WX/UEQJ01I-O5^:)MOX?48#A'+,XR5G$2YOMA*Q
M.;I^BDOV[K[$_;/[%EZ$1-QW;`0+FQ7^,4H/RH%V&95?P2\6>%>,'#2)U.[L
MU.`1U6)AY!&[6T,YN,5E!<3]FT!WPV@*9GR"=[E+N]\#>"J!F2JC]7]%=I!H
M6J%T-SMYL!>\YB)U+P]W!S\X+3[(!9;79&S$&\".X$9X_S@#[AXA8X22@)7#
M5=19]+]475*^2>F5__G2BYG^$GSJN^U["(%3]XHLAG'03=\IN.+L7MTD(G)N
MQ'D^N89+D`3+**S%;^K58H@!;5[O^(/)7O4\/K*/0,DRJL&?$S)3B'4JN<+L
M"6#==I!7R'=\X0/N,?I834R5^-YI:6Z2YS:)/$->4M>%^7[V:XLX$*R-\#NH
MZ]!,D[^(+C0N5"3NEJ@C/IZKJ`H5QQ80V.H1SC&X0Q%>+RE8EM"?(:ZQP:`!
M+R/J5E#!Q]0I_+^N5/QY5]+IXO^5=(672]M`Z0>P^K.]0K-&W66'*1BRK?II
M'IKQT$#!T?N=9-'<]^I\2;9&2^>)6(/&!;-:`NX.6R*IYAG*!R`+@.Y-KKF@
MI^8L!^LDJ4BY*M>UK@K?!X):?Z-01K4G#&$IJ1VL50.(0%>*&`.0M*7,!$4@
M8$0:C*39"QV<D8X;E1VH`.5MSL@I(DG/IY@VO<DKQZ5"HJ:!+@.VTJL`>@F=
M=30ZH.NPX\`2]A<Z#OKEYI:R&GNEEWOEE=MU+1/'8L$SBT1-2BD]"]8,(BA_
M!XS>DI,5K4_^FK0S&0=KQ@$,I0^U594$'C96<O-(Y0059#B]"8`LA!U*40;^
MFAON3PVN(=ZZNQ&>F7\X\%M(-3$5,8#-GE&%D\&-%[E;`R+M'^BH$T][,M_;
MXQM"Q8F\_NJ-SFX(^!]J_B4-QSYXRK2ZES'3,#M*LY1'+`WKNA\./*1(@O[0
M(7!1'7#FE0V6,:KE4U=&1)U%956:_]2;EGEU+U]Z[@T)DBM:^0S4_^V&=ND;
M-ZH)V0[H:G4K?:KL-B&JHCM)CXD*71I7-`#@YC"JIV?J7AK9$?VW"$!RGM?<
M[0I&0+^[4=+(6MYIF1?_N-3S*WZ\SXO\SXKW*2S1FI5P<0-D:@**`AX!-==N
M@_IW%LK&VHZH;M`V,'GNYPF\Y>B\AG-3/F17LQ#/?6\`U(!AC)*>4B!(?@24
MA!@X@L6ND`#G%H""*:91K-<F6W'K\>EL)RK[B&$L8@SUAY-JG3U@Z"`A\`.=
ME&O;>SI&T@]YC&7`!F5+;[I-`#6R-/NF:EP$B\V2OCCMF4KJ]YRQ"(I3U=(4
M=`E;5U_5P2_(#[<@XGNY@-Y>08K[2M.9[P\-S4:.!%[CI9HH\EU>Z;N(TCN0
M+1FJRT#>.`B9R\P7'!=V/+GB4:C(F0&JV9YD0"A:/>3HZ9&KR8IJ>BIA]ECZ
MCCVOO<GE`W&P40#?T!4R&?5$W_U>,XEY%%'H4J?X>^2"X-[VH#<L5BP27W%"
M3<4M#.A-U?3M$12JX/7BH&*9'A?G`0"./6]#^KAY5TZ2+%FW.CXU)%6U>`QV
M&@CS=<\C3^V^\P&`*:/>,):,D1'.;]$^ZM>9YT-3G_E=X,F4>I60?5&=9.+P
M&_4Y+-!>F!>Y9.=R'2%JU:MTU`0<N(8GV=ZX(<`"GRSO6Q(\=U*_@N4+<#EJ
M':2M.2M-\PVHS"PE71F9/'D(B<?D6>:EM\9#]E,-.?WE,65P*L1JDI.;/SP_
M7L8ZUX!)(41Y@2HK&8+/_4%Z&?.V#4-!>.^OT&@O@45'MC0&1H$"!;JD4YL.
M@D1$`FPK$.TT_1OYO1UZ[]XC+3E!EDZ6*8FD'LF[[\[Q,B01+U1=4>>F-Y_J
M]]G3S+3MP48GX]OS["X+-;7)*RL,9VNPCY#5S$7@XT>\@P2[X7#P8]/CV/!I
M-,S@8"0#3)!`/V&Z[_/R0L_KA&EXJ[-3G.W21B@09`3S':2!HL#S5"I8%?2W
M'V>NMT,52C19)W+G81%9M%06+:^W9]3C5=3!+Y3!FFA^;+'C*`Q;TIY;`%-[
M_FVZDU(I1FFQ9E^I%S7F6J&54P508E-NT/Q7/3&]>@7(<`GG8#"7P[K>3@C_
M87DCE79OTX&##[G\W720@D'Y7\'@XA6<5SS#0OXJQNU,R'M688B:=U31$'>[
M[VB:]>CU8E"M;/U(P0X,B:_9SIQ&>SVH97R88V<ZNHFIX@XZ&I8;Y:E*AJ5H
M=N@VQ]@8-KR"_0G^@G9AN8+T`PW:#+,_=4E$\_QV:M]%&LA$5,(+Q84)1IP+
M)/"[@Q[2'Q&0?":0H7XYC!$+4.%B:N=5['AM7X"DX<E=A8"2[+U6@ZFW[:W$
M2_32B^/LQTLLBX]@:#!@9__BA8^"B$$V9?56$%T,:V(>,BG)9/(NCN@HA*X]
MN87%M71+ZL"TI@E!Y"#8HZ)"_D6OC3R=0B-2U;/UL/^C2N54J0K;`@YK>;O*
MIPN2ISQI'-1Z'KFF;[&6-$22$1@X!)2*#N=1"\F;)]X*OCXQ&7*1M"(VT'6^
M2CRXBOCV;7BNN:''$XHP:*?HC5JVII9)_X9,=_M&=S^$#7ASDZ44*Z/(KMZ6
MZ1RK'W%<@\^?]W(NJL7C4I3U2!"I:'D8WP>>ND*I"24[^A=]('NJ.:-'_VMY
MT9'/WS_]$V``W+V]4PH-"F5N9'-T<F5A;0UE;F1O8FH--3@@,"!O8FH\/"]#
M<F]P0F]X6S`@,"`V,3(@-SDR72]087)E;G0@-C@@,"!2+T-O;G1E;G1S(#8P
M(#`@4B]2;W1A=&4@,"]-961I84)O>%LP(#`@-C$R(#<Y,ETO4F5S;W5R8V5S
M(#4Y(#`@4B]4>7!E+U!A9V4^/@UE;F1O8FH--3D@,"!O8FH\/"]#;VQO<E-P
M86-E/#PO0W,V(#<X(#`@4CX^+T9O;G0\/"]45#(@-S4@,"!2+U14-"`W-B`P
M(%(O5%0V(#<W(#`@4CX^+U!R;V-3971;+U!$1B]497AT72]%>'1'4W1A=&4\
M/"]'4S$@.#(@,"!2/CX^/@UE;F1O8FH--C`@,"!O8FH\/"],96YG=&@@-S<W
M+T9I;'1E<B]&;&%T941E8V]D93X^<W1R96%M#0I(B:Q4RV[;,!"\ZRMX)(N(
MYE)\Z9C$1=H<BB`5>BEZ4!W932/+@.6T\(_WW%U2DA]M$!0H#$BTEMR=G9WA
M[.8CL%6?7579K*HT`U8M,U!2::;PEU;!2.68-X4,@57K;';=.[;HXP[%^D67
M*58MZ/$SXTQ4W[-"FA)8[D$6WFM6S8?O6,.D&HJY(+4J'`5S+*,44)*X-(92
M?>97==^T%TSDCL^;1;,6@`GYUV;+P%PPK4!A#!26*3%_KKTVTIVLOE2W5-2-
M17,M?:#T0U&MIZ*Z2$4_B)S.;G[4(K=2\^V./EC^V+/+%+H9TPZ]6&F4)\(P
M*^;7J1.5TC&A3>$Q#V/"T8/.YL.1'/MQMJ"#D<+$DHK?3XBKWAP6$2W86`-7
M`^Q9/V/SK63SNAOP"H6T-"V5_41$MG6L_;;*`$JI#'/:2VM8<-(9IJ3Q91G8
MMLF6)(=S$6AEI0MXII1`(HB4.0*!+8.W4[=>N4@]-<MFPO)>:(1#*XI"P.B[
MNNM%P*_Y;7S]V@J'DUW1ACBY>V$0_/-#BR/GFV6,+D?X!>(NCM#[5\$;,`?D
M26+V2+*1V1SC."DX)C\V"6.3(?6(+(O4XM#-O,8F`N\>!?'>M/$UM8+<B\`;
M)"'P%$I/E%=!LA!@P8Y\)6(B+42*Q3.KJ<Z]P&X,?Q8Y3?8!HS#DVBR7<6]2
M%VKDW)"3?I(%$-G_\]W?/%:JHP)NE"I1B8@NV\6FNV#ONX4\O120+AU\,A+@
MG8-3.S(2U70V2#_4S(?M-"];_J.)7K(53%C=P5?7]7;/[NL]&0OX&BDO>-.E
M?[LS4QGC\8IA/BE0FD`$OZ1+""5=K<:4LC"3-D$/BM-0C+8"A7G+R58(:E1%
M]8V`:+Y)KS6)1/.ZGS;<R$F+=VW=/Z5]#:G(\MWNU%4#_%*1MUZ#;\#+8([@
MG\N./!4TLG+FJ338Z"F?.KP6!0ZV1I<`W^Z18<./='^([;$_<E+3[?`K*5YC
M`=H]4(-TT.'-L.\/'N+RKHV'R;>`]Q.I^ZE)"<>T`RN_!1@`&4>$D0H-"F5N
M9'-T<F5A;0UE;F1O8FH--C$@,"!O8FH\/"]3=6)T>7!E+U1R=654>7!E+T9O
M;G1$97-C<FEP=&]R(#8R(#`@4B],87-T0VAA<B`S,B]7:61T:'-;,C<X72]"
M87-E1F]N="]!<FEA;"U";VQD350O1FER<W1#:&%R(#,R+T5N8V]D:6YG+U=I
M;D%N<VE%;F-O9&EN9R]4>7!E+T9O;G0^/@UE;F1O8FH--C(@,"!O8FH\/"]3
M=&5M5B`Q,S@O1F]N=$YA;64O07)I86PM0F]L9$U4+T9O;G13=')E=&-H+TYO
M<FUA;"]&;VYT5V5I9VAT(#<P,"]&;&%G<R`S,B]$97-C96YT("TR,3$O1F]N
M=$)";WA;+38R."`M,S<V(#(P,#`@,3`Q,%TO07-C96YT(#DP-2]&;VYT1F%M
M:6QY*$%R:6%L*2]#87!(96EG:'0@-S$X+UA(96EG:'0@-3$U+U1Y<&4O1F]N
M=$1E<V-R:7!T;W(O271A;&EC06YG;&4@,#X^#65N9&]B:@TV,R`P(&]B:CP\
M+TYU;7-;,"`V-"`P(%)=/CX-96YD;V)J#38T(#`@;V)J/#PO4R]$/CX-96YD
M;V)J#38U(#`@;V)J/#PO0V]U;G0@,C$O5'EP92]086=E<R]+:61S6S8V(#`@
M4B`V-R`P(%(@-C@@,"!273X^#65N9&]B:@TV-B`P(&]B:CP\+U!A<F5N="`V
M-2`P(%(O0V]U;G0@,3`O5'EP92]086=E<R]+:61S6S<S(#`@4B`Q(#`@4B`T
M(#`@4B`W(#`@4B`Q,"`P(%(@,3,@,"!2(#$V(#`@4B`Q.2`P(%(@,C(@,"!2
M(#(U(#`@4ET^/@UE;F1O8FH--C<@,"!O8FH\/"]087)E;G0@-C4@,"!2+T-O
M=6YT(#$P+U1Y<&4O4&%G97,O2VED<ULR."`P(%(@,S$@,"!2(#,T(#`@4B`S
M-R`P(%(@-#`@,"!2(#0S(#`@4B`T-B`P(%(@-#D@,"!2(#4R(#`@4B`U-2`P
M(%)=/CX-96YD;V)J#38X(#`@;V)J/#PO4&%R96YT(#8U(#`@4B]#;W5N="`Q
M+U1Y<&4O4&%G97,O2VED<ULU."`P(%)=/CX-96YD;V)J#38Y(#`@;V)J/#PO
M4W5B='EP92]834PO3&5N9W1H(#,U-3@O5'EP92]-971A9&%T83X^<W1R96%M
M#0H\/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.
M5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O
M(B!X.GAM<'1K/2(S+C$M-S`Q(CX*("`@/')D9CI21$8@>&UL;G,Z<F1F/2)H
M='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S`R+S(R+7)D9BUS>6YT87@M;G,C(CX*
M("`@("`@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*("`@("`@("`@
M("`@>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*
M("`@("`@("`@/'!D9CI0<F]D=6-E<CY!8W)O8F%T($1I<W1I;&QE<B`W+C`@
M*%=I;F1O=W,I/"]P9&8Z4')O9'5C97(^"B`@("`@(#PO<F1F.D1E<V-R:7!T
M:6]N/@H@("`@("`\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@("`@
M("`@("`@("!X;6QN<SIX87`](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"\B/@H@("`@("`@("`\>&%P.D-R96%T;W)4;V]L/E!38W)I<'0U+F1L;"!6
M97)S:6]N(#4N,BXR/"]X87`Z0W)E871O<E1O;VP^"B`@("`@("`@(#QX87`Z
M36]D:69Y1&%T93XR,#$P+3$R+3$V5#`X.C0P.C4P+3`V.C`P/"]X87`Z36]D
M:69Y1&%T93X*("`@("`@("`@/'AA<#I#<F5A=&5$871E/C(P,3`M,3(M,394
M,#@Z-#`Z-3`M,#8Z,#`\+WAA<#I#<F5A=&5$871E/@H@("`@("`\+W)D9CI$
M97-C<FEP=&EO;CX*("`@("`@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70]
M(B(*("`@("`@("`@("`@>&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E
M;&5M96YT<R\Q+C$O(CX*("`@("`@("`@/&1C.F9O<FUA=#YA<'!L:6-A=&EO
M;B]P9&8\+V1C.F9O<FUA=#X*("`@("`@("`@/&1C.G1I=&QE/@H@("`@("`@
M("`@("`\<F1F.D%L=#X*("`@("`@("`@("`@("`@/')D9CIL:2!X;6PZ;&%N
M9STB>"UD969A=6QT(CY-:6-R;W-O9G0@5V]R9"`M(&%C;#9K,3(Q-F9I;F%L
M;65R9V5R97@Y.3$N9&]C/"]R9&8Z;&D^"B`@("`@("`@("`@(#PO<F1F.D%L
M=#X*("`@("`@("`@/"]D8SIT:71L93X*("`@("`@("`@/&1C.F-R96%T;W(^
M"B`@("`@("`@("`@(#QR9&8Z4V5Q/@H@("`@("`@("`@("`@("`\<F1F.FQI
M/G5S,#,Y.#$P/"]R9&8Z;&D^"B`@("`@("`@("`@(#PO<F1F.E-E<3X*("`@
M("`@("`@/"]D8SIC<F5A=&]R/@H@("`@("`\+W)D9CI$97-C<FEP=&EO;CX*
M("`@("`@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*("`@("`@("`@
M("`@>&UL;G,Z>&%P34T](FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M
M;2\B/@H@("`@("`@("`\>&%P34TZ1&]C=6UE;G1)1#YU=6ED.F8Y8F9F-V(Y
M+6%F9F,M-&$U,BUB,V8Q+30S-35F-&-C,&0R8CPO>&%P34TZ1&]C=6UE;G1)
M1#X*("`@("`@("`@/'AA<$U-.DEN<W1A;F-E240^=75I9#HP9F1A,#8W,BUD
M964R+31F83(M.34Y."UF96$T,CEB-F8Q,F0\+WAA<$U-.DEN<W1A;F-E240^
M"B`@("`@(#PO<F1F.D1E<V-R:7!T:6]N/@H@("`\+W)D9CI21$8^"CPO>#IX
M;7!M971A/@H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@"CP_>'!A8VME="!E;F0]
M(G<B/SX-"F5N9'-T<F5A;0UE;F1O8FH--S`@,"!O8FH\/"]#<F5A=&EO;D1A
M=&4H1#HR,#$P,3(Q-C`X-#`U,"TP-B<P,"<I+T%U=&AO<BAU<S`S.3@Q,"DO
M0W)E871O<BA04V-R:7!T-2YD;&P@5F5R<VEO;B`U+C(N,BDO4')O9'5C97(H
M06-R;V)A="!$:7-T:6QL97(@-RXP(%PH5VEN9&]W<UPI*2]-;V1$871E*$0Z
M,C`Q,#$R,38P.#0P-3`M,#8G,#`G*2]4:71L92A-:6-R;W-O9G0@5V]R9"`M
M(&%C;#9K,3(Q-F9I;F%L;65R9V5R97@Y.3$N9&]C*3X^#65N9&]B:@UX<F5F
M#0HP(#<Q#0HP,#`P,#`P,#`P(#8U-3,U(&8-"C`P,#`P,#@U-38@,#`P,#`@
M;@T*,#`P,#`P.#8X,B`P,#`P,"!N#0HP,#`P,#`X.#$S(#`P,#`P(&X-"C`P
M,#`P,3$S,CD@,#`P,#`@;@T*,#`P,#`Q,30U-2`P,#`P,"!N#0HP,#`P,#$Q
M-3@V(#`P,#`P(&X-"C`P,#`P,3,Q,S,@,#`P,#`@;@T*,#`P,#`Q,S(U.2`P
M,#`P,"!N#0HP,#`P,#$S,SDP(#`P,#`P(&X-"C`P,#`P,30S.34@,#`P,#`@
M;@T*,#`P,#`Q-#4R-"`P,#`P,"!N#0HP,#`P,#$T-C<Y(#`P,#`P(&X-"C`P
M,#`P,3@T,3<@,#`P,#`@;@T*,#`P,#`Q.#4T-B`P,#`P,"!N#0HP,#`P,#$X
M-CDP(#`P,#`P(&X-"C`P,#`P,C(W,C,@,#`P,#`@;@T*,#`P,#`R,C@U,B`P
M,#`P,"!N#0HP,#`P,#(R.3DV(#`P,#`P(&X-"C`P,#`P,C<W,S`@,#`P,#`@
M;@T*,#`P,#`R-S@U.2`P,#`P,"!N#0HP,#`P,#(X,#`S(#`P,#`P(&X-"C`P
M,#`P,S$U-3@@,#`P,#`@;@T*,#`P,#`S,38X-R`P,#`P,"!N#0HP,#`P,#,Q
M.#,Q(#`P,#`P(&X-"C`P,#`P,S8V,3`@,#`P,#`@;@T*,#`P,#`S-C<S.2`P
M,#`P,"!N#0HP,#`P,#,V.#@S(#`P,#`P(&X-"C`P,#`P-#$P,C$@,#`P,#`@
M;@T*,#`P,#`T,3$U,"`P,#`P,"!N#0HP,#`P,#0Q,S`U(#`P,#`P(&X-"C`P
M,#`P-#4U-C(@,#`P,#`@;@T*,#`P,#`T-38Y,2`P,#`P,"!N#0HP,#`P,#0U
M.#0V(#`P,#`P(&X-"C`P,#`P-3`R.3$@,#`P,#`@;@T*,#`P,#`U,#0R,"`P
M,#`P,"!N#0HP,#`P,#4P-38T(#`P,#`P(&X-"C`P,#`P-34Q-C`@,#`P,#`@
M;@T*,#`P,#`U-3(X.2`P,#`P,"!N#0HP,#`P,#4U-#,S(#`P,#`P(&X-"C`P
M,#`P-C`T,CD@,#`P,#`@;@T*,#`P,#`V,#4U."`P,#`P,"!N#0HP,#`P,#8P
M-S`R(#`P,#`P(&X-"C`P,#`P-C0V-38@,#`P,#`@;@T*,#`P,#`V-#<X-2`P
M,#`P,"!N#0HP,#`P,#8T.3(Y(#`P,#`P(&X-"C`P,#`P-CDX-38@,#`P,#`@
M;@T*,#`P,#`V.3DX-2`P,#`P,"!N#0HP,#`P,#<P,3(Y(#`P,#`P(&X-"C`P
M,#`P-S0P-#`@,#`P,#`@;@T*,#`P,#`W-#$V.2`P,#`P,"!N#0HP,#`P,#<T
M,S$S(#`P,#`P(&X-"C`P,#`P-S@R-#$@,#`P,#`@;@T*,#`P,#`W.#,W,"`P
M,#`P,"!N#0HP,#`P,#<X-3$T(#`P,#`P(&X-"C`P,#`P.#$Q-SD@,#`P,#`@
M;@T*,#`P,#`X,3,P."`P,#`P,"!N#0HP,#`P,#@Q-#8S(#`P,#`P(&X-"C`P
M,#`P.#0X-3@@,#`P,#`@;@T*,#`P,#`X-#DX-R`P,#`P,"!N#0HP,#`P,#@U
M,3$Y(#`P,#`P(&X-"C`P,#`P.#4Y-C4@,#`P,#`@;@T*,#`P,#`X-C$Q."`P
M,#`P,"!N#0HP,#`P,#@V,S0U(#`P,#`P(&X-"C`P,#`P.#8S.#`@,#`P,#`@
M;@T*,#`P,#`X-C0P-"`P,#`P,"!N#0HP,#`P,#@V-#<Q(#`P,#`P(&X-"C`P
M,#`P.#8U.3@@,#`P,#`@;@T*,#`P,#`X-C<R."`P,#`P,"!N#0HP,#`P,#@V
M-SDT(#`P,#`P(&X-"C`P,#`P.3`T,CD@,#`P,#`@;@T*=')A:6QE<@T*/#PO
B4VEZ92`W,3X^#0IS=&%R='AR968-"C$Q-@T*)25%3T8-"C\_
`
end
</PDF>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
